BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 887865 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C30H37N5O4S/c1-30(2,3)39-29(37)34(5)16-15-25(21-11-8-7-9-12-21)38-23-14-10-13-22(19-23)35-18-17-33(4)26-24(27(35)36)20-31-28(32-26)40-6/h7-14,19-20,25H,15-18H2,1-6H3 HKDCZMFGKHEMQQ-UHFFFAOYSA-N 436209 US10590140, Example 1::tert-butyl methyl(3-(3-(9- methyl-2-(methylthio)-5- oxo-5,7,8,9-tetrahydro- 6H-pyrimido[4,5-e] [1,4]diazepin-6- yl)phenoxy)-3- phenylpropyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436209&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089547 439657845 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887866 CSc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C30H37N5O4S/c1-30(2,3)39-29(37)34(5)16-15-25(21-11-8-7-9-12-21)38-23-14-10-13-22(19-23)35-18-17-33(4)26-24(27(35)36)20-31-28(32-26)40-6/h7-14,19-20,25H,15-18H2,1-6H3/t25-/m1/s1 HKDCZMFGKHEMQQ-RUZDIDTESA-N 436210 US10590140, Example 2::tert-butyl (R)-methyl(3- (3-(9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- phenylpropyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436210&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098765 439657846 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887867 CSc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C30H37N5O4S/c1-30(2,3)39-29(37)34(5)16-15-25(21-11-8-7-9-12-21)38-23-14-10-13-22(19-23)35-18-17-33(4)26-24(27(35)36)20-31-28(32-26)40-6/h7-14,19-20,25H,15-18H2,1-6H3/t25-/m0/s1 HKDCZMFGKHEMQQ-VWLOTQADSA-N 436213 US10590140, Example 3::tert-butyl (S)-methyl(3- (3-(9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- phenylpropyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436213&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098767 439657849 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887868 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C29H35N5O4S/c1-29(2,3)38-28(36)33(5)19-24(20-11-8-7-9-12-20)37-22-14-10-13-21(17-22)34-16-15-32(4)25-23(26(34)35)18-30-27(31-25)39-6/h7-14,17-18,24H,15-16,19H2,1-6H3 UWBAZJQUECSNLG-UHFFFAOYSA-N 436214 US10590140, Example 4::tert-butyl methyl(2-(3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-2- phenylethyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436214&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089197 439657850 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887869 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(CNC(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C28H33N5O4S/c1-28(2,3)37-27(35)30-18-23(19-10-7-6-8-11-19)36-21-13-9-12-20(16-21)33-15-14-32(4)24-22(25(33)34)17-29-26(31-24)38-5/h6-13,16-17,23H,14-15,18H2,1-5H3,(H,30,35) WCUUWVSENCLRBC-UHFFFAOYSA-N 436215 US10590140, Example 5::tert-butyl (2-(3-(9- methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-2- phenylethyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436215&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098768 439657851 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887870 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(C)CN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C24H33N5O4S/c1-16(15-28(6)23(31)33-24(2,3)4)32-18-10-8-9-17(13-18)29-12-11-27(5)20-19(21(29)30)14-25-22(26-20)34-7/h8-10,13-14,16H,11-12,15H2,1-7H3 BEZMFFJBCSDQSO-UHFFFAOYSA-N 436216 US10590140, Example 6::tert-butyl methyl(2-(3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436216&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089165 439657852 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887871 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN(C)C(=O)OC(C)(C)C)C(C)C)c1)C2=O InChI=1S/C26H37N5O4S/c1-17(2)21(16-30(7)25(33)35-26(3,4)5)34-19-11-9-10-18(14-19)31-13-12-29(6)22-20(23(31)32)15-27-24(28-22)36-8/h9-11,14-15,17,21H,12-13,16H2,1-8H3 TUYPAYHVMIMAKO-UHFFFAOYSA-N 436221 US10590140, Example 7::tert-butyl methyl(3- methyl-2- (3-(9-methyl- 2-(methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)butyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436221&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089286 439657857 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887872 CSc1ncc2c(n1)N(C)CCN(c1ccc(OC(CN(C)C(=O)OC(C)(C)C)c3ccccc3)cc1)C2=O InChI=1S/C29H35N5O4S/c1-29(2,3)38-28(36)33(5)19-24(20-10-8-7-9-11-20)37-22-14-12-21(13-15-22)34-17-16-32(4)25-23(26(34)35)18-30-27(31-25)39-6/h7-15,18,24H,16-17,19H2,1-6H3 RKOOPSCALGUEPZ-UHFFFAOYSA-N 436222 US10590140, Example 8::tert-butyl methyl(2-(4- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-2- phenylethyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436222&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088990 439657858 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887873 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H39N5O4S/c1-31(2,3)40-30(38)35(5)16-15-26(23-12-8-7-9-13-23)39-21-22-11-10-14-24(19-22)36-18-17-34(4)27-25(28(36)37)20-32-29(33-27)41-6/h7-14,19-20,26H,15-18,21H2,1-6H3 XNEOFFCCTIGIKS-UHFFFAOYSA-N 436223 US10590140, Example 9::tert-butyl methyl(3-((3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436223&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088744 439657859 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887874 CSc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H39N5O4S/c1-31(2,3)40-30(38)35(5)16-15-26(23-12-8-7-9-13-23)39-21-22-11-10-14-24(19-22)36-18-17-34(4)27-25(28(36)37)20-32-29(33-27)41-6/h7-14,19-20,26H,15-18,21H2,1-6H3/t26-/m1/s1 XNEOFFCCTIGIKS-AREMUKBSSA-N 436224 US10590140, Example 10::tert-butyl (R)-methyl(3- ((3-(9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436224&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098840 439657860 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887875 CSc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H39N5O4S/c1-31(2,3)40-30(38)35(5)16-15-26(23-12-8-7-9-13-23)39-21-22-11-10-14-24(19-22)36-18-17-34(4)27-25(28(36)37)20-32-29(33-27)41-6/h7-14,19-20,26H,15-18,21H2,1-6H3/t26-/m0/s1 XNEOFFCCTIGIKS-SANMLTNESA-N 436226 US10590140, Example 11::tert-butyl (S)-methyl(3- ((3-(9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436226&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098839 439657862 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887876 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C28H35N5O4S2/c1-28(2,3)37-27(35)32(5)13-12-22(23-11-8-16-39-23)36-20-10-7-9-19(17-20)33-15-14-31(4)24-21(25(33)34)18-29-26(30-24)38-6/h7-11,16-18,22H,12-15H2,1-6H3 FSVBCPCMEJHESF-UHFFFAOYSA-N 436227 US10590140, Example 12::tert-butyl methyl(3-(3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436227&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088835 439657863 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887877 CSc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C28H35N5O4S2/c1-28(2,3)37-27(35)32(5)13-12-22(23-11-8-16-39-23)36-20-10-7-9-19(17-20)33-15-14-31(4)24-21(25(33)34)18-29-26(30-24)38-6/h7-11,16-18,22H,12-15H2,1-6H3/t22-/m1/s1 FSVBCPCMEJHESF-JOCHJYFZSA-N 436228 US10590140, Example 13::tert-butyl (R)-methyl(3- (3-(9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5-e] [1,4]diazepin-6- yl)phenoxy)- 3-(thiophen-2- yl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436228&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098841 439657864 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887878 CSc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C28H35N5O4S2/c1-28(2,3)37-27(35)32(5)13-12-22(23-11-8-16-39-23)36-20-10-7-9-19(17-20)33-15-14-31(4)24-21(25(33)34)18-29-26(30-24)38-6/h7-11,16-18,22H,12-15H2,1-6H3/t22-/m0/s1 FSVBCPCMEJHESF-QFIPXVFZSA-N 436229 US10590140, Example 14::tert-butyl (S)-methyl(3- (3-(9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436229&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098838 439657865 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887879 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C29H37N5O4S2/c1-29(2,3)38-28(36)33(5)13-12-23(24-11-8-16-40-24)37-19-20-9-7-10-21(17-20)34-15-14-32(4)25-22(26(34)35)18-30-27(31-25)39-6/h7-11,16-18,23H,12-15,19H2,1-6H3 NTNHTEUGMZGEGT-UHFFFAOYSA-N 436230 US10590140, Example 15::tert-butyl methyl(3-((3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436230&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089127 439657866 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887880 CSc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C29H37N5O4S2/c1-29(2,3)38-28(36)33(5)13-12-23(24-11-8-16-40-24)37-19-20-9-7-10-21(17-20)34-15-14-32(4)25-22(26(34)35)18-30-27(31-25)39-6/h7-11,16-18,23H,12-15,19H2,1-6H3/t23-/m1/s1 NTNHTEUGMZGEGT-HSZRJFAPSA-N 436231 US10590140, Example 16::tert-butyl (R)-methyl(3- ((3-(9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436231&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633066 439657867 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887881 CSc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C29H37N5O4S2/c1-29(2,3)38-28(36)33(5)13-12-23(24-11-8-16-40-24)37-19-20-9-7-10-21(17-20)34-15-14-32(4)25-22(26(34)35)18-30-27(31-25)39-6/h7-11,16-18,23H,12-15,19H2,1-6H3/t23-/m0/s1 NTNHTEUGMZGEGT-QHCPKHFHSA-N 436232 US10590140, Example 17::tert-butyl (S)-methyl(3- ((3-(9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436232&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098822 439657868 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887882 CSc1ncc2c(n1)N(C)CCN(c1cccc(COCC(N(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C30H37N5O4S/c1-30(2,3)39-29(37)34(5)25(22-12-8-7-9-13-22)20-38-19-21-11-10-14-23(17-21)35-16-15-33(4)26-24(27(35)36)18-31-28(32-26)40-6/h7-14,17-18,25H,15-16,19-20H2,1-6H3 GIHZJZYTYIZBKR-UHFFFAOYSA-N 436233 US10590140, Example 18::tert-butyl methyl(2-((3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-1- phenylethyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436233&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089138 439657869 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887883 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC(CN(C)C(=O)OCC[Si](C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H41N5O4SSi/c1-34-15-16-36(29(37)26-20-32-30(41-3)33-28(26)34)25-14-10-11-23(19-25)22-40-27(24-12-8-7-9-13-24)21-35(2)31(38)39-17-18-42(4,5)6/h7-14,19-20,27H,15-18,21-22H2,1-6H3 UWGIDRVKBCGDPI-UHFFFAOYSA-N 436234 2-(trimethyl- silyl)ethyl methyl(2-((3- (9-methyl- 2-(methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-2- phenylethyl) carbamate::US10590140, Example 19 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436234&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665928 439657870 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887884 CSc1ncc2c(n1)N(C)CCN(c1cccc(OCCCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C24H33N5O4S/c1-24(2,3)33-23(31)28(5)11-8-14-32-18-10-7-9-17(15-18)29-13-12-27(4)20-19(21(29)30)16-25-22(26-20)34-6/h7,9-10,15-16H,8,11-14H2,1-6H3 WHQXOQGSHUPQPD-UHFFFAOYSA-N 436235 US10590140, Example 20::tert-butyl methyl(3-(3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436235&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089082 439657871 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887885 CSc1ncc2c(n1)N(C)CCN(c1cccc(OCCCN(Cc3ccccc3)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C30H37N5O4S/c1-30(2,3)39-29(37)34(21-22-11-7-6-8-12-22)15-10-18-38-24-14-9-13-23(19-24)35-17-16-33(4)26-25(27(35)36)20-31-28(32-26)40-5/h6-9,11-14,19-20H,10,15-18,21H2,1-5H3 QNZAULXMMSNPLH-UHFFFAOYSA-N 436236 US10590140, Example 21::tert-butyl benzyl(3-(3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436236&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089207 439657872 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887886 CSc1ncc2c(n1)N(C)CCN(c1cccc(OCCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C23H31N5O4S/c1-23(2,3)32-22(30)27(5)12-13-31-17-9-7-8-16(14-17)28-11-10-26(4)19-18(20(28)29)15-24-21(25-19)33-6/h7-9,14-15H,10-13H2,1-6H3 UWVNCXYGTQKUFF-UHFFFAOYSA-N 436239 US10590140, Example 22::tert-butyl methyl(2-(3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)ethyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436239&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089050 439657874 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887887 CSc1ncc2c(n1)N(C)CCN(c1cccc(CCCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C24H33N5O3S/c1-24(2,3)32-23(31)28(5)12-8-10-17-9-7-11-18(15-17)29-14-13-27(4)20-19(21(29)30)16-25-22(26-20)33-6/h7,9,11,15-16H,8,10,12-14H2,1-6H3 LNEAZRBYLAEOOM-UHFFFAOYSA-N 436241 US10590140, Example 23::tert-butyl methyl(3-(3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436241&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088917 439657876 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887888 CSc1ncc2c(n1)N(C)CCN(c1cccc(CCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C23H31N5O3S/c1-23(2,3)31-22(30)27(5)11-10-16-8-7-9-17(14-16)28-13-12-26(4)19-18(20(28)29)15-24-21(25-19)32-6/h7-9,14-15H,10-13H2,1-6H3 QUOWSTQSIYCKTD-UHFFFAOYSA-N 436242 US10590140, Example 24::tert-butyl methyl(3-(9- methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenethyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436242&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089029 439657877 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887889 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)C(C)(C)CN(C)C(=O)OC(C)(C)C)C2=O InChI=1S/C25H35N5O3S/c1-24(2,3)33-23(32)29(7)16-25(4,5)17-10-9-11-18(14-17)30-13-12-28(6)20-19(21(30)31)15-26-22(27-20)34-8/h9-11,14-15H,12-13,16H2,1-8H3 YLVYGUMMMDZRJM-UHFFFAOYSA-N 436243 US10590140, Example 25::tert-butyl methyl(2- methyl-2-(3- (9-methyl- 2-(methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436243&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089031 439657878 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887890 CSc1ncc2c(n1)N(C)CCN(c1cccc(CN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C22H29N5O3S/c1-22(2,3)30-21(29)26(5)14-15-8-7-9-16(12-15)27-11-10-25(4)18-17(19(27)28)13-23-20(24-18)31-6/h7-9,12-13H,10-11,14H2,1-6H3 WSQGREWDTWUOFN-UHFFFAOYSA-N 436244 US10590140, Example 26::tert-butyl methyl(3-(9- methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436244&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089054 439657879 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887891 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC3CCN(C3)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C24H31N5O4S/c1-24(2,3)33-23(31)28-10-9-18(15-28)32-17-8-6-7-16(13-17)29-12-11-27(4)20-19(21(29)30)14-25-22(26-20)34-5/h6-8,13-14,18H,9-12,15H2,1-5H3 AIJUTEZPUNNJIN-UHFFFAOYSA-N 436245 US10590140, Example 27::tert-butyl 3-(3-(9- methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy) pyrrolidine- 1-carboxylate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436245&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089060 439657880 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887892 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCN(CC3)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C32H39N5O4S/c1-31(2,3)41-30(39)36-16-14-32(15-17-36,24-11-7-6-8-12-24)40-22-23-10-9-13-25(20-23)37-19-18-35(4)27-26(28(37)38)21-33-29(34-27)42-5/h6-13,20-21H,14-19,22H2,1-5H3 JZUZJVWCYPJHTF-UHFFFAOYSA-N 436246 US10590140, Example 28::tert-butyl 4-((3-(9- methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-4- phenylpiperidine- 1-carboxylate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436246&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089101 439657881 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887893 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(C)o1)C2=O InChI=1S/C18H18N6O2S/c1-11-21-22-16(26-11)12-5-4-6-13(9-12)24-8-7-23(2)15-14(17(24)25)10-19-18(20-15)27-3/h4-6,9-10H,7-8H2,1-3H3 OFOVPNFNRKXRFW-UHFFFAOYSA-N 436247 9-methyl-6-(3-(5- methyl-1,3,4- oxadiazol-2- yl)phenyl)- 2-(methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 29 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436247&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089353 439657882 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887894 CCN1CCN(c2cccc(c2)-c2nnc(C)o2)C(=O)c2cnc(SC)nc12 InChI=1S/C19H20N6O2S/c1-4-24-8-9-25(18(26)15-11-20-19(28-3)21-16(15)24)14-7-5-6-13(10-14)17-23-22-12(2)27-17/h5-7,10-11H,4,8-9H2,1-3H3 BNNPNGHIZCEZHD-UHFFFAOYSA-N 436248 9-ethyl-6- (3-(5-methyl- 1,3,4-oxadiazol-2- yl)phenyl)-2- (methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 30 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436248&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088754 439657883 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887895 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1noc(C)n1)C2=O InChI=1S/C18H18N6O2S/c1-11-20-15(22-26-11)12-5-4-6-13(9-12)24-8-7-23(2)16-14(17(24)25)10-19-18(21-16)27-3/h4-6,9-10H,7-8H2,1-3H3 CZSCSEVDFZMMRB-UHFFFAOYSA-N 436249 9-methyl-6-(3-(5- methyl-1,2,4- oxadiazol-3- yl)phenyl)- 2-(methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 31 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436249&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088860 439657884 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887896 COc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O InChI=1S/C16H18N4O2S/c1-19-7-8-20(11-5-4-6-12(9-11)22-2)15(21)13-10-17-16(23-3)18-14(13)19/h4-6,9-10H,7-8H2,1-3H3 OGWSPVDANXSTSL-UHFFFAOYSA-N 436250 6-(3- methoxyphenyl)- 9-methyl-2- (methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 32 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436250&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089161 439657885 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887897 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)C#N)C2=O InChI=1S/C16H15N5OS/c1-20-6-7-21(12-5-3-4-11(8-12)9-17)15(22)13-10-18-16(23-2)19-14(13)20/h3-5,8,10H,6-7H2,1-2H3 WQSZXXCBPMPAMN-UHFFFAOYSA-N 436251 3-(9-methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzonitrile::US10590140, Example 33 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436251&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089439 439657886 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887898 CSc1ncc2c(n1)N(C)CCN(c1cccc(O[Si](C)(C)C(C)(C)C)c1)C2=O InChI=1S/C21H30N4O2SSi/c1-21(2,3)29(6,7)27-16-10-8-9-15(13-16)25-12-11-24(4)18-17(19(25)26)14-22-20(23-18)28-5/h8-10,13-14H,11-12H2,1-7H3 UNHPGNIBLGFJJK-UHFFFAOYSA-N 436252 6-(3-((tert- butyldimethyl- silyl)oxy) phenyl)-9- methyl-2- (methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 34 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436252&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665945 439657887 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887899 CSc1ncc2c(n1)N(C)CCN(c1cccc(Br)c1)C2=O InChI=1S/C15H15BrN4OS/c1-19-6-7-20(11-5-3-4-10(16)8-11)14(21)12-9-17-15(22-2)18-13(12)19/h3-5,8-9H,6-7H2,1-2H3 RBODRKLUJKTZSP-UHFFFAOYSA-N 436253 6-(3- bromophenyl)-9- methyl-2- (methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 35 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436253&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089100 439657888 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887900 CSc1ncc2c(n1)N(C)CCN(c1cccc(CCO)c1)C2=O InChI=1S/C17H20N4O2S/c1-20-7-8-21(13-5-3-4-12(10-13)6-9-22)16(23)14-11-18-17(24-2)19-15(14)20/h3-5,10-11,22H,6-9H2,1-2H3 UZDGTXKEEXCESG-UHFFFAOYSA-N 436254 6-(3-(2- hydroxyethyl) phenyl)-9- methyl-2- (methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 36 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436254&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089084 439657889 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887901 COc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O InChI=1S/C16H18N4O2S/c1-19-8-9-20(11-4-6-12(22-2)7-5-11)15(21)13-10-17-16(23-3)18-14(13)19/h4-7,10H,8-9H2,1-3H3 AMHQMQCPHPFHJJ-UHFFFAOYSA-N 436255 6-(4- methoxyphenyl)- 9-methyl-2- (methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 37 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436255&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088725 439657890 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887902 CSc1ncc2c(n1)N(C)CCN(c1ccc(O[Si](C)(C)C(C)(C)C)cc1)C2=O InChI=1S/C21H30N4O2SSi/c1-21(2,3)29(6,7)27-16-10-8-15(9-11-16)25-13-12-24(4)18-17(19(25)26)14-22-20(23-18)28-5/h8-11,14H,12-13H2,1-7H3 CXVBRFWONNCJBZ-UHFFFAOYSA-N 436256 6-(4-((tert- butyldimethyl- silyl)oxy) phenyl)-9- methyl-2- (methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 38 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436256&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665929 439657891 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887903 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)C(=O)OC(C)(C)C)nn1)C2=O InChI=1S/C24H30N8O3S/c1-24(2,3)35-23(34)30(5)14-16-15-32(28-27-16)18-9-7-8-17(12-18)31-11-10-29(4)20-19(21(31)33)13-25-22(26-20)36-6/h7-9,12-13,15H,10-11,14H2,1-6H3 VPZGBTWVGCJYNB-UHFFFAOYSA-N 436257 US10590140, Example 39::tert-butyl methyl((1-(3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)- 1H-1,2,3- triazol-4- yl)methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436257&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089032 439657892 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887904 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNC(=O)OC(C)(C)C)nn1)C2=O InChI=1S/C23H28N8O3S/c1-23(2,3)34-22(33)25-12-15-14-31(28-27-15)17-8-6-7-16(11-17)30-10-9-29(4)19-18(20(30)32)13-24-21(26-19)35-5/h6-8,11,13-14H,9-10,12H2,1-5H3,(H,25,33) GSSZWUZVGUBOMJ-UHFFFAOYSA-N 436258 US10590140, Example 40::tert-butyl ((1-(3-(9- methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)- 1H-1,2,3- triazol-4- yl)methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436258&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633000 439657893 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887905 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(Cc3ccccc3)C(=O)OC(C)(C)C)nn1)C2=O InChI=1S/C30H34N8O3S/c1-30(2,3)41-29(40)36(18-21-10-7-6-8-11-21)19-22-20-38(34-33-22)24-13-9-12-23(16-24)37-15-14-35(4)26-25(27(37)39)17-31-28(32-26)42-5/h6-13,16-17,20H,14-15,18-19H2,1-5H3 RSKUYGQFQDSEPA-UHFFFAOYSA-N 436259 US10590140, Example 41::tert-butyl benzyl((1-(3 (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)- 1H-1,2,3- triazol-4- yl)methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436259&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089070 439657894 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887906 CCOC(OCC)c1cn(nn1)-c1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O InChI=1S/C22H27N7O3S/c1-5-31-21(32-6-2)18-14-29(26-25-18)16-9-7-8-15(12-16)28-11-10-27(3)19-17(20(28)30)13-23-22(24-19)33-4/h7-9,12-14,21H,5-6,10-11H2,1-4H3 MTTBTHSAYUBOBL-UHFFFAOYSA-N 436260 6-(3-(4- (diethoxymethyl)- 1H- 1,2,3-triazol-1- yl)phenyl)- 9-methyl-2- (methylthio)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin- 5-one::US10590140, Example 42 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436260&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089250 439657895 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887907 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CCN(C)C(=O)OC(C)(C)C)nn1)C2=O InChI=1S/C25H32N8O3S/c1-25(2,3)36-24(35)31(5)11-10-17-16-33(29-28-17)19-9-7-8-18(14-19)32-13-12-30(4)21-20(22(32)34)15-26-23(27-21)37-6/h7-9,14-16H,10-13H2,1-6H3 FDTUCCBOBSYXBS-UHFFFAOYSA-N 436261 US10590140, Example 43::tert-butyl methyl(2-(1- (3-(9-methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)- 1H-1,2,3- triazol-4- yl)ethyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436261&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089237 439657896 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887908 CSc1ncc2c(n1)N(C)CCN(c1cccc(Cn3cc(CN(C)C(=O)OC(C)(C)C)nn3)c1)C2=O InChI=1S/C25H32N8O3S/c1-25(2,3)36-24(35)31(5)15-18-16-32(29-28-18)14-17-8-7-9-19(12-17)33-11-10-30(4)21-20(22(33)34)13-26-23(27-21)37-6/h7-9,12-13,16H,10-11,14-15H2,1-6H3 WJWZSLAWLFRIMW-UHFFFAOYSA-N 436262 US10590140, Example 44::tert-butyl methyl((1-(3- (9-methyl-2- (methylthio)-5- oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)- 1H-1,2,3- triazol-4- yl)methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436262&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089021 439657897 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887909 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)C(=O)OC(C)(C)C)cn1)C2=O InChI=1S/C25H31N7O3S/c1-25(2,3)35-24(34)30(5)15-17-13-27-32(16-17)19-9-7-8-18(12-19)31-11-10-29(4)21-20(22(31)33)14-26-23(28-21)36-6/h7-9,12-14,16H,10-11,15H2,1-6H3 CXBGMFQKAADSES-UHFFFAOYSA-N 436263 US10590140, Example 45::tert-butyl methyl((1-(3- (9-methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)- 1H-pyrazol- 4-yl)methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436263&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088820 439657898 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887910 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C25H31N7O3S/c1-25(2,3)35-24(34)30(5)14-17-15-31(16-27-17)18-8-7-9-19(12-18)32-11-10-29(4)21-20(22(32)33)13-26-23(28-21)36-6/h7-9,12-13,15-16H,10-11,14H2,1-6H3 FSIOJWOHFWYRFI-UHFFFAOYSA-N 436264 US10590140, Example 46::tert-butyl methyl((1-(3- (9-methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)- 1H-imidazol- 4-yl)methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436264&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089254 439657899 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887911 CSc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(CN(C)C(=O)OC(C)(C)C)o1)C2=O InChI=1S/C24H29N7O4S/c1-24(2,3)35-23(33)30(5)14-18-27-28-20(34-18)15-8-7-9-16(12-15)31-11-10-29(4)19-17(21(31)32)13-25-22(26-19)36-6/h7-9,12-13H,10-11,14H2,1-6H3 UCMDQJRNSMGFAU-UHFFFAOYSA-N 436265 US10590140, Example 47::tert-butyl methyl((5-(3- (9-methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-1,3,4- oxadiazol-2- yl)methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436265&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089340 439657900 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887912 CSc1ncc2c(n1)N(C)CCN(c1ccccc1OC(CCN(C)C(=O)OC(C)(C)C)c1ccccc1)C2=O InChI=1S/C30H37N5O4S/c1-30(2,3)39-29(37)34(5)17-16-24(21-12-8-7-9-13-21)38-25-15-11-10-14-23(25)35-19-18-33(4)26-22(27(35)36)20-31-28(32-26)40-6/h7-15,20,24H,16-19H2,1-6H3 MABWUEKVJMPHNL-UHFFFAOYSA-N 436266 US10590140, Example 48::tert-butyl methyl(3-(2- (9-methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido [4,5-e][1,4] diazepin-6-yl) phenoxy)-3- phenylpropyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436266&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138607917 439657901 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887913 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCN(C)C(=O)OC(C)(C)C)C(C)C)c1)C2=O InChI=1S/C28H41N5O4S/c1-19(2)23(12-13-32(7)27(35)37-28(3,4)5)36-18-20-10-9-11-21(16-20)33-15-14-31(6)24-22(25(33)34)17-29-26(30-24)38-8/h9-11,16-17,19,23H,12-15,18H2,1-8H3 DHTNNOZGAFOBRZ-UHFFFAOYSA-N 436267 US10590140, Example 49::tert-butyl methyl (4- methyl-3- ((3-(9-methyl- 2-(methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin- 6-yl)benzyl) oxy)pentyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436267&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089214 439657902 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887914 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC(C)CCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C26H37N5O4S/c1-18(11-12-30(6)25(33)35-26(2,3)4)34-17-19-9-8-10-20(15-19)31-14-13-29(5)22-21(23(31)32)16-27-24(28-22)36-7/h8-10,15-16,18H,11-14,17H2,1-7H3 YTZVDQSEGQNUHC-UHFFFAOYSA-N 436268 US10590140, Example 50::tert-butyl methyl(3-((3- (9-methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4] diazepin-6- yl)benzyl) oxy)butyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436268&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089183 439657903 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887915 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OCC[Si](C)(C)C)c3cccs3)c1)C2=O InChI=1S/C29H39N5O4S2Si/c1-32-14-15-34(27(35)23-20-30-28(39-3)31-26(23)32)21-9-7-10-22(19-21)38-24(25-11-8-17-40-25)12-13-33(2)29(36)37-16-18-41(4,5)6/h7-11,17,19-20,24H,12-16,18H2,1-6H3 WAKRREVYIBUCMY-UHFFFAOYSA-N 436269 2-(trimethyl- silyl)ethyl methyl(3- (3-(9-methyl- 2-(methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin- 6-yl)phenoxy)-3- (thiophen-2- yl)propyl) carbamate::US10590140, Example 51 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436269&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665927 439657904 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887916 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OC(C)(C)C)c3ccccn3)c1)C2=O InChI=1S/C29H36N6O4S/c1-29(2,3)39-28(37)34(5)15-13-24(23-12-7-8-14-30-23)38-21-11-9-10-20(18-21)35-17-16-33(4)25-22(26(35)36)19-31-27(32-25)40-6/h7-12,14,18-19,24H,13,15-17H2,1-6H3 LJJOENCORVPGIX-UHFFFAOYSA-N 436270 US10590140, Example 52::tert-butyl methyl(3-(3- (9-methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)- 3-(pyridin- 2-yl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436270&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089137 439657905 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887917 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OC(C)(C)C)c3cccnc3)c1)C2=O InChI=1S/C29H36N6O4S/c1-29(2,3)39-28(37)34(5)14-12-24(20-9-8-13-30-18-20)38-22-11-7-10-21(17-22)35-16-15-33(4)25-23(26(35)36)19-31-27(32-25)40-6/h7-11,13,17-19,24H,12,14-16H2,1-6H3 CIRFHOPCSIEXRF-UHFFFAOYSA-N 436271 US10590140, Example 53::tert-butyl methyl(3-(3- (9-methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4] diazepin-6- yl)phenoxy)- 3-(pyridin- 3-yl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436271&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089292 439657906 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887918 CCNc1cc2N(C)CCN(c3cccc(c3)-c3nnc(C)o3)C(=O)c2cn1 InChI=1S/C20H22N6O2/c1-4-21-18-11-17-16(12-22-18)20(27)26(9-8-25(17)3)15-7-5-6-14(10-15)19-24-23-13(2)28-19/h5-7,10-12H,4,8-9H2,1-3H3,(H,21,22) CWUIPKIYRHELIH-UHFFFAOYSA-N 436272 8-(ethylamino)-1- methyl-4-(3- (5-methyl- 1,3,4-oxadiazol-2- yl)phenyl)- 1,2,3,4- tetrahydro-5H- pyrido[4,3- e][1,4]diazepin- 5-one::US10590140, Example 54 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436272&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088941 439657907 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887919 CCNc1cc2N(C)CCN(c3cccc(c3)-c3nnc(C)n3CC)C(=O)c2cn1 InChI=1S/C22H27N7O/c1-5-23-20-13-19-18(14-24-20)22(30)29(11-10-27(19)4)17-9-7-8-16(12-17)21-26-25-15(3)28(21)6-2/h7-9,12-14H,5-6,10-11H2,1-4H3,(H,23,24) AWICGVDLCKWVDE-UHFFFAOYSA-N 436273 4-(3-(4-ethyl- 5-methyl- 4H-1,2,4-triazol-3- yl)phenyl)-8- (ethylamino)- 1-methyl- 1,2,3,4- tetrahydro-5H- pyrido[4,3- e][1,4]diazepin- 5-one::US10590140, Example 55 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436273&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089157 439657908 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887920 CCNc1cc2N(C)CCN(c3cccc(OC(CCN(C)C(=O)OC(C)(C)C)c4ccccc4)c3)C(=O)c2cn1 InChI=1S/C32H41N5O4/c1-7-33-29-21-27-26(22-34-29)30(38)37(19-18-35(27)5)24-14-11-15-25(20-24)40-28(23-12-9-8-10-13-23)16-17-36(6)31(39)41-32(2,3)4/h8-15,20-22,28H,7,16-19H2,1-6H3,(H,33,34) AKDUFNSCPQPWDU-UHFFFAOYSA-N 436276 US10590140, Example 56::tert-butyl (3-(3-(8- (ethylamino)- 1-methyl- 5-oxo-1,2,3,5- tetrahydro-4H- pyrido[4,3- e][1,4]diazepin-4- yl)phenoxy)-3- phenylpropyl) (methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436276&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098820 439657911 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887921 CCNc1cc2N(C)CCN(c3cccc(COC(CCN(C)C(=O)OC(C)(C)C)c4ccccc4)c3)C(=O)c2cn1 InChI=1S/C33H43N5O4/c1-7-34-30-21-28-27(22-35-30)31(39)38(19-18-36(28)5)26-15-11-12-24(20-26)23-41-29(25-13-9-8-10-14-25)16-17-37(6)32(40)42-33(2,3)4/h8-15,20-22,29H,7,16-19,23H2,1-6H3,(H,34,35) WKLRLVXQYYYKSM-UHFFFAOYSA-N 436277 US10590140, Example 57::tert-butyl (3-((3-(8- (ethylamino)- 1-methyl- 5-oxo-1,2,3,5- tetrahydro-4H- pyrido[4,3-e] [1,4]diazepin-4- yl)benzyl)oxy)- 3-phenylpropyl) (methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436277&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098819 439657912 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887922 CCNc1cc2N(C)CCN(c3cccc(OC(CCN(C)C(=O)OCC[Si](C)(C)C)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C31H43N5O4SSi/c1-7-32-29-21-26-25(22-33-29)30(37)36(16-15-34(26)2)23-10-8-11-24(20-23)40-27(28-12-9-18-41-28)13-14-35(3)31(38)39-17-19-42(4,5)6/h8-12,18,20-22,27H,7,13-17,19H2,1-6H3,(H,32,33) HZSKRCATXKRJQV-UHFFFAOYSA-N 436278 2-(trimethyl- silyl)ethyl (3-(3-(8- (ethylamino)- 1-methyl-5-oxo- 1,2,3,5- tetrahydro-4H- pyrido[4,3-e] [1,4]diazepin-4- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate::US10590140, Example 58 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436278&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665930 439657913 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887923 CN(C)c1cc2N(C)CCN(c3cccc(OC(CCN(C)C(=O)OCC[Si](C)(C)C)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C31H43N5O4SSi/c1-33(2)29-21-26-25(22-32-29)30(37)36(16-15-34(26)3)23-10-8-11-24(20-23)40-27(28-12-9-18-41-28)13-14-35(4)31(38)39-17-19-42(5,6)7/h8-12,18,20-22,27H,13-17,19H2,1-7H3 LZFGGHLBWHVGEG-UHFFFAOYSA-N 436279 2-(trimethyl- silyl)ethyl (3-(3-(8- (dimethylamino)- 1-methyl-5- oxo-1,2,3,5- tetrahydro-4H- pyrido[4,3-e] [1,4]diazepin-4- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate::US10590140, Example 59 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436279&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665932 439657914 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887924 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCN(C)C(=O)OCC[Si](C)(C)C)c3cccs3)c1)C2=O InChI=1S/C31H44N6O4SSi/c1-7-32-30-33-21-25-28(34-30)35(2)15-16-37(29(25)38)24-11-8-10-23(20-24)22-41-26(27-12-9-18-42-27)13-14-36(3)31(39)40-17-19-43(4,5)6/h8-12,18,20-21,26H,7,13-17,19,22H2,1-6H3,(H,32,33,34) WDQGKZMBKVHQCK-UHFFFAOYSA-N 436280 2-(trimethyl- silyl)ethyl (3-((3-(8- (ethylamino)- 1-methyl-5-oxo- 1,2,3,5- tetrahydro-4H- pyrido[4,3-e] [1,4]diazepin-4- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl) (methyl) carbamate::US10590140, Example 60 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436280&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665943 439657915 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887925 CSc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(CCF)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C29H36FN5O4S2/c1-29(2,3)39-28(37)34(14-12-30)13-11-23(24-10-7-17-41-24)38-21-9-6-8-20(18-21)35-16-15-33(4)25-22(26(35)36)19-31-27(32-25)40-5/h6-10,17-19,23H,11-16H2,1-5H3 NGLFBMQWEOIDRO-UHFFFAOYSA-N 436281 US10590140, Example 61::tert-butyl (2- fluoroethyl) (3-(3-(9- methyl-2- (methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436281&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098769 439657916 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887926 CSc1ncc2c(n1)N(C)CCN(Cc1cccc(OC(CN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C30H37N5O4S/c1-30(2,3)39-29(37)34(5)20-25(22-12-8-7-9-13-22)38-23-14-10-11-21(17-23)19-35-16-15-33(4)26-24(27(35)36)18-31-28(32-26)40-6/h7-14,17-18,25H,15-16,19-20H2,1-6H3 VYNMJRHOKATNFN-UHFFFAOYSA-N 436282 US10590140, Example 62::tert-butyl methyl(2-(3-((9- methyl-2-(methylthio)-5- oxo-5,7,8,9-tetahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)methyl)phenoxy)-2- phenylethyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436282&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089450 439657917 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887927 CSc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CN(C)C(=O)OC(C)(C)C)c3ccccc3)cc1)C2=O InChI=1S/C30H37N5O4S/c1-30(2,3)39-29(37)34(5)20-25(22-10-8-7-9-11-22)38-23-14-12-21(13-15-23)19-35-17-16-33(4)26-24(27(35)36)18-31-28(32-26)40-6/h7-15,18,25H,16-17,19-20H2,1-6H3 RBKNTRFQVAPKLP-UHFFFAOYSA-N 436283 US10590140, Example 63::tert-butyl methyl(2-(4- ((9-methyl-2- (methylthio)-5-oxo- 5,7,8,9-tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)methyl)phenoxy)-2- phenylethyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436283&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089203 439657918 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887928 CSc1ncc2c(n1)N(C)CCN(Cc1ccc(CN(C)C(=O)OC(C)(C)C)cc1)C2=O InChI=1S/C23H31N5O3S/c1-23(2,3)31-22(30)27(5)14-16-7-9-17(10-8-16)15-28-12-11-26(4)19-18(20(28)29)13-24-21(25-19)32-6/h7-10,13H,11-12,14-15H2,1-6H3 PALATSVXEZBLOL-UHFFFAOYSA-N 436284 US10590140, Example 64::tert-butyl methyl(4-((9- methyl-2-(methylthio)- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)methyl)benzyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436284&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088750 439657919 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887929 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C32H42N6O4/c1-7-33-30-34-21-26-28(35-30)36(5)18-19-38(29(26)39)25-15-11-12-23(20-25)22-41-27(24-13-9-8-10-14-24)16-17-37(6)31(40)42-32(2,3)4/h8-15,20-21,27H,7,16-19,22H2,1-6H3,(H,33,34,35)/t27-/m1/s1 XOTGLJDOHSIDLC-HHHXNRCGSA-N 436285 US10590140, Example 65::US10590140, Example 78::tert-butyl (R)-(3-((3-(2- (ethylamino)-9-methyl- 5,7,8,9-tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436285&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098788 439657920 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887930 CCNc1ncc2CN(CCN(C)c2n1)c1cccc(c1)-c1nnc(C)o1 InChI=1S/C19H23N7O/c1-4-20-19-21-11-15-12-26(9-8-25(3)17(15)22-19)16-7-5-6-14(10-16)18-24-23-13(2)27-18/h5-7,10-11H,4,8-9,12H2,1-3H3,(H,20,21,22) OOWMYUXZLGOTTK-UHFFFAOYSA-N 436286 N-ethyl-9-methyl-6-(3- (5-methyl-1,3,4- oxadiazol-2-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-2- amine::US10590140, Example 66 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436286&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088904 439657921 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887931 CCNc1ncc2CN(Cc3cccc(OC)c3)CCN(C)c2n1 InChI=1S/C18H25N5O/c1-4-19-18-20-11-15-13-23(9-8-22(2)17(15)21-18)12-14-6-5-7-16(10-14)24-3/h5-7,10-11H,4,8-9,12-13H2,1-3H3,(H,19,20,21) WQJVWQTYQLHMJP-UHFFFAOYSA-N 436287 N-ethyl-6-(3- methoxybenzyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-2-amine::US10590140, Example 67 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436287&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089128 439657922 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887932 CCNc1ncc2CN(Cc3ccc(OC)cc3)CCN(C)c2n1 InChI=1S/C18H25N5O/c1-4-19-18-20-11-15-13-23(10-9-22(2)17(15)21-18)12-14-5-7-16(24-3)8-6-14/h5-8,11H,4,9-10,12-13H2,1-3H3,(H,19,20,21) UBIZGPJAQZJMCD-UHFFFAOYSA-N 436288 N-ethyl-6-(4- methoxybenzyl)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-2- amine::US10590140, Example 68 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436288&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088726 439657923 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887933 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H40N6O4/c1-7-32-29-33-21-25-27(34-29)35(5)18-19-37(28(25)38)23-14-11-15-24(20-23)40-26(22-12-9-8-10-13-22)16-17-36(6)30(39)41-31(2,3)4/h8-15,20-21,26H,7,16-19H2,1-6H3,(H,32,33,34) SLEFXHCFKAQWDN-UHFFFAOYSA-N 436289 US10590140, Example 69::tert-butyl (3-(3-(2- (ethylamino)-9-methyl-5- oxo-5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436289&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098777 439657924 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887934 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H40N6O4/c1-7-32-29-33-21-25-27(34-29)35(5)18-19-37(28(25)38)23-14-11-15-24(20-23)40-26(22-12-9-8-10-13-22)16-17-36(6)30(39)41-31(2,3)4/h8-15,20-21,26H,7,16-19H2,1-6H3,(H,32,33,34)/t26-/m1/s1 SLEFXHCFKAQWDN-AREMUKBSSA-N 436290 US10590140, Example 70::tert-butyl (R)-(3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436290&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098782 439657925 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887935 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H40N6O4/c1-7-32-29-33-21-25-27(34-29)35(5)18-19-37(28(25)38)23-14-11-15-24(20-23)40-26(22-12-9-8-10-13-22)16-17-36(6)30(39)41-31(2,3)4/h8-15,20-21,26H,7,16-19H2,1-6H3,(H,32,33,34)/t26-/m0/s1 SLEFXHCFKAQWDN-SANMLTNESA-N 436292 US10590140, Example 71::tert-butyl (S)-(3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436292&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098779 439657927 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887936 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C30H38N6O4/c1-7-31-28-32-19-24-26(33-28)34(5)16-17-36(27(24)37)22-14-11-15-23(18-22)39-25(21-12-9-8-10-13-21)20-35(6)29(38)40-30(2,3)4/h8-15,18-19,25H,7,16-17,20H2,1-6H3,(H,31,32,33) QPMNICWQDRYFBK-UHFFFAOYSA-N 436293 US10590140, Example 72::tert-butyl (2-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-2- phenylethyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436293&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633086 439657928 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887937 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CNC(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C29H36N6O4/c1-6-30-27-31-18-23-25(33-27)34(5)15-16-35(26(23)36)21-13-10-14-22(17-21)38-24(20-11-8-7-9-12-20)19-32-28(37)39-29(2,3)4/h7-14,17-18,24H,6,15-16,19H2,1-5H3,(H,32,37)(H,30,31,33) ISWBZWHGRKVVPE-UHFFFAOYSA-N 436294 US10590140, Example 73::tert-butyl (2-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-2- phenylethyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436294&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633067 439657929 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887938 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(C)CN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C25H36N6O4/c1-8-26-23-27-15-20-21(28-23)29(6)12-13-31(22(20)32)18-10-9-11-19(14-18)34-17(2)16-30(7)24(33)35-25(3,4)5/h9-11,14-15,17H,8,12-13,16H2,1-7H3,(H,26,27,28) GENWNUAMZIFKEU-UHFFFAOYSA-N 436295 US10590140, Example 74::tert-butyl (2-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)propyl) (methyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436295&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633071 439657930 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887939 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN(C)C(=O)OC(C)(C)C)C(C)C)c1)C2=O InChI=1S/C27H40N6O4/c1-9-28-25-29-16-21-23(30-25)31(7)13-14-33(24(21)34)19-11-10-12-20(15-19)36-22(18(2)3)17-32(8)26(35)37-27(4,5)6/h10-12,15-16,18,22H,9,13-14,17H2,1-8H3,(H,28,29,30) XMAVZSVWHYQRKA-UHFFFAOYSA-N 436296 US10590140, Example 75::tert-butyl (2-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5-e][1,4] diazepin-6-yl)phenoxy)- 3-methylbutyl) (methyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436296&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098994 439657931 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887940 CCNc1ncc2c(n1)N(C)CCN(c1ccc(OC(CN(C)C(=O)OC(C)(C)C)c3ccccc3)cc1)C2=O InChI=1S/C30H38N6O4/c1-7-31-28-32-19-24-26(33-28)34(5)17-18-36(27(24)37)22-13-15-23(16-14-22)39-25(21-11-9-8-10-12-21)20-35(6)29(38)40-30(2,3)4/h8-16,19,25H,7,17-18,20H2,1-6H3,(H,31,32,33) PJKFXDIRNRDAJV-UHFFFAOYSA-N 436297 US10590140, Example 76::tert-butyl (2-(4-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-2- phenylethyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436297&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098798 439657932 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887941 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C32H42N6O4/c1-7-33-30-34-21-26-28(35-30)36(5)18-19-38(29(26)39)25-15-11-12-23(20-25)22-41-27(24-13-9-8-10-14-24)16-17-37(6)31(40)42-32(2,3)4/h8-15,20-21,27H,7,16-19,22H2,1-6H3,(H,33,34,35) XOTGLJDOHSIDLC-UHFFFAOYSA-N 436298 US10590140, Example 77::tert-butyl (3-((3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436298&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633050 439657933 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887942 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C32H42N6O4/c1-7-33-30-34-21-26-28(35-30)36(5)18-19-38(29(26)39)25-15-11-12-23(20-25)22-41-27(24-13-9-8-10-14-24)16-17-37(6)31(40)42-32(2,3)4/h8-15,20-21,27H,7,16-19,22H2,1-6H3,(H,33,34,35)/t27-/m1/s1 XOTGLJDOHSIDLC-HHHXNRCGSA-N 436285 US10590140, Example 65::US10590140, Example 78::tert-butyl (R)-(3-((3-(2- (ethylamino)-9-methyl- 5,7,8,9-tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436285&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098788 439657920 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887943 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C32H42N6O4/c1-7-33-30-34-21-26-28(35-30)36(5)18-19-38(29(26)39)25-15-11-12-23(20-25)22-41-27(24-13-9-8-10-14-24)16-17-37(6)31(40)42-32(2,3)4/h8-15,20-21,27H,7,16-19,22H2,1-6H3,(H,33,34,35)/t27-/m0/s1 XOTGLJDOHSIDLC-MHZLTWQESA-N 436300 US10590140, Example 79::tert-butyl (S)-(3-((3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436300&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138632996 439657934 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887944 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C29H38N6O4S/c1-7-30-27-31-19-22-25(32-27)33(5)15-16-35(26(22)36)20-10-8-11-21(18-20)38-23(24-12-9-17-40-24)13-14-34(6)28(37)39-29(2,3)4/h8-12,17-19,23H,7,13-16H2,1-6H3,(H,30,31,32) BUGYHCFZTCRDJA-UHFFFAOYSA-N 436301 US10590140, Example 80::tert-butyl (3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436301&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633037 439657935 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887945 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C29H38N6O4S/c1-7-30-27-31-19-22-25(32-27)33(5)15-16-35(26(22)36)20-10-8-11-21(18-20)38-23(24-12-9-17-40-24)13-14-34(6)28(37)39-29(2,3)4/h8-12,17-19,23H,7,13-16H2,1-6H3,(H,30,31,32)/t23-/m1/s1 BUGYHCFZTCRDJA-HSZRJFAPSA-N 436302 US10590140, Example 81::tert-butyl (R)-(3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436302&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633069 439657936 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887946 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C29H38N6O4S/c1-7-30-27-31-19-22-25(32-27)33(5)15-16-35(26(22)36)20-10-8-11-21(18-20)38-23(24-12-9-17-40-24)13-14-34(6)28(37)39-29(2,3)4/h8-12,17-19,23H,7,13-16H2,1-6H3,(H,30,31,32)/t23-/m0/s1 BUGYHCFZTCRDJA-QHCPKHFHSA-N 436303 US10590140, Example 82::tert-butyl (S)-(3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436303&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633185 439657937 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887947 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C30H40N6O4S/c1-7-31-28-32-19-23-26(33-28)34(5)15-16-36(27(23)37)22-11-8-10-21(18-22)20-39-24(25-12-9-17-41-25)13-14-35(6)29(38)40-30(2,3)4/h8-12,17-19,24H,7,13-16,20H2,1-6H3,(H,31,32,33) ZCQLRKNWEPHCHM-UHFFFAOYSA-N 436304 US10590140, Example 83::tert-butyl (3-((3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436304&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098880 439657938 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887948 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C30H40N6O4S/c1-7-31-28-32-19-23-26(33-28)34(5)15-16-36(27(23)37)22-11-8-10-21(18-22)20-39-24(25-12-9-17-41-25)13-14-35(6)29(38)40-30(2,3)4/h8-12,17-19,24H,7,13-16,20H2,1-6H3,(H,31,32,33)/t24-/m1/s1 ZCQLRKNWEPHCHM-XMMPIXPASA-N 436305 US10590140, Example 84::tert-butyl (R)-(3-((3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436305&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098882 439657939 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887949 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C30H40N6O4S/c1-7-31-28-32-19-23-26(33-28)34(5)15-16-36(27(23)37)22-11-8-10-21(18-22)20-39-24(25-12-9-17-41-25)13-14-35(6)29(38)40-30(2,3)4/h8-12,17-19,24H,7,13-16,20H2,1-6H3,(H,31,32,33)/t24-/m0/s1 ZCQLRKNWEPHCHM-DEOSSOPVSA-N 436306 US10590140, Example 85::tert-butyl (S)-(3-((3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436306&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098849 439657940 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887950 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COCC(N(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H40N6O4/c1-7-32-29-33-19-25-27(34-29)35(5)16-17-37(28(25)38)24-15-11-12-22(18-24)20-40-21-26(23-13-9-8-10-14-23)36(6)30(39)41-31(2,3)4/h8-15,18-19,26H,7,16-17,20-21H2,1-6H3,(H,32,33,34) BNMYXRKPXXKVNJ-UHFFFAOYSA-N 436307 US10590140, Example 86::tert-butyl (2-((3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-1- phenylethyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436307&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633014 439657941 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887951 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CN(C)C(=O)OCC[Si](C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C32H44N6O4Si/c1-7-33-31-34-21-27-29(35-31)36(2)16-17-38(30(27)39)26-15-11-12-24(20-26)23-42-28(25-13-9-8-10-14-25)22-37(3)32(40)41-18-19-43(4,5)6/h8-15,20-21,28H,7,16-19,22-23H2,1-6H3,(H,33,34,35) BBBOJGPLDMYFNP-UHFFFAOYSA-N 436308 2-(trimethylsilyl)ethyl (2-((3-(2-(ethylamino)- 9-methyl-5-oxo- 5,7,8,9-tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-2- phenylethyl)(methyl) carbamate::US10590140, Example 87 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436308&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665923 439657942 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887952 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C25H36N6O4/c1-7-26-23-27-17-20-21(28-23)29(5)13-14-31(22(20)32)18-10-8-11-19(16-18)34-15-9-12-30(6)24(33)35-25(2,3)4/h8,10-11,16-17H,7,9,12-15H2,1-6H3,(H,26,27,28) UFASXPOLTVKKFH-UHFFFAOYSA-N 436309 US10590140, Example 88::tert-butyl (3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)propyl) (methyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436309&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098794 439657943 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887953 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCN(Cc3ccccc3)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C31H40N6O4/c1-6-32-29-33-21-26-27(34-29)35(5)17-18-37(28(26)38)24-14-10-15-25(20-24)40-19-11-16-36(30(39)41-31(2,3)4)22-23-12-8-7-9-13-23/h7-10,12-15,20-21H,6,11,16-19,22H2,1-5H3,(H,32,33,34) USOOGRXPTYMVHO-UHFFFAOYSA-N 436310 US10590140, Example 89::tert-butyl benzyl (3-(3- (2-(ethylamino)-9- methyl-5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)propyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436310&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088786 439657944 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887954 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C24H34N6O4/c1-7-25-22-26-16-19-20(27-22)28(5)11-12-30(21(19)31)17-9-8-10-18(15-17)33-14-13-29(6)23(32)34-24(2,3)4/h8-10,15-16H,7,11-14H2,1-6H3,(H,25,26,27) UVNJESWXPSHSAP-UHFFFAOYSA-N 436311 US10590140, Example 90::tert-butyl (2-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)ethyl) (methyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436311&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098799 439657945 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887955 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C25H36N6O3/c1-7-26-23-27-17-20-21(28-23)29(5)14-15-31(22(20)32)19-12-8-10-18(16-19)11-9-13-30(6)24(33)34-25(2,3)4/h8,10,12,16-17H,7,9,11,13-15H2,1-6H3,(H,26,27,28) VQYMJOTVWINZGQ-UHFFFAOYSA-N 436312 US10590140, Example 91::tert-butyl (3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)propyl) (methyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436312&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098790 439657946 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887956 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C24H34N6O3/c1-7-25-22-26-16-19-20(27-22)28(5)13-14-30(21(19)31)18-10-8-9-17(15-18)11-12-29(6)23(32)33-24(2,3)4/h8-10,15-16H,7,11-14H2,1-6H3,(H,25,26,27) FCBULPRCWGIQDX-UHFFFAOYSA-N 436313 US10590140, Example 92::tert-butyl (3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenethyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436313&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098791 439657947 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887957 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C(C)(C)CN(C)C(=O)OC(C)(C)C)C2=O InChI=1S/C26H38N6O3/c1-9-27-23-28-16-20-21(29-23)30(7)13-14-32(22(20)33)19-12-10-11-18(15-19)26(5,6)17-31(8)24(34)35-25(2,3)4/h10-12,15-16H,9,13-14,17H2,1-8H3,(H,27,28,29) RJQATNDZBCDALC-UHFFFAOYSA-N 436314 US10590140, Example 93::tert-butyl (2-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-2- methylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436314&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098792 439657948 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887958 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C23H32N6O3/c1-7-24-21-25-14-18-19(26-21)27(5)11-12-29(20(18)30)17-10-8-9-16(13-17)15-28(6)22(31)32-23(2,3)4/h8-10,13-14H,7,11-12,15H2,1-6H3,(H,24,25,26) GNIODSXUFSPAFI-UHFFFAOYSA-N 436315 US10590140, Example 94::tert-butyl (3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436315&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098793 439657949 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887959 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC3CCN(C3)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C25H34N6O4/c1-6-26-23-27-15-20-21(28-23)29(5)12-13-31(22(20)32)17-8-7-9-18(14-17)34-19-10-11-30(16-19)24(33)35-25(2,3)4/h7-9,14-15,19H,6,10-13,16H2,1-5H3,(H,26,27,28) ZUHYYDUVUOMRKX-UHFFFAOYSA-N 436316 US10590140, Example 95::tert-butyl 3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)pyrrolidine- 1-carboxylate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436316&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088771 439657950 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887960 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCN(CC3)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C33H42N6O4/c1-6-34-30-35-22-27-28(36-30)37(5)19-20-39(29(27)40)26-14-10-11-24(21-26)23-42-33(25-12-8-7-9-13-25)15-17-38(18-16-33)31(41)43-32(2,3)4/h7-14,21-22H,6,15-20,23H2,1-5H3,(H,34,35,36) KAKJBZGHQJFPLM-UHFFFAOYSA-N 436317 US10590140, Example 96::tert-butyl 4-((3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-4- phenylpiperidine-1- carboxylate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436317&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088968 439657951 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887961 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(C)o1)C2=O InChI=1S/C19H21N7O2/c1-4-20-19-21-11-15-16(22-19)25(3)8-9-26(18(15)27)14-7-5-6-13(10-14)17-24-23-12(2)28-17/h5-7,10-11H,4,8-9H2,1-3H3,(H,20,21,22) UUKNXPMVCQJCPY-UHFFFAOYSA-N 436318 2-(ethylamino)-9- methyl-6-(3-(5-methyl- 1,3,4-oxadiazol-2- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 97 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human <100 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436318&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089169 439657952 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887962 CC(C)CNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(C)o1)C2=O InChI=1S/C21H25N7O2/c1-13(2)11-22-21-23-12-17-18(24-21)27(4)8-9-28(20(17)29)16-7-5-6-15(10-16)19-26-25-14(3)30-19/h5-7,10,12-13H,8-9,11H2,1-4H3,(H,22,23,24) GSLIJRWTUDLIKY-UHFFFAOYSA-N 436319 2-(isobutylamino)-9- methyl-6-(3-(5-methyl- 1,3,4-oxadiazol-2- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 98 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436319&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088721 439657953 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887963 COCCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(C)o1)C2=O InChI=1S/C20H23N7O3/c1-13-24-25-18(30-13)14-5-4-6-15(11-14)27-9-8-26(2)17-16(19(27)28)12-22-20(23-17)21-7-10-29-3/h4-6,11-12H,7-10H2,1-3H3,(H,21,22,23) UITIZVOWNYPKSR-UHFFFAOYSA-N 436320 2-((2- methoxyethyl)amino)- 9-methyl-6-(3-(5- methyl-1,3,4- oxadiazol-2-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 99 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436320&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088730 439657954 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887964 CNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(C)o1)C2=O InChI=1S/C18H19N7O2/c1-11-22-23-16(27-11)12-5-4-6-13(9-12)25-8-7-24(3)15-14(17(25)26)10-20-18(19-2)21-15/h4-6,9-10H,7-8H2,1-3H3,(H,19,20,21) BBMZMJUGZDHJCS-UHFFFAOYSA-N 436321 9-methyl-6-(3-(5- methyl-1,3,4- oxadiazol-2-yl)phenyl)- 2-(methylamino)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 100 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436321&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088780 439657955 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887965 CN1CCN(c2cccc(c2)-c2nnc(C)o2)C(=O)c2cnc(N)nc12 InChI=1S/C17H17N7O2/c1-10-21-22-15(26-10)11-4-3-5-12(8-11)24-7-6-23(2)14-13(16(24)25)9-19-17(18)20-14/h3-5,8-9H,6-7H2,1-2H3,(H2,18,19,20) FSUYVSCMMRDIOY-UHFFFAOYSA-N 436322 2-amino-9-methyl-6- (3-(5-methyl-1,3,4- oxadiazol-2-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 101 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436322&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098900 439657956 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887966 CN1CCN(c2cccc(c2)-c2nnc(C)o2)C(=O)c2cnc(NCc3ccccc3)nc12 InChI=1S/C24H23N7O2/c1-16-28-29-22(33-16)18-9-6-10-19(13-18)31-12-11-30(2)21-20(23(31)32)15-26-24(27-21)25-14-17-7-4-3-5-8-17/h3-10,13,15H,11-12,14H2,1-2H3,(H,25,26,27) KVJBFLATXWGBCV-UHFFFAOYSA-N 436323 2-(benzylamino)-9- methyl-6-(3-(5-methyl- 1,3,4-oxadiazol-2- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 102 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436323&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089001 439657957 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887967 CN1CCN(c2cccc(c2)-c2nnc(C)o2)C(=O)c2cnc(NC3CCCCC3)nc12 InChI=1S/C23H27N7O2/c1-15-27-28-21(32-15)16-7-6-10-18(13-16)30-12-11-29(2)20-19(22(30)31)14-24-23(26-20)25-17-8-4-3-5-9-17/h6-7,10,13-14,17H,3-5,8-9,11-12H2,1-2H3,(H,24,25,26) VTFLGKIAJYKSRG-UHFFFAOYSA-N 436324 2-(cyclohexylamino)-9- methyl-6-(3-(5-methyl- 1,3,4-oxadiazol-2- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 103 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436324 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436324&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089239 439657958 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887968 CN(Cc1ccccc1)c1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(C)o1)C2=O InChI=1S/C25H25N7O2/c1-17-28-29-23(34-17)19-10-7-11-20(14-19)32-13-12-30(2)22-21(24(32)33)15-26-25(27-22)31(3)16-18-8-5-4-6-9-18/h4-11,14-15H,12-13,16H2,1-3H3 IDEPOVHMWNOWDQ-UHFFFAOYSA-N 436325 2-(benzyl(methyl) amino)-9-methyl-6-(3- (5-methyl-1,3,4- oxadiazol-2-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 104 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436325&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089140 439657959 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887969 CN1CCN(c2cccc(c2)-c2nnc(C)o2)C(=O)c2cnc(NCCc3ccccc3)nc12 InChI=1S/C25H25N7O2/c1-17-29-30-23(34-17)19-9-6-10-20(15-19)32-14-13-31(2)22-21(24(32)33)16-27-25(28-22)26-12-11-18-7-4-3-5-8-18/h3-10,15-16H,11-14H2,1-2H3,(H,26,27,28) GBKBMKMHPMFPFR-UHFFFAOYSA-N 436326 9-methyl-6-(3-(5- methyl-1,3,4- oxadiazol-2-yl)phenyl)- 2-(phenethylamino)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 105 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436326&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088972 439657960 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887970 CN(Cc1ccccn1)c1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(C)o1)C2=O InChI=1S/C24H24N8O2/c1-16-28-29-22(34-16)17-7-6-9-19(13-17)32-12-11-30(2)21-20(23(32)33)14-26-24(27-21)31(3)15-18-8-4-5-10-25-18/h4-10,13-14H,11-12,15H2,1-3H3 YFAHEUJGENMDPK-UHFFFAOYSA-N 436327 9-methyl-2-(methyl (pyridin-2-ylmethyl) amino)-6-(3-(5-methyl- 1,3,4-oxadiazol-2- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 106 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436327&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088928 439657961 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887971 CCNc1ncc2c(n1)N(CC)CCN(c1cccc(c1)-c1nnc(C)o1)C2=O InChI=1S/C20H23N7O2/c1-4-21-20-22-12-16-17(23-20)26(5-2)9-10-27(19(16)28)15-8-6-7-14(11-15)18-25-24-13(3)29-18/h6-8,11-12H,4-5,9-10H2,1-3H3,(H,21,22,23) KHEAUDGDAOTKCC-UHFFFAOYSA-N 436328 9-ethyl-2-(ethylamino)- 6-(3-(5-methyl-1,3,4- oxadiazol-2-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 107 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436328&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089220 439657962 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887972 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1noc(C)n1)C2=O InChI=1S/C19H21N7O2/c1-4-20-19-21-11-15-17(23-19)25(3)8-9-26(18(15)27)14-7-5-6-13(10-14)16-22-12(2)28-24-16/h5-7,10-11H,4,8-9H2,1-3H3,(H,20,21,23) FPMLJRKZGIOTNX-UHFFFAOYSA-N 436329 2-(ethylamino)-9- methyl-6-(3-(5-methyl- 1,2,4-oxadiazol-3- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 108 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436329&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089318 439657963 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887973 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC)c1)C2=O InChI=1S/C17H21N5O2/c1-4-18-17-19-11-14-15(20-17)21(2)8-9-22(16(14)23)12-6-5-7-13(10-12)24-3/h5-7,10-11H,4,8-9H2,1-3H3,(H,18,19,20) KQIMJTPEKQEFLX-UHFFFAOYSA-N 436330 2-(ethylamino)-6-(3- methoxyphenyl)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 109 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436330&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088909 439657964 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887974 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C#N)C2=O InChI=1S/C17H18N6O/c1-3-19-17-20-11-14-15(21-17)22(2)7-8-23(16(14)24)13-6-4-5-12(9-13)10-18/h4-6,9,11H,3,7-8H2,1-2H3,(H,19,20,21) KDEBGPKMOXBCFC-UHFFFAOYSA-N 436331 3-(2-(ethylamino)-9- methyl-5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzonitrile::US10590140, Example 110 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436331&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089305 439657965 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887975 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[Si](C)(C)C(C)(C)C)c1)C2=O InChI=1S/C22H33N5O2Si/c1-8-23-21-24-15-18-19(25-21)26(5)12-13-27(20(18)28)16-10-9-11-17(14-16)29-30(6,7)22(2,3)4/h9-11,14-15H,8,12-13H2,1-7H3,(H,23,24,25) WAXNRMJGEWRIFS-UHFFFAOYSA-N 436332 6-(3-((tert- butyldimethylsilyl)oxy) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 111 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436332&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665920 439657966 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887976 CCNc1ncc2c(n1)N(C)CCN(c1cccc(Br)c1)C2=O InChI=1S/C16H18BrN5O/c1-3-18-16-19-10-13-14(20-16)21(2)7-8-22(15(13)23)12-6-4-5-11(17)9-12/h4-6,9-10H,3,7-8H2,1-2H3,(H,18,19,20) STRHISYXYVMUPL-UHFFFAOYSA-N 436333 6-(3-bromophenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 112::US10590140, Example 311 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436333&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089284 439657967 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887977 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCO)c1)C2=O InChI=1S/C18H23N5O2/c1-3-19-18-20-12-15-16(21-18)22(2)8-9-23(17(15)25)14-6-4-5-13(11-14)7-10-24/h4-6,11-12,24H,3,7-10H2,1-2H3,(H,19,20,21) MKGORJFHXBDCPS-UHFFFAOYSA-N 436334 2-(ethylamino)-6-(3-(2- hydroxyethyl)phenyl)- 9-methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 113::US10590140, Example 310 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436334&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088831 439657968 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887978 CCNc1ncc2c(n1)N(C)CCN(c1ccc(OC)cc1)C2=O InChI=1S/C17H21N5O2/c1-4-18-17-19-11-14-15(20-17)21(2)9-10-22(16(14)23)12-5-7-13(24-3)8-6-12/h5-8,11H,4,9-10H2,1-3H3,(H,18,19,20) QGMDGHKNWZHZJO-UHFFFAOYSA-N 436335 2-(ethylamino)-6-(4- methoxyphenyl)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 114 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436335&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088796 439657969 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887979 CCNc1ncc2c(n1)N(C)CCN(c1ccc(O[Si](C)(C)C(C)(C)C)cc1)C2=O InChI=1S/C22H33N5O2Si/c1-8-23-21-24-15-18-19(25-21)26(5)13-14-27(20(18)28)16-9-11-17(12-10-16)29-30(6,7)22(2,3)4/h9-12,15H,8,13-14H2,1-7H3,(H,23,24,25) CLTLEFHPMCJHSD-UHFFFAOYSA-N 436336 6-(4-((tert- butyldimethylsilyl)oxy) phenyl)-2-(ethylamino)- 9-methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e1[1,4]diazepin-5-one::US10590140, Example 115 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436336&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665935 439657970 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887980 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)C(=O)OC(C)(C)C)nn1)C2=O InChI=1S/C25H33N9O3/c1-7-26-23-27-14-20-21(28-23)31(5)11-12-33(22(20)35)18-9-8-10-19(13-18)34-16-17(29-30-34)15-32(6)24(36)37-25(2,3)4/h8-10,13-14,16H,7,11-12,15H2,1-6H3,(H,26,27,28) WTZHVEAVCPWGAR-UHFFFAOYSA-N 436337 US10590140, Example 116::tert-butyl ((1-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-1H-1,2,3- triazol-4- yl)methyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436337&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633054 439657971 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887981 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNC(=O)OC(C)(C)C)nn1)C2=O InChI=1S/C24H31N9O3/c1-6-25-22-26-14-19-20(28-22)31(5)10-11-32(21(19)34)17-8-7-9-18(12-17)33-15-16(29-30-33)13-27-23(35)36-24(2,3)4/h7-9,12,14-15H,6,10-11,13H2,1-5H3,(H,27,35)(H,25,26,28) KPJZDUJNGPIIRS-UHFFFAOYSA-N 436338 US10590140, Example 117::tert-butyl ((1-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-1H-1,2,3- triazol-4- yl)methyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436338&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633015 439657972 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887982 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(Cc3ccccc3)C(=O)OC(C)(C)C)nn1)C2=O InChI=1S/C31H37N9O3/c1-6-32-29-33-18-26-27(34-29)37(5)15-16-39(28(26)41)24-13-10-14-25(17-24)40-21-23(35-36-40)20-38(30(42)43-31(2,3)4)19-22-11-8-7-9-12-22/h7-14,17-18,21H,6,15-16,19-20H2,1-5H3,(H,32,33,34) FNCTUDSDQNGBHT-UHFFFAOYSA-N 436339 US10590140, Example 118::tert-butyl benzyl((1-(3- (2-(ethylamino)-9- methyl-5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-1H-1,2,3- triazol-4- yl)methyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436339&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088776 439657973 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887983 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(nn1)C(OCC)OCC)C2=O InChI=1S/C23H30N8O3/c1-5-24-23-25-14-18-20(26-23)29(4)11-12-30(21(18)32)16-9-8-10-17(13-16)31-15-19(27-28-31)22(33-6-2)34-7-3/h8-10,13-15,22H,5-7,11-12H2,1-4H3,(H,24,25,26) ZCGMTEJGIFYODU-UHFFFAOYSA-N 436340 6-(3-(4- (diethoxymethyl)-1H- 1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 119 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436340&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089255 439657974 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887984 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CCN(C)C(=O)OC(C)(C)C)nn1)C2=O InChI=1S/C26H35N9O3/c1-7-27-24-28-16-21-22(29-24)32(5)13-14-34(23(21)36)19-9-8-10-20(15-19)35-17-18(30-31-35)11-12-33(6)25(37)38-26(2,3)4/h8-10,15-17H,7,11-14H2,1-6H3,(H,27,28,29) DRQIFSGREBBRDB-UHFFFAOYSA-N 436341 US10590140, Example 120::tert-butyl (2-(1-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-1H-1,2,3- triazol-4- yl)ethyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436341&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633074 439657975 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887985 CCNc1ncc2c(n1)N(C)CCN(c1cccc(Cn3cc(CN(C)C(=O)OC(C)(C)C)nn3)c1)C2=O InChI=1S/C26H35N9O3/c1-7-27-24-28-14-21-22(29-24)32(5)11-12-35(23(21)36)20-10-8-9-18(13-20)15-34-17-19(30-31-34)16-33(6)25(37)38-26(2,3)4/h8-10,13-14,17H,7,11-12,15-16H2,1-6H3,(H,27,28,29) CYWOLYZCMBNFEB-UHFFFAOYSA-N 436342 US10590140, Example 121::tert-butyl ((1-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)-1H-1,2,3- triazol-4- yl)methyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436342&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098811 439657976 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887986 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)C(=O)OC(C)(C)C)cn1)C2=O InChI=1S/C26H34N8O3/c1-7-27-24-28-15-21-22(30-24)31(5)11-12-33(23(21)35)19-9-8-10-20(13-19)34-17-18(14-29-34)16-32(6)25(36)37-26(2,3)4/h8-10,13-15,17H,7,11-12,16H2,1-6H3,(H,27,28,30) QYFBIHQANJDQMK-UHFFFAOYSA-N 436343 US10590140, Example 122::tert-butyl ((1-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-1H-pyrazol- 4- yl)methyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436343&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633076 439657977 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887987 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C26H34N8O3/c1-7-27-24-28-14-21-22(30-24)31(5)11-12-34(23(21)35)20-10-8-9-19(13-20)33-16-18(29-17-33)15-32(6)25(36)37-26(2,3)4/h8-10,13-14,16-17H,7,11-12,15H2,1-6H3,(H,27,28,30) PRUVFTVZHAMKOH-UHFFFAOYSA-N 436344 US10590140, Example 123::tert-butyl ((1-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-1H- imidazol-4- yl)methyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436344&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633068 439657978 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887988 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(CN(C)C(=O)OC(C)(C)C)o1)C2=O InChI=1S/C25H32N8O4/c1-7-26-23-27-14-18-20(28-23)31(5)11-12-33(22(18)34)17-10-8-9-16(13-17)21-30-29-19(36-21)15-32(6)24(35)37-25(2,3)4/h8-10,13-14H,7,11-12,15H2,1-6H3,(H,26,27,28) BDYDBINQTZSPNK-UHFFFAOYSA-N 436345 US10590140, Example 124::tert-butyl ((5-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-1,3,4- oxadiazol-2- yl)methyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436345&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633181 439657979 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887989 CCNc1ncc2c(n1)N(C)CCN(c1ccccc1OC(CCN(C)C(=O)OC(C)(C)C)c1ccccc1)C2=O InChI=1S/C31H40N6O4/c1-7-32-29-33-21-23-27(34-29)35(5)19-20-37(28(23)38)24-15-11-12-16-26(24)40-25(22-13-9-8-10-14-22)17-18-36(6)30(39)41-31(2,3)4/h8-16,21,25H,7,17-20H2,1-6H3,(H,32,33,34) MQZJQMLQALVAMO-UHFFFAOYSA-N 436346 US10590140, Example 125::tert-butyl (3-(2-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436346&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633053 439657980 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887990 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCN(C)C(=O)OC(C)(C)C)C(C)C)c1)C2=O InChI=1S/C29H44N6O4/c1-9-30-27-31-18-23-25(32-27)33(7)15-16-35(26(23)36)22-12-10-11-21(17-22)19-38-24(20(2)3)13-14-34(8)28(37)39-29(4,5)6/h10-12,17-18,20,24H,9,13-16,19H2,1-8H3,(H,30,31,32) UBJXRXLTDHUXQJ-UHFFFAOYSA-N 436347 US10590140, Example 126::tert-butyl (3-((3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-4- methylpentyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436347&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633072 439657981 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887991 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(C)CCN(C)C(=O)OC(C)(C)C)c1)C2=O InChI=1S/C27H40N6O4/c1-8-28-25-29-17-22-23(30-25)31(6)14-15-33(24(22)34)21-11-9-10-20(16-21)18-36-19(2)12-13-32(7)26(35)37-27(3,4)5/h9-11,16-17,19H,8,12-15,18H2,1-7H3,(H,28,29,30) LTEZLOFAJKXQFP-UHFFFAOYSA-N 436348 US10590140, Example 127::tert-butyl (3-((3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)butyl) (methyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436348&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633097 439657982 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887992 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OC(C)(C)C)c3ccccn3)c1)C2=O InChI=1S/C30H39N7O4/c1-7-31-28-33-20-23-26(34-28)35(5)17-18-37(27(23)38)21-11-10-12-22(19-21)40-25(24-13-8-9-15-32-24)14-16-36(6)29(39)41-30(2,3)4/h8-13,15,19-20,25H,7,14,16-18H2,1-6H3,(H,31,33,34) QKIANSWYNDTCJZ-UHFFFAOYSA-N 436349 US10590140, Example 128::tert-butyl (3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3-(pyridin- 2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436349&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633070 439657983 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887993 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OC(C)(C)C)c3cccnc3)c1)C2=O InChI=1S/C30H39N7O4/c1-7-32-28-33-20-24-26(34-28)35(5)16-17-37(27(24)38)22-11-8-12-23(18-22)40-25(21-10-9-14-31-19-21)13-15-36(6)29(39)41-30(2,3)4/h8-12,14,18-20,25H,7,13,15-17H2,1-6H3,(H,32,33,34) ICTSBGDYRKYYLY-UHFFFAOYSA-N 436350 US10590140, Example 129::tert-butyl (3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3-(pyridin- 3- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436350&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098796 439657984 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887994 CN(CC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1ccccc1)C(=O)OC(C)(C)C InChI=1S/C30H38N6O4/c1-30(2,3)40-29(38)35(5)15-14-25(22-11-7-6-8-12-22)39-20-21-10-9-13-23(18-21)36-17-16-34(4)26-24(27(36)37)19-32-28(31)33-26/h6-13,18-19,25H,14-17,20H2,1-5H3,(H2,31,32,33)/t25-/m1/s1 ZNCRGSCCYXXPQQ-RUZDIDTESA-N 436351 US10590140, Example 130::tert-butyl (R)-(3-((3-(2- amino-9-methyl-5-oxo- 5,7,8,9-tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436351&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633001 439657985 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887995 CN(C)c1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C32H42N6O4/c1-32(2,3)42-31(40)37(7)17-16-27(24-13-9-8-10-14-24)41-22-23-12-11-15-25(20-23)38-19-18-36(6)28-26(29(38)39)21-33-30(34-28)35(4)5/h8-15,20-21,27H,16-19,22H2,1-7H3/t27-/m1/s1 MGXBSHPFBMKKPF-HHHXNRCGSA-N 436352 US10590140, Example 131::tert-butyl (R)-(3-((3-(2- (dimethylamino)-9- methyl-5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436352&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633055 439657986 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887996 CNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H40N6O4/c1-31(2,3)41-30(39)36(6)16-15-26(23-12-8-7-9-13-23)40-21-22-11-10-14-24(19-22)37-18-17-35(5)27-25(28(37)38)20-33-29(32-4)34-27/h7-14,19-20,26H,15-18,21H2,1-6H3,(H,32,33,34)/t26-/m1/s1 ALMWLEFGOTYYPN-AREMUKBSSA-N 436353 US10590140, Example 132::tert-butyl (R)-methyl(3- ((3-(9-methyl-2- (methylamino)-5-oxo- 5,7,8,9-tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436353&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098875 439657987 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887997 CN(C)c1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C(=O)OCC[Si](C)(C)C)c3cccs3)c1)C2=O InChI=1S/C30H42N6O4SSi/c1-33(2)29-31-21-24-27(32-29)34(3)15-16-36(28(24)37)22-10-8-11-23(20-22)40-25(26-12-9-18-41-26)13-14-35(4)30(38)39-17-19-42(5,6)7/h8-12,18,20-21,25H,13-17,19H2,1-7H3 QMQCLWDHTMUYIU-UHFFFAOYSA-N 436354 2-(trimethylsilyl)ethyl (3-(3-(2- (dimethylamino)-9- methyl-5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate::US10590140, Example 133 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436354&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665918 439657988 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887998 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(CCF)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C30H39FN6O4S/c1-6-32-28-33-20-23-26(34-28)35(5)16-17-37(27(23)38)21-9-7-10-22(19-21)40-24(25-11-8-18-42-25)12-14-36(15-13-31)29(39)41-30(2,3)4/h7-11,18-20,24H,6,12-17H2,1-5H3,(H,32,33,34) UXANOAXEZSDNDB-UHFFFAOYSA-N 436355 US10590140, Example 134::tert-butyl (3-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl)(2- fluoroethyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436355&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098867 439657989 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 887999 CCNc1ncc2c(n1)N(C)CCN(Cc1cccc(OC(CN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H40N6O4/c1-7-32-29-33-19-25-27(34-29)35(5)16-17-37(28(25)38)20-22-12-11-15-24(18-22)40-26(23-13-9-8-10-14-23)21-36(6)30(39)41-31(2,3)4/h8-15,18-19,26H,7,16-17,20-21H2,1-6H3,(H,32,33,34) WLSIMERUZDRIBW-UHFFFAOYSA-N 436356 US10590140, Example 135::tert-butyl (2-(3-((2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)methyl)phenoxy)-2- phenylethyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436356&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098878 439657990 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888000 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CN(C)C(=O)OC(C)(C)C)c3ccccc3)cc1)C2=O InChI=1S/C31H40N6O4/c1-7-32-29-33-19-25-27(34-29)35(5)17-18-37(28(25)38)20-22-13-15-24(16-14-22)40-26(23-11-9-8-10-12-23)21-36(6)30(39)41-31(2,3)4/h8-16,19,26H,7,17-18,20-21H2,1-6H3,(H,32,33,34) LXZQOIRKNRSKFS-UHFFFAOYSA-N 436357 US10590140, Example 136::tert-butyl (2-(4-((2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)methyl)phenoxy)-2- phenylethyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436357&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098866 439657991 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888001 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(CN(C)C(=O)OC(C)(C)C)cc1)C2=O InChI=1S/C24H34N6O3/c1-7-25-22-26-14-19-20(27-22)28(5)12-13-30(21(19)31)16-18-10-8-17(9-11-18)15-29(6)23(32)33-24(2,3)4/h8-11,14H,7,12-13,15-16H2,1-6H3,(H,25,26,27) UKRCTOIDEAGTEP-UHFFFAOYSA-N 436358 US10590140, Example 137::tert-butyl (4-((2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)methyl)benzyl) (methyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436358&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098809 439657992 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888002 COc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C(=O)OC(C)(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H39N5O5/c1-31(2,3)41-30(38)35(5)16-15-26(23-12-8-7-9-13-23)40-21-22-11-10-14-24(19-22)36-18-17-34(4)27-25(28(36)37)20-32-29(33-27)39-6/h7-14,19-20,26H,15-18,21H2,1-6H3/t26-/m1/s1 IQFZOZBKQXCWEB-AREMUKBSSA-N 436359 US10590140, Example 138::tert-butyl (R)-(3-((3-(2- methoxy-9-methyl-5-oxo- 5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436359&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633073 439657993 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888003 COc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCN(C)C(=O)OC(C)(C)C)c3cccs3)c1)C2=O InChI=1S/C29H37N5O5S/c1-29(2,3)39-28(36)33(5)13-12-23(24-11-8-16-40-24)38-19-20-9-7-10-21(17-20)34-15-14-32(4)25-22(26(34)35)18-30-27(31-25)37-6/h7-11,16-18,23H,12-15,19H2,1-6H3 VHMHYLLKLSCDIP-UHFFFAOYSA-N 436360 US10590140, Example 139::tert-butyl (3-((3-(2- methoxy-9-methyl-5- oxo-5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436360&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098813 439657994 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888004 CN(CC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(O)ncc2C1=O)c1ccccc1)C(=O)OC(C)(C)C InChI=1S/C30H37N5O5/c1-30(2,3)40-29(38)34(5)15-14-25(22-11-7-6-8-12-22)39-20-21-10-9-13-23(18-21)35-17-16-33(4)26-24(27(35)36)19-31-28(37)32-26/h6-13,18-19,25H,14-17,20H2,1-5H3,(H,31,32,37)/t25-/m1/s1 HZZUHVDVVGDWNY-RUZDIDTESA-N 436361 US10590140, Example 140::tert-butyl (R)-(3-((3-(2- hydroxy-9-methyl-5-oxo- 5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6-yl) benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436361&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098887 439657995 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888005 CN(CCC(OCc1cccc(c1)N1CCN(C)c2nc(O)ncc2C1=O)c1cccs1)C(=O)OC(C)(C)C InChI=1S/C28H35N5O5S/c1-28(2,3)38-27(36)32(5)12-11-22(23-10-7-15-39-23)37-18-19-8-6-9-20(16-19)33-14-13-31(4)24-21(25(33)34)17-29-26(35)30-24/h6-10,15-17,22H,11-14,18H2,1-5H3,(H,29,30,35) ZTPGDAHIIALZHT-UHFFFAOYSA-N 436362 US10590140, Example 141::tert-butyl (3-((3-(2- hydroxy-9-methyl-5- oxo-5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436362&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633018 439657996 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888006 CN(CC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1)C(=O)OC(C)(C)C InChI=1S/C31H39N5O4/c1-22-32-20-26-28(33-22)34(5)17-18-36(29(26)37)25-14-10-11-23(19-25)21-39-27(24-12-8-7-9-13-24)15-16-35(6)30(38)40-31(2,3)4/h7-14,19-20,27H,15-18,21H2,1-6H3/t27-/m1/s1 CDRIBCCNLFNIAQ-HHHXNRCGSA-N 436363 US10590140, Example 142::tert-butyl (R)-(3-((3-(2,9- dimethyl-5-oxo-5,7,8,9- tetrahydro-6H-pyrimido [4,5-e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436363&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098851 439657997 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888007 CN(CCC(OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1)C(=O)OC(C)(C)C InChI=1S/C29H37N5O4S/c1-20-30-18-23-26(31-20)32(5)14-15-34(27(23)35)22-10-7-9-21(17-22)19-37-24(25-11-8-16-39-25)12-13-33(6)28(36)38-29(2,3)4/h7-11,16-18,24H,12-15,19H2,1-6H3 HDLVIZOESPPVDP-UHFFFAOYSA-N 436364 US10590140, Example 143::tert-butyl (3-((3-(2,9- dimethyl-5-oxo- 5,7,8,9-tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436364&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098888 439657998 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888008 CN(CCC(Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1)C(=O)OCC[Si](C)(C)C InChI=1S/C29H39N5O4SSi/c1-21-30-20-24-27(31-21)32(2)14-15-34(28(24)35)22-9-7-10-23(19-22)38-25(26-11-8-17-39-26)12-13-33(3)29(36)37-16-18-40(4,5)6/h7-11,17,19-20,25H,12-16,18H2,1-6H3 ZFOXVWVHVDMIBT-UHFFFAOYSA-N 436365 2-(trimethylsilyl)ethyl (3-(3-(2,9-dimethyl-5- oxo-5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate::US10590140, Example 144 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436365&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665917 439657999 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888009 CN(CC[C@@H](OCc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1ccccc1)C(=O)OC(C)(C)C InChI=1S/C30H37N5O4/c1-30(2,3)39-29(37)34(5)15-14-26(23-11-7-6-8-12-23)38-20-22-10-9-13-24(18-22)35-17-16-33(4)27-25(28(35)36)19-31-21-32-27/h6-13,18-19,21,26H,14-17,20H2,1-5H3/t26-/m1/s1 XPGVDZWPAVYYKB-AREMUKBSSA-N 436366 US10590140, Example 145::tert-butyl (R)-methyl(3- ((3-(9-methyl-5-oxo- 5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- phenylpropyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436366&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098786 439658000 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888010 CN(CCC(OCc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1)C(=O)OC(C)(C)C InChI=1S/C28H35N5O4S/c1-28(2,3)37-27(35)32(5)12-11-23(24-10-7-15-38-24)36-18-20-8-6-9-21(16-20)33-14-13-31(4)25-22(26(33)34)17-29-19-30-25/h6-10,15-17,19,23H,11-14,18H2,1-5H3 ILOIWXDMSNYECO-UHFFFAOYSA-N 436367 US10590140, Example 146::tert-butyl methyl(3-((3- (9-methyl-5-oxo- 5,7,8,9-tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzyl)oxy)-3- (thiophen-2- yl)propyl)carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436367&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089094 439658001 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888011 CN(CCC(Oc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1)C(=O)OCC[Si](C)(C)C InChI=1S/C28H37N5O4SSi/c1-31-13-14-33(27(34)23-19-29-20-30-26(23)31)21-8-6-9-22(18-21)37-24(25-10-7-16-38-25)11-12-32(2)28(35)36-15-17-39(3,4)5/h6-10,16,18-20,24H,11-15,17H2,1-5H3 JSGVIYUFFBYPDO-UHFFFAOYSA-N 436368 2-(trimethylsilyl)ethyl methyl(3-(3-(9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)phenoxy)-3- (thiophen-2- yl)propyl)carbamate::US10590140, Example 147 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436368&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665940 439658002 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888012 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)15-16-32(25(22)33)20-11-8-12-21(17-20)34-23(13-14-27-2)19-9-6-5-7-10-19/h5-12,17-18,23,27H,4,13-16H2,1-3H3,(H,28,29,30) MGGCXTKDCMPNFI-UHFFFAOYSA-N 436369 2-(ethylamino)-9-methyl- 6-(3-(3-(methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 148 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436369&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089092 439658003 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888013 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)15-16-32(25(22)33)20-11-8-12-21(17-20)34-23(13-14-27-2)19-9-6-5-7-10-19/h5-12,17-18,23,27H,4,13-16H2,1-3H3,(H,28,29,30)/t23-/m1/s1 MGGCXTKDCMPNFI-HSZRJFAPSA-N 436371 (R)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 149 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436371&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089090 439658005 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888014 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)15-16-32(25(22)33)20-11-8-12-21(17-20)34-23(13-14-27-2)19-9-6-5-7-10-19/h5-12,17-18,23,27H,4,13-16H2,1-3H3,(H,28,29,30)/t23-/m0/s1 MGGCXTKDCMPNFI-QHCPKHFHSA-N 436373 (S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 150 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436373&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089355 439658007 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888015 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-13-12-22(18-8-5-4-6-9-18)32-20-11-7-10-19(16-20)30-15-14-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-11,16-17,22,26H,12-15H2,1-3H3 QBVVGONNVGILBA-UHFFFAOYSA-N 436374 9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 151 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436374&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088741 439658008 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888016 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-13-12-22(18-8-5-4-6-9-18)32-20-11-7-10-19(16-20)30-15-14-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-11,16-17,22,26H,12-15H2,1-3H3/t22-/m1/s1 QBVVGONNVGILBA-JOCHJYFZSA-N 436375 (R)-9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 152 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436375&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088740 439658009 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888017 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-13-12-22(18-8-5-4-6-9-18)32-20-11-7-10-19(16-20)30-15-14-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-11,16-17,22,26H,12-15H2,1-3H3/t22-/m0/s1 QBVVGONNVGILBA-QFIPXVFZSA-N 436376 (S)-9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 153 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436376&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088806 439658010 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888018 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CNC)c3ccccc3)c1)C2=O InChI=1S/C25H30N6O2/c1-4-27-25-28-16-21-23(29-25)30(3)13-14-31(24(21)32)19-11-8-12-20(15-19)33-22(17-26-2)18-9-6-5-7-10-18/h5-12,15-16,22,26H,4,13-14,17H2,1-3H3,(H,27,28,29) ZPAUTBDMXAHDBQ-UHFFFAOYSA-N 436377 2-(ethylamino)-9- methyl-6-(3-(2- (methylamino)-1- phenylethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 154 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436377&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088920 439658011 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888019 CNCC(Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C24H27N5O2S/c1-25-16-21(17-8-5-4-6-9-17)31-19-11-7-10-18(14-19)29-13-12-28(2)22-20(23(29)30)15-26-24(27-22)32-3/h4-11,14-15,21,25H,12-13,16H2,1-3H3 HCXYEHUZKOHMCE-UHFFFAOYSA-N 436378 9-methyl-6-(3-(2- (methylamino)-1- phenylethoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 155 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436378&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089108 439658012 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888020 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN)c3ccccc3)c1)C2=O InChI=1S/C24H28N6O2/c1-3-26-24-27-16-20-22(28-24)29(2)12-13-30(23(20)31)18-10-7-11-19(14-18)32-21(15-25)17-8-5-4-6-9-17/h4-11,14,16,21H,3,12-13,15,25H2,1-2H3,(H,26,27,28) LFEHCMKACROQQQ-UHFFFAOYSA-N 436379 6-(3-(2-amino-1- phenylethoxy)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 156 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436379&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088960 439658013 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888021 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(C)CNC)c1)C2=O InChI=1S/C20H28N6O2/c1-5-22-20-23-13-17-18(24-20)25(4)9-10-26(19(17)27)15-7-6-8-16(11-15)28-14(2)12-21-3/h6-8,11,13-14,21H,5,9-10,12H2,1-4H3,(H,22,23,24) FFVFTWZKOBMITA-UHFFFAOYSA-N 436380 2-(ethylamino)-9- methyl-6-(3-((1- (methylamino)propan- 2-yl)oxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 157 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436380&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089024 439658014 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888022 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CNC)C(C)C)c1)C2=O InChI=1S/C22H32N6O2/c1-6-24-22-25-13-18-20(26-22)27(5)10-11-28(21(18)29)16-8-7-9-17(12-16)30-19(14-23-4)15(2)3/h7-9,12-13,15,19,23H,6,10-11,14H2,1-5H3,(H,24,25,26) ISUMTMWNFLWHLC-UHFFFAOYSA-N 436381 2-(ethylamino)-9- methyl-6-(3-((3- methyl-1- (methylamino)butan-2- yl)oxy)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 158 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436381&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089058 439658015 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888023 CCNc1ncc2c(n1)N(C)CCN(c1ccc(OC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C25H30N6O2/c1-4-27-25-28-16-21-23(29-25)30(3)14-15-31(24(21)32)19-10-12-20(13-11-19)33-22(17-26-2)18-8-6-5-7-9-18/h5-13,16,22,26H,4,14-15,17H2,1-3H3,(H,27,28,29) ZPDLVPVVMUDJJV-UHFFFAOYSA-N 436384 2-(ethylamino)-9- methyl-6-(4-(2- (methylamino)-1- phenylethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 159 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436384&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089243 439658017 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888024 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)22-12-8-9-20(17-22)19-35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31) CHQJWHDWPUGTOO-UHFFFAOYSA-N 436385 2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 160 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436385&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088848 439658018 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888025 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)22-12-8-9-20(17-22)19-35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31)/t24-/m1/s1 CHQJWHDWPUGTOO-XMMPIXPASA-N 436386 (R)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 161 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436386&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089079 439658019 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888026 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)22-12-8-9-20(17-22)19-35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31)/t24-/m0/s1 CHQJWHDWPUGTOO-DEOSSOPVSA-N 436387 (S)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 162 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436387&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088846 439658020 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888027 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3 KVXVYTXQWCDYQC-UHFFFAOYSA-N 436388 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 163 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436388&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089018 439658021 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888028 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3/t23-/m1/s1 KVXVYTXQWCDYQC-HSZRJFAPSA-N 436389 (R)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 164 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436389&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089017 439658022 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888029 CNCC[C@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3/t23-/m0/s1 KVXVYTXQWCDYQC-QHCPKHFHSA-N 436390 (S)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 165 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436390&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098976 439658023 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888030 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COCC(NC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)13-14-32(25(22)33)21-12-8-9-19(15-21)17-34-18-23(27-2)20-10-6-5-7-11-20/h5-12,15-16,23,27H,4,13-14,17-18H2,1-3H3,(H,28,29,30) PWQZZRUUAPCYPI-UHFFFAOYSA-N 436391 2-(ethylamino)-9- methyl-6-(3-((2- (methylamino)-2- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 166 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436391&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088880 439658024 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888031 CNC(COCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-22(19-9-5-4-6-10-19)17-32-16-18-8-7-11-20(14-18)30-13-12-29(2)23-21(24(30)31)15-27-25(28-23)33-3/h4-11,14-15,22,26H,12-13,16-17H2,1-3H3 CXMKCHCPOIXOFO-UHFFFAOYSA-N 436392 9-methyl-6-(3-((2- (methylamino)-2- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 167 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436392&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088752 439658025 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888032 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCNC)c1)C2=O InChI=1S/C20H28N6O2/c1-4-22-20-23-14-17-18(24-20)25(3)10-11-26(19(17)27)15-7-5-8-16(13-15)28-12-6-9-21-2/h5,7-8,13-14,21H,4,6,9-12H2,1-3H3,(H,22,23,24) YDYYWGQXEZDLHG-UHFFFAOYSA-N 436393 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)propoxy) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 168 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436393&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089198 439658026 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888033 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCNCc3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-3-28-26-29-19-23-24(30-26)31(2)14-15-32(25(23)33)21-11-7-12-22(17-21)34-16-8-13-27-18-20-9-5-4-6-10-20/h4-7,9-12,17,19,27H,3,8,13-16,18H2,1-2H3,(H,28,29,30) ARJQUHZAOAYLKD-UHFFFAOYSA-N 436394 6-(3-(3- (benzylamino)propoxy) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 169 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436394&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088713 439658027 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888034 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCNC)c1)C2=O InChI=1S/C19H26N6O2/c1-4-21-19-22-13-16-17(23-19)24(3)9-10-25(18(16)26)14-6-5-7-15(12-14)27-11-8-20-2/h5-7,12-13,20H,4,8-11H2,1-3H3,(H,21,22,23) LPNLXHKVRFACHX-UHFFFAOYSA-N 436395 2-(ethylamino)-9- methyl-6-(3-(2- (methylamino)ethoxy) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 170 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436395&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088865 439658028 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888035 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCCNC)c1)C2=O InChI=1S/C20H28N6O/c1-4-22-20-23-14-17-18(24-20)25(3)11-12-26(19(17)27)16-9-5-7-15(13-16)8-6-10-21-2/h5,7,9,13-14,21H,4,6,8,10-12H2,1-3H3,(H,22,23,24) YCSXNFFKYOYLHA-UHFFFAOYSA-N 436396 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)propyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 171 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436396&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089403 439658029 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888036 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCNC)c1)C2=O InChI=1S/C19H26N6O/c1-4-21-19-22-13-16-17(23-19)24(3)10-11-25(18(16)26)15-7-5-6-14(12-15)8-9-20-2/h5-7,12-13,20H,4,8-11H2,1-3H3,(H,21,22,23) VJRMHODAZBAPES-UHFFFAOYSA-N 436397 2-(ethylamino)-9- methyl-6-(3-(2- (methylamino)ethyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 172 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436397&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089257 439658030 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888037 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C(C)(C)CNC)C2=O InChI=1S/C21H30N6O/c1-6-23-20-24-13-17-18(25-20)26(5)10-11-27(19(17)28)16-9-7-8-15(12-16)21(2,3)14-22-4/h7-9,12-13,22H,6,10-11,14H2,1-5H3,(H,23,24,25) BHQPAGKRKRGPFF-UHFFFAOYSA-N 436398 2-(ethylamino)-9- methyl-6-(3-(2-methyl- 1-(methylamino) propan- 2-yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 173 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436398&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088994 439658031 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888038 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CNC)c1)C2=O InChI=1S/C18H24N6O/c1-4-20-18-21-12-15-16(22-18)23(3)8-9-24(17(15)25)14-7-5-6-13(10-14)11-19-2/h5-7,10,12,19H,4,8-9,11H2,1-3H3,(H,20,21,22) IFLQKCMLUXJREE-UHFFFAOYSA-N 436399 2-(ethylamino)-9- methyl-6-(3- ((methylamino)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 174 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436399&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089003 439658032 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888039 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC3CCNC3)c1)C2=O InChI=1S/C20H26N6O2/c1-3-22-20-23-13-17-18(24-20)25(2)9-10-26(19(17)27)14-5-4-6-15(11-14)28-16-7-8-21-12-16/h4-6,11,13,16,21H,3,7-10,12H2,1-2H3,(H,22,23,24) CMJVXLYQODLWRY-UHFFFAOYSA-N 436400 2-(ethylamino)-9- methyl-6-(3-(pyrrolidin- 3-yloxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 175 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436400&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088913 439658033 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888040 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCNCC3)c3ccccc3)c1)C2=O InChI=1S/C28H34N6O2/c1-3-30-27-31-19-24-25(32-27)33(2)16-17-34(26(24)35)23-11-7-8-21(18-23)20-36-28(12-14-29-15-13-28)22-9-5-4-6-10-22/h4-11,18-19,29H,3,12-17,20H2,1-2H3,(H,30,31,32) XLFFYNPNRFDLQJ-UHFFFAOYSA-N 436401 2-(ethylamino)-9- methyl-6-(3-(((4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 176 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436401&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088977 439658034 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888041 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O)c1)C2=O InChI=1S/C16H19N5O2/c1-3-17-16-18-10-13-14(19-16)20(2)7-8-21(15(13)23)11-5-4-6-12(22)9-11/h4-6,9-10,22H,3,7-8H2,1-2H3,(H,17,18,19) JUTODCFWZKMMQE-UHFFFAOYSA-N 436402 2-(ethylamino)-6-(3- hydroxyphenyl)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 177 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436402&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089436 439658035 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888042 CCNc1ncc2c(n1)N(C)CCN(c1ccc(O)cc1)C2=O InChI=1S/C16H19N5O2/c1-3-17-16-18-10-13-14(19-16)20(2)8-9-21(15(13)23)11-4-6-12(22)7-5-11/h4-7,10,22H,3,8-9H2,1-2H3,(H,17,18,19) LKVOFRCKKLGEQY-UHFFFAOYSA-N 436403 2-(ethylamino)-6-(4- hydroxyphenyl)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 178 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436403&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088723 439658036 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888043 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCNCC3)c3ccccc3)c1)C2=O InChI=1S/C27H31N5O2S/c1-31-15-16-32(25(33)23-18-29-26(35-2)30-24(23)31)22-10-6-7-20(17-22)19-34-27(11-13-28-14-12-27)21-8-4-3-5-9-21/h3-10,17-18,28H,11-16,19H2,1-2H3 STZOTCANDMGQHG-UHFFFAOYSA-N 436404 9-methyl-2- (methylthio)-6-(3-(((4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 179 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436404&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089317 439658037 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888044 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNC)nn1)C2=O InChI=1S/C20H25N9O/c1-4-22-20-23-12-17-18(24-20)27(3)8-9-28(19(17)30)15-6-5-7-16(10-15)29-13-14(11-21-2)25-26-29/h5-7,10,12-13,21H,4,8-9,11H2,1-3H3,(H,22,23,24) USUWLJINYLMRPC-UHFFFAOYSA-N 436405 2-(ethylamino)-9- methyl-6-(3-(4- ((methylamino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 180 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436405&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089170 439658038 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888045 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN)nn1)C2=O InChI=1S/C19H23N9O/c1-3-21-19-22-11-16-17(23-19)26(2)7-8-27(18(16)29)14-5-4-6-15(9-14)28-12-13(10-20)24-25-28/h4-6,9,11-12H,3,7-8,10,20H2,1-2H3,(H,21,22,23) JURPSAFYZJRZSY-UHFFFAOYSA-N 436406 6-(3-(4-(aminomethyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 181 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436406&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098804 439658039 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888046 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNCc3ccccc3)nn1)C2=O InChI=1S/C26H29N9O/c1-3-28-26-29-17-23-24(30-26)33(2)12-13-34(25(23)36)21-10-7-11-22(14-21)35-18-20(31-32-35)16-27-15-19-8-5-4-6-9-19/h4-11,14,17-18,27H,3,12-13,15-16H2,1-2H3,(H,28,29,30) XMQMKCVOYHQFMM-UHFFFAOYSA-N 436407 6-(3-(4- ((benzylamino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 182 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436407&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089181 439658040 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888047 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CCNC)nn1)C2=O InChI=1S/C21H27N9O/c1-4-23-21-24-13-18-19(25-21)28(3)10-11-29(20(18)31)16-6-5-7-17(12-16)30-14-15(26-27-30)8-9-22-2/h5-7,12-14,22H,4,8-11H2,1-3H3,(H,23,24,25) CFBFTFILZYUSEP-UHFFFAOYSA-N 436408 2-(ethylamino)-9- methyl-6-(3-(4-(2- (methylamino)ethyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 183 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436408&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089492 439658041 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888048 CCNc1ncc2c(n1)N(C)CCN(c1cccc(Cn3cc(CNC)nn3)c1)C2=O InChI=1S/C21H27N9O/c1-4-23-21-24-12-18-19(25-21)28(3)8-9-30(20(18)31)17-7-5-6-15(10-17)13-29-14-16(11-22-2)26-27-29/h5-7,10,12,14,22H,4,8-9,11,13H2,1-3H3,(H,23,24,25) KTQYDDLRSPUCSM-UHFFFAOYSA-N 436409 2-(ethylamino)-9- methyl-6-(3-((4- ((methylamino)methyl)- 1H-1,2,3-triazol-1- yl)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 184 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436409&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089226 439658042 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888049 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNC)cn1)C2=O InChI=1S/C21H26N8O/c1-4-23-21-24-13-18-19(26-21)27(3)8-9-28(20(18)30)16-6-5-7-17(10-16)29-14-15(11-22-2)12-25-29/h5-7,10,12-14,22H,4,8-9,11H2,1-3H3,(H,23,24,26) QWJQVONMLUAILW-UHFFFAOYSA-N 436410 2-(ethylamino)-9- methyl-6-(3-(4- ((methylamino)methyl)- 1H-pyrazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 185 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436410&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098806 439658043 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888050 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CNC)c1)C2=O InChI=1S/C21H26N8O/c1-4-23-21-24-12-18-19(26-21)27(3)8-9-29(20(18)30)17-7-5-6-16(10-17)28-13-15(11-22-2)25-14-28/h5-7,10,12-14,22H,4,8-9,11H2,1-3H3,(H,23,24,26) YTGCBRFRVQARFE-UHFFFAOYSA-N 436411 2-(ethylamino)-9- methyl-6-(3-(4- ((methylamino)methyl)- 1H-imidazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 186 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436411&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138607915 439658044 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888051 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(CNC)o1)C2=O InChI=1S/C20H24N8O2/c1-4-22-20-23-11-15-17(24-20)27(3)8-9-28(19(15)29)14-7-5-6-13(10-14)18-26-25-16(30-18)12-21-2/h5-7,10-11,21H,4,8-9,12H2,1-3H3,(H,22,23,24) OHEDKNVOEQIXQG-UHFFFAOYSA-N 436412 2-(ethylamino)-9- methyl-6-(3-(5- ((methylamino)methyl)- 1,3,4-oxadiazol-2- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 187 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436412&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088955 439658045 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888052 CCNc1ncc2c(n1)N(C)CCN(c1ccccc1OC(CCNC)c1ccccc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-20-24(30-26)31(3)16-17-32(25(20)33)21-12-8-9-13-23(21)34-22(14-15-27-2)19-10-6-5-7-11-19/h5-13,18,22,27H,4,14-17H2,1-3H3,(H,28,29,30) OQARDIVTQJINDH-UHFFFAOYSA-N 436413 2-(ethylamino)-9- methyl-6-(2-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 188 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436413&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088918 439658046 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888053 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)C(C)C)c1)C2=O InChI=1S/C24H36N6O2/c1-6-26-24-27-15-20-22(28-24)29(5)12-13-30(23(20)31)19-9-7-8-18(14-19)16-32-21(17(2)3)10-11-25-4/h7-9,14-15,17,21,25H,6,10-13,16H2,1-5H3,(H,26,27,28) RPSFSJMMYIORHB-UHFFFAOYSA-N 436414 2-(ethylamino)-9- methyl-6-(3-(((4- methyl-1- (methylamino)pentan- 3- yl)oxy)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 189 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436414&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089273 439658047 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888054 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)C(C)C InChI=1S/C23H33N5O2S/c1-16(2)20(9-10-24-3)30-15-17-7-6-8-18(13-17)28-12-11-27(4)21-19(22(28)29)14-25-23(26-21)31-5/h6-8,13-14,16,20,24H,9-12,15H2,1-5H3 TYJDZKABIWQJPT-UHFFFAOYSA-N 436415 9-methyl-6-(3-(((4- methyl-1- (methylamino)pentan- 3-yl)oxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 190 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436415&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089189 439658048 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888055 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(C)CCNC)c1)C2=O InChI=1S/C22H32N6O2/c1-5-24-22-25-14-19-20(26-22)27(4)11-12-28(21(19)29)18-8-6-7-17(13-18)15-30-16(2)9-10-23-3/h6-8,13-14,16,23H,5,9-12,15H2,1-4H3,(H,24,25,26) ZMJMVWYBVPMKAI-UHFFFAOYSA-N 436416 2-(ethylamino)-9- methyl-6-(3-(((4- (methylamino)butan-2- yl)oxy)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 191 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436416&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088837 439658049 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888056 CNCCC(C)OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O InChI=1S/C21H29N5O2S/c1-15(8-9-22-2)28-14-16-6-5-7-17(12-16)26-11-10-25(3)19-18(20(26)27)13-23-21(24-19)29-4/h5-7,12-13,15,22H,8-11,14H2,1-4H3 LXWVDJDGMQJDKN-UHFFFAOYSA-N 436417 9-methyl-6-(3-(((4- (methylamino)butan-2- yl)oxy)methyl)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 192 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436417&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089302 439658050 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888057 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3ccccn3)c1)C2=O InChI=1S/C25H31N7O2/c1-4-27-25-29-17-20-23(30-25)31(3)14-15-32(24(20)33)18-8-7-9-19(16-18)34-22(11-13-26-2)21-10-5-6-12-28-21/h5-10,12,16-17,22,26H,4,11,13-15H2,1-3H3,(H,27,29,30) AWBSENWJRYCHOK-UHFFFAOYSA-N 436418 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (pyridin-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 193 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436418&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088900 439658051 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888058 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3cccnc3)c1)C2=O InChI=1S/C25H31N7O2/c1-4-28-25-29-17-21-23(30-25)31(3)13-14-32(24(21)33)19-8-5-9-20(15-19)34-22(10-12-26-2)18-7-6-11-27-16-18/h5-9,11,15-17,22,26H,4,10,12-14H2,1-3H3,(H,28,29,30) WKAZWRBRFSPHSO-UHFFFAOYSA-N 436419 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (pyridin-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 194 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436419&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088969 439658052 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888059 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1ccccc1 InChI=1S/C25H30N6O2/c1-27-12-11-22(19-8-4-3-5-9-19)33-17-18-7-6-10-20(15-18)31-14-13-30(2)23-21(24(31)32)16-28-25(26)29-23/h3-10,15-16,22,27H,11-14,17H2,1-2H3,(H2,26,28,29)/t22-/m1/s1 NBOBGWSKDGTTTF-JOCHJYFZSA-N 436420 (R)-2-amino-9-methyl- 6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 195 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436420&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089211 439658053 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888060 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)C)c1ccccc1 InChI=1S/C27H34N6O2/c1-28-14-13-24(21-10-6-5-7-11-21)35-19-20-9-8-12-22(17-20)33-16-15-32(4)25-23(26(33)34)18-29-27(30-25)31(2)3/h5-12,17-18,24,28H,13-16,19H2,1-4H3/t24-/m1/s1 CDYPJHDIRLXZGD-XMMPIXPASA-N 436421 (R)-2-(dimethylamino)- 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 196 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436421&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089114 439658054 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888061 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(NC)ncc2C1=O)c1ccccc1 InChI=1S/C26H32N6O2/c1-27-13-12-23(20-9-5-4-6-10-20)34-18-19-8-7-11-21(16-19)32-15-14-31(3)24-22(25(32)33)17-29-26(28-2)30-24/h4-11,16-17,23,27H,12-15,18H2,1-3H3,(H,28,29,30)/t23-/m1/s1 LYULKSAOWFGIIM-HSZRJFAPSA-N 436422 (R)-9-methyl-2- (methylamino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 197 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436422&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089173 439658055 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888062 CCNc1cc2N(C)CCN(c3cccc(OC(CCNC)c4ccccc4)c3)C(=O)c2cn1 InChI=1S/C27H33N5O2/c1-4-29-26-18-24-23(19-30-26)27(33)32(16-15-31(24)3)21-11-8-12-22(17-21)34-25(13-14-28-2)20-9-6-5-7-10-20/h5-12,17-19,25,28H,4,13-16H2,1-3H3,(H,29,30) KRPGVVAIUXEMBJ-UHFFFAOYSA-N 436423 8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 198 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436423&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089219 439658056 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888063 CCNc1cc2N(C)CCN(c3cccc(COC(CCNC)c4ccccc4)c3)C(=O)c2cn1 InChI=1S/C28H35N5O2/c1-4-30-27-18-25-24(19-31-27)28(34)33(16-15-32(25)3)23-12-8-9-21(17-23)20-35-26(13-14-29-2)22-10-6-5-7-11-22/h5-12,17-19,26,29H,4,13-16,20H2,1-3H3,(H,30,31) UGLSMSONQDUWTK-UHFFFAOYSA-N 436424 8-(ethylamino)-1- methyl-4-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-1,2,3,4- tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 199 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436424&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098870 439658057 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888064 CCNc1ncc2c(n1)N(C)CCN(Cc1cccc(OC(CNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)13-14-32(25(22)33)18-19-9-8-12-21(15-19)34-23(17-27-2)20-10-6-5-7-11-20/h5-12,15-16,23,27H,4,13-14,17-18H2,1-3H3,(H,28,29,30) UOBVHUAGVWVKPT-UHFFFAOYSA-N 436425 2-(ethylamino)-9- methyl-6-(3-(2- (methylamino)-1- phenylethoxy)benzyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 200 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436425&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088758 439658058 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888065 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)14-15-32(25(22)33)18-19-10-12-21(13-11-19)34-23(17-27-2)20-8-6-5-7-9-20/h5-13,16,23,27H,4,14-15,17-18H2,1-3H3,(H,28,29,30) GJGWYWKLHSDJKA-UHFFFAOYSA-N 436426 2-(ethylamino)-9- methyl-6-(4-(2- (methylamino)-1- phenylethoxy)benzyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 201 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436426&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089230 439658059 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888066 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(CNC)cc1)C2=O InChI=1S/C19H26N6O/c1-4-21-19-22-12-16-17(23-19)24(3)9-10-25(18(16)26)13-15-7-5-14(6-8-15)11-20-2/h5-8,12,20H,4,9-11,13H2,1-3H3,(H,21,22,23) LQLPKFPKSBWWGM-UHFFFAOYSA-N 436427 2-(ethylamino)-9- methyl-6-(4- ((methylamino)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 202 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436427&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089201 439658060 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888067 CCNc1ncc2CN(CCN(C)c2n1)c1cccc(CO[C@H](CCNC)c2ccccc2)c1 InChI=1S/C27H36N6O/c1-4-29-27-30-18-23-19-33(16-15-32(3)26(23)31-27)24-12-8-9-21(17-24)20-34-25(13-14-28-2)22-10-6-5-7-11-22/h5-12,17-18,25,28H,4,13-16,19-20H2,1-3H3,(H,29,30,31)/t25-/m1/s1 JPTFPOGWDCHQKW-RUZDIDTESA-N 436428 (R)-N-ethyl-9-methyl- 6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-2- amine::US10590140, Example 203 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436428&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088970 439658061 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888068 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(OC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O3/c1-27-13-12-23(20-9-5-4-6-10-20)34-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)33-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3/t23-/m1/s1 XGZCTJPTWRWPPQ-HSZRJFAPSA-N 436429 (R)-2-methoxy-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 204 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436429&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088993 439658062 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888069 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(O)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O3/c1-26-12-11-22(19-8-4-3-5-9-19)33-17-18-7-6-10-20(15-18)30-14-13-29(2)23-21(24(30)31)16-27-25(32)28-23/h3-10,15-16,22,26H,11-14,17H2,1-2H3,(H,27,28,32)/t22-/m1/s1 MFVCDOIXYGRALQ-JOCHJYFZSA-N 436430 (R)-2-hydroxy-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 205 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436430&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089199 439658063 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888070 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-17-23-25(29-19)30(3)14-15-31(26(23)32)22-11-7-8-20(16-22)18-33-24(12-13-27-2)21-9-5-4-6-10-21/h4-11,16-17,24,27H,12-15,18H2,1-3H3/t24-/m1/s1 FGHVDUIPGXFWJC-XMMPIXPASA-N 436431 (R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 206 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436431&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088794 439658064 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888071 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-12-11-23(20-8-4-3-5-9-20)32-17-19-7-6-10-21(15-19)30-14-13-29(2)24-22(25(30)31)16-27-18-28-24/h3-10,15-16,18,23,26H,11-14,17H2,1-2H3/t23-/m1/s1 JPDXVFKPRNDKAL-HSZRJFAPSA-N 436432 (R)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 207 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436432&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088867 439658065 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888072 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-10-9-20(21-8-5-13-33-21)31-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3 QZTSBVNAYFBWIC-UHFFFAOYSA-N 436433 9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 208 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436433&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088802 439658066 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888073 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-10-9-20(21-8-5-13-33-21)31-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3/t20-/m1/s1 QZTSBVNAYFBWIC-HXUWFJFHSA-N 436434 (R)-9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 209 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436434&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089343 439658067 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888074 CNCC[C@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-10-9-20(21-8-5-13-33-21)31-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3/t20-/m0/s1 QZTSBVNAYFBWIC-FQEVSTJZSA-N 436435 (S)-9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 210 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436435&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088799 439658068 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888075 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)c3cccs3)c1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)12-13-31(24(20)32)19-8-5-7-18(15-19)17-33-21(10-11-26-2)22-9-6-14-34-22/h5-9,14-16,21,26H,4,10-13,17H2,1-3H3,(H,27,28,29) XJHDXJNNMHSVDG-UHFFFAOYSA-N 436436 2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 211 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436436&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088833 439658069 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888076 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)12-13-31(24(20)32)19-8-5-7-18(15-19)17-33-21(10-11-26-2)22-9-6-14-34-22/h5-9,14-16,21,26H,4,10-13,17H2,1-3H3,(H,27,28,29)/t21-/m1/s1 XJHDXJNNMHSVDG-OAQYLSRUSA-N 436437 (R)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 212 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436437&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088832 439658070 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888077 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)12-13-31(24(20)32)19-8-5-7-18(15-19)17-33-21(10-11-26-2)22-9-6-14-34-22/h5-9,14-16,21,26H,4,10-13,17H2,1-3H3,(H,27,28,29)/t21-/m0/s1 XJHDXJNNMHSVDG-NRFANRHFSA-N 436438 (S)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 213 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436438&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098805 439658071 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888078 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3cccs3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-16-19-22(28-24)29(3)12-13-30(23(19)31)17-7-5-8-18(15-17)32-20(10-11-25-2)21-9-6-14-33-21/h5-9,14-16,20,25H,4,10-13H2,1-3H3,(H,26,27,28) JRMKRCWDAUYJRA-UHFFFAOYSA-N 436439 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 214 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436439&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088768 439658072 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888079 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-16-19-22(28-24)29(3)12-13-30(23(19)31)17-7-5-8-18(15-17)32-20(10-11-25-2)21-9-6-14-33-21/h5-9,14-16,20,25H,4,10-13H2,1-3H3,(H,26,27,28)/t20-/m1/s1 JRMKRCWDAUYJRA-HXUWFJFHSA-N 436440 (R)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 215 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436440&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089019 439658073 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888080 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-16-19-22(28-24)29(3)12-13-30(23(19)31)17-7-5-8-18(15-17)32-20(10-11-25-2)21-9-6-14-33-21/h5-9,14-16,20,25H,4,10-13H2,1-3H3,(H,26,27,28)/t20-/m0/s1 JRMKRCWDAUYJRA-FQEVSTJZSA-N 436441 (S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 216 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436441&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088914 439658074 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888081 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S2/c1-24-10-9-19(20-8-5-13-32-20)30-17-7-4-6-16(14-17)28-12-11-27(2)21-18(22(28)29)15-25-23(26-21)31-3/h4-8,13-15,19,24H,9-12H2,1-3H3 LRBRSWLNUGPGBK-UHFFFAOYSA-N 436442 9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 217 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436442&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089059 439658075 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888082 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S2/c1-24-10-9-19(20-8-5-13-32-20)30-17-7-4-6-16(14-17)28-12-11-27(2)21-18(22(28)29)15-25-23(26-21)31-3/h4-8,13-15,19,24H,9-12H2,1-3H3/t19-/m1/s1 LRBRSWLNUGPGBK-LJQANCHMSA-N 436443 (R)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 218 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436443&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098986 439658076 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888083 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S2/c1-24-10-9-19(20-8-5-13-32-20)30-17-7-4-6-16(14-17)28-12-11-27(2)21-18(22(28)29)15-25-23(26-21)31-3/h4-8,13-15,19,24H,9-12H2,1-3H3/t19-/m0/s1 LRBRSWLNUGPGBK-IBGZPJMESA-N 436444 (S)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 219 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436444&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089081 439658077 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888084 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNCCF)c3cccs3)c1)C2=O InChI=1S/C25H31FN6O2S/c1-3-28-25-29-17-20-23(30-25)31(2)13-14-32(24(20)33)18-6-4-7-19(16-18)34-21(9-11-27-12-10-26)22-8-5-15-35-22/h4-8,15-17,21,27H,3,9-14H2,1-2H3,(H,28,29,30) LGCBBPIBXKFSJC-UHFFFAOYSA-N 436445 2-(ethylamino)-6-(3-(3- ((2-fluoroethyl)amino)- 1-(thiophen-2- yl)propoxy)phenyl)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 220 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436445&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089276 439658078 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888085 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(OC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O3S/c1-25-10-9-20(21-8-5-13-33-21)32-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)31-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3 WKIWZYVELZLXOB-UHFFFAOYSA-N 436446 2-methoxy-9-methyl-6- (3-((3-(methylamino)- 1-(thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 221 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436446&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088997 439658079 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888086 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(O)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O3S/c1-24-9-8-19(20-7-4-12-32-20)31-15-16-5-3-6-17(13-16)28-11-10-27(2)21-18(22(28)29)14-25-23(30)26-21/h3-7,12-14,19,24H,8-11,15H2,1-2H3,(H,25,26,30) UYKJZILKOZJTOW-UHFFFAOYSA-N 436447 2-hydroxy-9-methyl-6- (3-((3-(methylamino)- 1-(thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 222 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436447&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089299 439658080 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888087 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)11-12-29(24(20)30)19-7-4-6-18(14-19)16-31-21(9-10-25-2)22-8-5-13-32-22/h4-8,13-15,21,25H,9-12,16H2,1-3H3 DDWJAWDHKATTEZ-UHFFFAOYSA-N 436448 2,9-dimethyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 223 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436448&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088766 439658081 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888088 CNCCC(OCc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-9-8-20(21-7-4-12-31-21)30-15-17-5-3-6-18(13-17)28-11-10-27(2)22-19(23(28)29)14-25-16-26-22/h3-7,12-14,16,20,24H,8-11,15H2,1-2H3 WXSFJWUCHFZTTH-UHFFFAOYSA-N 436449 9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 224 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436449&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088814 439658082 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888089 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)13-14-32(25(22)33)21-12-8-9-19(15-21)18-34-23(17-27-2)20-10-6-5-7-11-20/h5-12,15-16,23,27H,4,13-14,17-18H2,1-3H3,(H,28,29,30) MEOLTPHCLOQZCR-UHFFFAOYSA-N 436450 2-(ethylamino)-9-methyl- 6-(3-((2-(methylamino)-1- phenylethoxy)methyl) phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 225 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436450&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088999 439658083 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888090 CNCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-16-22(19-9-5-4-6-10-19)32-17-18-8-7-11-20(14-18)30-13-12-29(2)23-21(24(30)31)15-27-25(28-23)33-3/h4-11,14-15,22,26H,12-13,16-17H2,1-3H3 SGXUKVBSKHLQJE-UHFFFAOYSA-N 436451 9-methyl-6-(3-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 226 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436451&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089205 439658084 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888091 CCNc1cc2N(C)CCN(c3cccc(OC(CCNC)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C25H31N5O2S/c1-4-27-24-16-21-20(17-28-24)25(31)30(13-12-29(21)3)18-7-5-8-19(15-18)32-22(10-11-26-2)23-9-6-14-33-23/h5-9,14-17,22,26H,4,10-13H2,1-3H3,(H,27,28) JOLCTAVEKPKHAQ-UHFFFAOYSA-N 436452 8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 227 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436452&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089111 439658085 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888092 CCNc1cc2N(C)CCN(c3cccc(COC(CCNC)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C26H33N5O2S/c1-4-28-25-16-22-21(17-29-25)26(32)31(13-12-30(22)3)20-8-5-7-19(15-20)18-33-23(10-11-27-2)24-9-6-14-34-24/h5-9,14-17,23,27H,4,10-13,18H2,1-3H3,(H,28,29) CTUAHRGEVUYYDN-UHFFFAOYSA-N 436453 8-(ethylamino)-1- methyl-4-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 228 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436453&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088817 439658086 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888093 CNCCC(Oc1cccc(c1)N1CCN(C)c2cc(ncc2C1=O)N(C)C)c1cccs1 InChI=1S/C25H31N5O2S/c1-26-11-10-22(23-9-6-14-33-23)32-19-8-5-7-18(15-19)30-13-12-29(4)21-16-24(28(2)3)27-17-20(21)25(30)31/h5-9,14-17,22,26H,10-13H2,1-4H3 RPJMFEMGOQFHBY-UHFFFAOYSA-N 436454 8-(dimethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 229 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436454&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089297 439658087 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888094 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)C)c1cccs1 InChI=1S/C24H30N6O2S/c1-25-11-10-20(21-9-6-14-33-21)32-18-8-5-7-17(15-18)30-13-12-29(4)22-19(23(30)31)16-26-24(27-22)28(2)3/h5-9,14-16,20,25H,10-13H2,1-4H3 YCGNFTGPXBAEMC-UHFFFAOYSA-N 436455 2-(dimethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 230 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436455&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089498 439658088 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888095 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-16-25-15-19-22(26-16)27(3)11-12-28(23(19)29)17-6-4-7-18(14-17)30-20(9-10-24-2)21-8-5-13-31-21/h4-8,13-15,20,24H,9-12H2,1-3H3 QSGMFCUAWLYRRU-UHFFFAOYSA-N 436456 2,9-dimethyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 231 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436456&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088711 439658089 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888096 CNCCC(Oc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C22H25N5O2S/c1-23-9-8-19(20-7-4-12-30-20)29-17-6-3-5-16(13-17)27-11-10-26(2)21-18(22(27)28)14-24-15-25-21/h3-7,12-15,19,23H,8-11H2,1-2H3 KYQUYMHBNNIIFU-UHFFFAOYSA-N 436457 9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 232 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436457&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089012 439658090 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888097 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C1=CCN(CC1)C(=O)OC(C)(C)C)C2=O InChI=1S/C26H34N6O3/c1-6-27-24-28-17-21-22(29-24)30(5)14-15-32(23(21)33)20-9-7-8-19(16-20)18-10-12-31(13-11-18)25(34)35-26(2,3)4/h7-10,16-17H,6,11-15H2,1-5H3,(H,27,28,29) ANQCUHKIMUMRHX-UHFFFAOYSA-N 436458 US10590140, Example 233::tert-butyl 4-(3-(2- (ethylamino)-9-methyl-5- oxo-5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)-3,6- dihydropyridine-1(2H)- carboxylate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436458&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089537 439658091 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888098 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C1CCN(CC1)C(=O)OC(C)(C)C)C2=O InChI=1S/C26H36N6O3/c1-6-27-24-28-17-21-22(29-24)30(5)14-15-32(23(21)33)20-9-7-8-19(16-20)18-10-12-31(13-11-18)25(34)35-26(2,3)4/h7-9,16-18H,6,10-15H2,1-5H3,(H,27,28,29) BCSXWFCMFQDDGI-UHFFFAOYSA-N 436459 US10590140, Example 234::tert-butyl 4-(3-(2- (ethylamino)-9-methyl-5- oxo-5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)phenyl)piperidine-1- carboxylate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436459&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089130 439658092 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888099 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C1CCNCC1)C2=O InChI=1S/C21H28N6O/c1-3-23-21-24-14-18-19(25-21)26(2)11-12-27(20(18)28)17-6-4-5-16(13-17)15-7-9-22-10-8-15/h4-6,13-15,22H,3,7-12H2,1-2H3,(H,23,24,25) ARJLCBOALPHDQJ-UHFFFAOYSA-N 436460 2-(ethylamino)-9-methyl- 6-(3-(piperidin-4- yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 235 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436460&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089303 439658093 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888100 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C)c3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-5-29-28-30-19-24-26(31-28)33(4)16-17-34(27(24)35)23-13-9-10-21(18-23)20-36-25(14-15-32(2)3)22-11-7-6-8-12-22/h6-13,18-19,25H,5,14-17,20H2,1-4H3,(H,29,30,31)/t25-/m1/s1 GKLAATWMSQRFGB-RUZDIDTESA-N 436461 (R)-6-(3-((3- (dimethylamino)-1- phenylpropoxy)methyl) phenyl)-2-(ethylamino)-9- methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 236 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436461&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089330 439658094 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888101 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCN(C)C)c3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-5-29-28-30-19-24-26(31-28)33(4)16-17-34(27(24)35)23-13-9-10-21(18-23)20-36-25(14-15-32(2)3)22-11-7-6-8-12-22/h6-13,18-19,25H,5,14-17,20H2,1-4H3,(H,29,30,31)/t25-/m0/s1 GKLAATWMSQRFGB-VWLOTQADSA-N 436462 (S)-6-(3-((3- (dimethylamino)-1- phenylpropoxy)methyl) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 237 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436462&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088784 439658095 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888102 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-5-28-27-29-19-23-25(30-27)32(4)16-17-33(26(23)34)21-12-9-13-22(18-21)35-24(14-15-31(2)3)20-10-7-6-8-11-20/h6-13,18-19,24H,5,14-17H2,1-4H3,(H,28,29,30) YMFQGYSHWSFIGC-UHFFFAOYSA-N 436463 6-(3-(3- (dimethylamino)-1- phenylpropoxy)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 238 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436463&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088987 439658096 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888103 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN(C)C)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-5-27-26-28-17-22-24(29-26)31(4)14-15-32(25(22)33)20-12-9-13-21(16-20)34-23(18-30(2)3)19-10-7-6-8-11-19/h6-13,16-17,23H,5,14-15,18H2,1-4H3,(H,27,28,29) AVLCWIQTMYHXCT-UHFFFAOYSA-N 436464 6-(3-(2- (dimethylamino)-1- phenylethoxy)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 239 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436464&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089308 439658097 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888104 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C27H34N6O/c1-4-28-27-29-19-24-25(30-27)32(3)16-17-33(26(24)34)23-14-8-12-21(18-23)13-9-15-31(2)20-22-10-6-5-7-11-22/h5-8,10-12,14,18-19H,4,9,13,15-17,20H2,1-3H3,(H,28,29,30) QIQGSCFPOMYFCX-UHFFFAOYSA-N 436465 6-(3-(3- (benzyl(methyl)amino) propyl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 240 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436465&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089159 439658098 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888105 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCCN(C)C)c1)C2=O InChI=1S/C21H30N6O/c1-5-22-21-23-15-18-19(24-21)26(4)12-13-27(20(18)28)17-10-6-8-16(14-17)9-7-11-25(2)3/h6,8,10,14-15H,5,7,9,11-13H2,1-4H3,(H,22,23,24) VHLVLBGGLGNCMM-UHFFFAOYSA-N 436466 6-(3-(3- (dimethylamino)propyl) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 241 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436466&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089373 439658099 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888106 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)C)nn1)C2=O InChI=1S/C21H27N9O/c1-5-22-21-23-12-18-19(24-21)28(4)9-10-29(20(18)31)16-7-6-8-17(11-16)30-14-15(25-26-30)13-27(2)3/h6-8,11-12,14H,5,9-10,13H2,1-4H3,(H,22,23,24) GOYQKEOPQFVFBK-UHFFFAOYSA-N 436467 6-(3-(4- ((dimethylamino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 242 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436467&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089440 439658100 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888107 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccccc3)nn1)C2=O InChI=1S/C27H31N9O/c1-4-28-27-29-16-24-25(30-27)34(3)13-14-35(26(24)37)22-11-8-12-23(15-22)36-19-21(31-32-36)18-33(2)17-20-9-6-5-7-10-20/h5-12,15-16,19H,4,13-14,17-18H2,1-3H3,(H,28,29,30) KPPZNUCOJQDNDL-UHFFFAOYSA-N 436468 6-(3-(4- ((benzyl(methyl)amino) methyl)-1H-1,2,3- triazol-1-yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 243 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436468&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138608016 439658101 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888108 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CCc3ccccc3)nn1)C2=O InChI=1S/C28H33N9O/c1-4-29-28-30-18-25-26(31-28)35(3)15-16-36(27(25)38)23-11-8-12-24(17-23)37-20-22(32-33-37)19-34(2)14-13-21-9-6-5-7-10-21/h5-12,17-18,20H,4,13-16,19H2,1-3H3,(H,29,30,31) UIBHNYCFYTXLGB-UHFFFAOYSA-N 436469 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(phenethyl) amino)methyl)-1H-1,2,3- triazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 244 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436469&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088751 439658102 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888109 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(CC3CC3)CC3CC3)nn1)C2=O InChI=1S/C27H35N9O/c1-3-28-27-29-14-24-25(30-27)33(2)11-12-35(26(24)37)22-5-4-6-23(13-22)36-18-21(31-32-36)17-34(15-19-7-8-19)16-20-9-10-20/h4-6,13-14,18-20H,3,7-12,15-17H2,1-2H3,(H,28,29,30) GDBVILSEFXPBSR-UHFFFAOYSA-N 436470 6-(3-(4-((bis (cyclopropylmethyl) amino)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 245 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436470&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089065 439658103 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888110 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CC3CC3)nn1)C2=O InChI=1S/C24H31N9O/c1-4-25-24-26-13-21-22(27-24)31(3)10-11-32(23(21)34)19-6-5-7-20(12-19)33-16-18(28-29-33)15-30(2)14-17-8-9-17/h5-7,12-13,16-17H,4,8-11,14-15H2,1-3H3,(H,25,26,27) LKHGZBCJCIQCLI-UHFFFAOYSA-N 436471 6-(3-(4- (((cyclopropylmethyl) (methyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 246 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436471&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089307 439658104 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888111 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CCN(C)Cc3ccccc3)nn1)C2=O InChI=1S/C28H33N9O/c1-4-29-28-30-18-25-26(31-28)35(3)15-16-36(27(25)38)23-11-8-12-24(17-23)37-20-22(32-33-37)13-14-34(2)19-21-9-6-5-7-10-21/h5-12,17-18,20H,4,13-16,19H2,1-3H3,(H,29,30,31) AVMLBXZHMMPUCI-UHFFFAOYSA-N 436472 6-(3-(4-(2- (benzyl(methyl)amino) ethyl)-1H-1,2,3-triazol- 1-yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 247 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436472&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089377 439658105 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888112 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CCN(C)C)nn1)C2=O InChI=1S/C22H29N9O/c1-5-23-22-24-14-19-20(25-22)29(4)11-12-30(21(19)32)17-7-6-8-18(13-17)31-15-16(26-27-31)9-10-28(2)3/h6-8,13-15H,5,9-12H2,1-4H3,(H,23,24,25) NHDPGHNSQXEUKA-UHFFFAOYSA-N 436473 6-(3-(4-(2- (dimethylamino)ethyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 248 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436473&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089022 439658106 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888113 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CCN(C)CCc3ccccc3)nn1)C2=O InChI=1S/C29H35N9O/c1-4-30-29-31-20-26-27(32-29)36(3)17-18-37(28(26)39)24-11-8-12-25(19-24)38-21-23(33-34-38)14-16-35(2)15-13-22-9-6-5-7-10-22/h5-12,19-21H,4,13-18H2,1-3H3,(H,30,31,32) PTTMNIDOYABQDY-UHFFFAOYSA-N 436474 2-(ethylamino)-9- methyl-6-(3-(4-(2- (methyl(phenethyl) amino)ethyl)-1H-1,2,3- triazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 249 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436474&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088859 439658107 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888114 CCNc1ncc2c(n1)N(C)CCN(c1cccc(Cn3cc(CN(C)Cc4ccccc4)nn3)c1)C2=O InChI=1S/C28H33N9O/c1-4-29-28-30-16-25-26(31-28)35(3)13-14-37(27(25)38)24-12-8-11-22(15-24)18-36-20-23(32-33-36)19-34(2)17-21-9-6-5-7-10-21/h5-12,15-16,20H,4,13-14,17-19H2,1-3H3,(H,29,30,31) RPWQBPFQGJTSJS-UHFFFAOYSA-N 436475 6-(3-((4-((benzyl (methyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)methyl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 250 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436475&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089456 439658108 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888115 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccccc3)cn1)C2=O InChI=1S/C28H32N8O/c1-4-29-28-30-17-25-26(32-28)34(3)13-14-35(27(25)37)23-11-8-12-24(15-23)36-20-22(16-31-36)19-33(2)18-21-9-6-5-7-10-21/h5-12,15-17,20H,4,13-14,18-19H2,1-3H3,(H,29,30,32) KDFRVKNUWIJPTM-UHFFFAOYSA-N 436476 6-(3-(4- ((benzyl(methyl)amino) methyl)-1H-pyrazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 251 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436476&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089342 439658109 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888116 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CCc3ccccc3)cn1)C2=O InChI=1S/C29H34N8O/c1-4-30-29-31-19-26-27(33-29)35(3)15-16-36(28(26)38)24-11-8-12-25(17-24)37-21-23(18-32-37)20-34(2)14-13-22-9-6-5-7-10-22/h5-12,17-19,21H,4,13-16,20H2,1-3H3,(H,30,31,33) FTEMBSLZESKZCN-UHFFFAOYSA-N 436477 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(phenethyl) amino)methyl)-1H- pyrazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 252 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436477&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089154 439658110 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888117 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CN(C)Cc3ccccc3)c1)C2=O InChI=1S/C28H32N8O/c1-4-29-28-30-16-25-26(32-28)34(3)13-14-36(27(25)37)24-12-8-11-23(15-24)35-19-22(31-20-35)18-33(2)17-21-9-6-5-7-10-21/h5-12,15-16,19-20H,4,13-14,17-18H2,1-3H3,(H,29,30,32) AVTMNEXAHMXYMJ-UHFFFAOYSA-N 436478 6-(3-(4- ((benzyl(methyl)amino) methyl)-1H-imidazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 253 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436478&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088798 439658111 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888118 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CN(C)CCc3ccccc3)c1)C2=O InChI=1S/C29H34N8O/c1-4-30-29-31-18-26-27(33-29)35(3)15-16-37(28(26)38)25-12-8-11-24(17-25)36-20-23(32-21-36)19-34(2)14-13-22-9-6-5-7-10-22/h5-12,17-18,20-21H,4,13-16,19H2,1-3H3,(H,30,31,33) LNSSJCXVEUGCAK-UHFFFAOYSA-N 436479 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(phenethyl) amino)methyl)-1H- imidazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 254 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436479&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088778 439658112 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888119 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(CN(C)Cc3ccccc3)o1)C2=O InChI=1S/C27H30N8O2/c1-4-28-27-29-16-22-24(30-27)34(3)13-14-35(26(22)36)21-12-8-11-20(15-21)25-32-31-23(37-25)18-33(2)17-19-9-6-5-7-10-19/h5-12,15-16H,4,13-14,17-18H2,1-3H3,(H,28,29,30) IPKRXXSZJBGTBA-UHFFFAOYSA-N 436480 6-(3-(5- ((benzyl(methyl)amino) methyl)-1,3,4- oxadiazol-2-yl)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 255 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436480&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098895 439658113 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888120 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-28-27-29-19-24-25(30-27)32(3)15-16-33(26(24)34)22-12-8-13-23(18-22)35-17-9-14-31(2)20-21-10-6-5-7-11-21/h5-8,10-13,18-19H,4,9,14-17,20H2,1-3H3,(H,28,29,30) YLLGDFRXKJITEN-UHFFFAOYSA-N 436481 6-(3-(3- (benzyl(methyl)amino) propoxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 256 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436481&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088722 439658114 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888121 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCN(C)C)c1)C2=O InChI=1S/C21H30N6O2/c1-5-22-21-23-15-18-19(24-21)26(4)11-12-27(20(18)28)16-8-6-9-17(14-16)29-13-7-10-25(2)3/h6,8-9,14-15H,5,7,10-13H2,1-4H3,(H,22,23,24) WZCLXNHWLRRWJH-UHFFFAOYSA-N 436482 6-(3-(3- (dimethylamino) propoxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 257 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436482&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089083 439658115 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888122 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCN(C)CCc3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-4-29-28-30-21-25-26(31-28)33(3)17-18-34(27(25)35)23-12-8-13-24(20-23)36-19-9-15-32(2)16-14-22-10-6-5-7-11-22/h5-8,10-13,20-21H,4,9,14-19H2,1-3H3,(H,29,30,31) XTPMEXMRRYUQBI-UHFFFAOYSA-N 436483 2-(ethylamino)-9- methyl-6-(3-(3- (methyl(phenethyl) amino)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 258 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436483&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088851 439658116 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888123 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C1CCN(Cc3ccccc3)CC1)C2=O InChI=1S/C28H34N6O/c1-3-29-28-30-19-25-26(31-28)32(2)16-17-34(27(25)35)24-11-7-10-23(18-24)22-12-14-33(15-13-22)20-21-8-5-4-6-9-21/h4-11,18-19,22H,3,12-17,20H2,1-2H3,(H,29,30,31) NWELVKZSTYWREX-UHFFFAOYSA-N 436484 6-(3-(1- benzylpiperidin-4- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 259 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436484&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088736 439658117 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888124 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C1CCN(C)CC1)C2=O InChI=1S/C22H30N6O/c1-4-23-22-24-15-19-20(25-22)27(3)12-13-28(21(19)29)18-7-5-6-17(14-18)16-8-10-26(2)11-9-16/h5-7,14-16H,4,8-13H2,1-3H3,(H,23,24,25) RRNTUSIJLWBBKJ-UHFFFAOYSA-N 436485 2-(ethylamino)-9- methyl-6-(3-(1- methylpiperidin-4- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 260 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436485&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088885 439658118 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888125 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C1CCN(CCc3ccccc3)CC1)C2=O InChI=1S/C29H36N6O/c1-3-30-29-31-21-26-27(32-29)33(2)18-19-35(28(26)36)25-11-7-10-24(20-25)23-13-16-34(17-14-23)15-12-22-8-5-4-6-9-22/h4-11,20-21,23H,3,12-19H2,1-2H3,(H,30,31,32) LYLPBSIHVCVZJN-UHFFFAOYSA-N 436486 2-(ethylamino)-9- methyl-6-(3-(1- phenethylpiperidin-4- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 261 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436486&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089660 439658119 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888126 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(C)CN(C)Cc3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-5-28-27-29-17-24-25(30-27)32(4)14-15-33(26(24)34)22-12-9-13-23(16-22)35-20(2)18-31(3)19-21-10-7-6-8-11-21/h6-13,16-17,20H,5,14-15,18-19H2,1-4H3,(H,28,29,30) GSAHIEJOZUYGBM-UHFFFAOYSA-N 436487 6-(3-((1- (benzyl(methyl)amino) propan-2- yl)oxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 262 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436487&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089014 439658120 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888127 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(C)CN(C)CCc3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-5-29-28-30-19-25-26(31-28)33(4)16-17-34(27(25)35)23-12-9-13-24(18-23)36-21(2)20-32(3)15-14-22-10-7-6-8-11-22/h6-13,18-19,21H,5,14-17,20H2,1-4H3,(H,29,30,31) ZHBYOEXDTUXKLO-UHFFFAOYSA-N 436488 2-(ethylamino)-9- methyl-6-(3-((1- (methyl(phenethyl) amino)propan-2- yl)oxy)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 263 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436488&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088890 439658121 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888128 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-27-26-28-18-23-24(29-26)31(3)13-14-32(25(23)33)21-11-8-12-22(17-21)34-16-15-30(2)19-20-9-6-5-7-10-20/h5-12,17-18H,4,13-16,19H2,1-3H3,(H,27,28,29) FRRQCGNUGNBAIU-UHFFFAOYSA-N 436489 6-(3-(2- (benzyl(methyl)amino) ethoxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 264 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436489&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089262 439658122 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888129 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCN(C)CCc3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-28-27-29-20-24-25(30-27)32(3)15-16-33(26(24)34)22-11-8-12-23(19-22)35-18-17-31(2)14-13-21-9-6-5-7-10-21/h5-12,19-20H,4,13-18H2,1-3H3,(H,28,29,30) PNEPGBCHAGDKHQ-UHFFFAOYSA-N 436490 2-(ethylamino)-9- methyl-6-(3-(2- (methyl(phenethyl) amino)ethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 265 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436490&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089457 439658123 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888130 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC3CCN(Cc4ccccc4)C3)c1)C2=O InChI=1S/C27H32N6O2/c1-3-28-27-29-17-24-25(30-27)31(2)14-15-33(26(24)34)21-10-7-11-22(16-21)35-23-12-13-32(19-23)18-20-8-5-4-6-9-20/h4-11,16-17,23H,3,12-15,18-19H2,1-2H3,(H,28,29,30) LUNSRNGGRWARCO-UHFFFAOYSA-N 436491 6-(3-((1- benzylpyrrolidin-3- yl)oxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 266 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436491&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089365 439658124 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888131 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN(C)Cc3ccccc3)C(C)C)c1)C2=O InChI=1S/C29H38N6O2/c1-6-30-29-31-18-25-27(32-29)34(5)15-16-35(28(25)36)23-13-10-14-24(17-23)37-26(21(2)3)20-33(4)19-22-11-8-7-9-12-22/h7-14,17-18,21,26H,6,15-16,19-20H2,1-5H3,(H,30,31,32) SWDOAWFBNDRVOU-UHFFFAOYSA-N 436492 6-(3-((1- (benzyl(methyl)amino)- 3-methylbutan-2- yl)oxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 267 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436492 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436492&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089242 439658125 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888132 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN(C)CCc3ccccc3)C(C)C)c1)C2=O InChI=1S/C30H40N6O2/c1-6-31-30-32-20-26-28(33-30)35(5)17-18-36(29(26)37)24-13-10-14-25(19-24)38-27(22(2)3)21-34(4)16-15-23-11-8-7-9-12-23/h7-14,19-20,22,27H,6,15-18,21H2,1-5H3,(H,31,32,33) HZMRZVPKPMCIFT-UHFFFAOYSA-N 436493 2-(ethylamino)-9- methyl-6-(3-((3-methyl- 1-(methyl(phenethyl) amino)butan-2- yl)oxy)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 268 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436493&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089304 439658126 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888133 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C26H32N6O/c1-4-27-26-28-18-23-24(29-26)31(3)15-16-32(25(23)33)22-12-8-11-20(17-22)13-14-30(2)19-21-9-6-5-7-10-21/h5-12,17-18H,4,13-16,19H2,1-3H3,(H,27,28,29) YWIBWKFXLCEQDF-UHFFFAOYSA-N 436494 6-(3-(2- (benzyl(methyl)amino) ethyl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 269 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436494 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436494&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089171 439658127 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888134 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCN(C)CCc3ccccc3)c1)C2=O InChI=1S/C27H34N6O/c1-4-28-27-29-20-24-25(30-27)32(3)17-18-33(26(24)34)23-12-8-11-22(19-23)14-16-31(2)15-13-21-9-6-5-7-10-21/h5-12,19-20H,4,13-18H2,1-3H3,(H,28,29,30) QJXILFMZNNUDAK-UHFFFAOYSA-N 436495 2-(ethylamino)-9- methyl-6-(3-(2- (methyl(phenethyl) amino)ethyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 270 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436495 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436495&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089168 439658128 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888135 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCN(C)CC3)c3ccccc3)c1)C2=O InChI=1S/C28H33N5O2S/c1-31-14-12-28(13-15-31,22-9-5-4-6-10-22)35-20-21-8-7-11-23(18-21)33-17-16-32(2)25-24(26(33)34)19-29-27(30-25)36-3/h4-11,18-19H,12-17,20H2,1-3H3 UGPFOLLZARPZBL-UHFFFAOYSA-N 436496 9-methyl-6-(3-(((1- methyl-4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 271 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436496&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088717 439658129 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888136 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCN(C)CC3)c3ccccc3)c1)C2=O InChI=1S/C29H36N6O2/c1-4-30-28-31-20-25-26(32-28)34(3)17-18-35(27(25)36)24-12-8-9-22(19-24)21-37-29(13-15-33(2)16-14-29)23-10-6-5-7-11-23/h5-12,19-20H,4,13-18,21H2,1-3H3,(H,30,31,32) VMENSNPIUZFIQT-UHFFFAOYSA-N 436497 2-(ethylamino)-9- methyl-6-(3-(((1- methyl-4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 272 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436497&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088975 439658130 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888137 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CCOCCO)nn1)C2=O InChI=1S/C24H33N9O3/c1-4-25-24-26-15-21-22(27-24)31(3)8-9-32(23(21)35)19-6-5-7-20(14-19)33-17-18(28-29-33)16-30(2)10-12-36-13-11-34/h5-7,14-15,17,34H,4,8-13,16H2,1-3H3,(H,25,26,27) SQGNHSGKULPRKW-UHFFFAOYSA-N 436498 2-(ethylamino)-6-(3-(4- (((2-(2- hydroxyethoxy)ethyl) (methyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 273 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436498&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088720 439658131 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888138 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCOS(=O)(=O)c3ccc(C)cc3)c1)C2=O InChI=1S/C25H29N5O4S/c1-4-26-25-27-17-22-23(28-25)29(3)13-14-30(24(22)31)20-7-5-6-19(16-20)12-15-34-35(32,33)21-10-8-18(2)9-11-21/h5-11,16-17H,4,12-15H2,1-3H3,(H,26,27,28) RDCILYBSJKMPQF-UHFFFAOYSA-N 436499 3-(2-(ethylamino)-9- methyl-5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5-e] [1,4]diazepin-6- yl)phenethyl 4- methylbenzenesulfonate::US10590140, Example 274 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436499 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436499&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089011 439658132 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888139 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCN3CCC(CC3)c3cccc(O)c3)c1)C2=O InChI=1S/C29H36N6O2/c1-3-30-29-31-20-26-27(32-29)33(2)16-17-35(28(26)37)24-8-4-6-21(18-24)10-13-34-14-11-22(12-15-34)23-7-5-9-25(36)19-23/h4-9,18-20,22,36H,3,10-17H2,1-2H3,(H,30,31,32) PZUBKBDQWUCFBG-UHFFFAOYSA-N 436500 2-(ethylamino)-6-(3-(2-(4- (3-hydroxyphenyl) piperidin-1-yl)ethyl) phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 275 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436500&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089131 439658133 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888140 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCN3CCC4(CC3)CN(C(C)C)C(=O)[C@@H](C)O4)c1)C2=O InChI=1S/C30H43N7O3/c1-6-31-29-32-19-25-26(33-29)34(5)16-17-36(28(25)39)24-9-7-8-23(18-24)10-13-35-14-11-30(12-15-35)20-37(21(2)3)27(38)22(4)40-30/h7-9,18-19,21-22H,6,10-17,20H2,1-5H3,(H,31,32,33)/t22-/m1/s1 DXOSRRPBTGJLEJ-JOCHJYFZSA-N 436501 (R)-9-(3-(2- (ethylamino)-9- methyl-5-oxo- 5,7,8,9-tetrahydro- 6H-pyrimido[4,5- e][1,4]diazepin-6- yl)phenethyl)-4- isopropyl-2-methyl- 1-oxa-4,9- diazaspiro[5.5] undecan-3-one::US10590140, Example 276 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436501&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088887 439658134 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888141 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)c3ccccc3)nn1)C2=O InChI=1S/C30H35N9O/c1-3-31-30-32-19-27-28(33-30)36(2)16-17-38(29(27)40)25-10-7-11-26(18-25)39-21-24(34-35-39)20-37-14-12-23(13-15-37)22-8-5-4-6-9-22/h4-11,18-19,21,23H,3,12-17,20H2,1-2H3,(H,31,32,33) JYRQXTKKIFNFMD-UHFFFAOYSA-N 436502 2-(ethylamino)-9-methyl- 6-(3-(4-((4- phenylpiperidin-1- yl)methyl)-1H-1,2,3- triazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 278 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436502&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089352 439658135 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888142 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)c3cccc(O)c3)nn1)C2=O InChI=1S/C30H35N9O2/c1-3-31-30-32-18-27-28(33-30)36(2)14-15-38(29(27)41)24-7-5-8-25(17-24)39-20-23(34-35-39)19-37-12-10-21(11-13-37)22-6-4-9-26(40)16-22/h4-9,16-18,20-21,40H,3,10-15,19H2,1-2H3,(H,31,32,33) HFUHDEKDBSEMRJ-UHFFFAOYSA-N 436503 2-(ethylamino)-6-(3-(4- ((4-(3- hydroxyphenyl)piperidin- 1-yl)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 279 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436503 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436503&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088732 439658136 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888143 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCN(CC3)c3ccccc3)nn1)C2=O InChI=1S/C29H34N10O/c1-3-30-29-31-19-26-27(32-29)35(2)12-17-38(28(26)40)24-10-7-11-25(18-24)39-21-22(33-34-39)20-36-13-15-37(16-14-36)23-8-5-4-6-9-23/h4-11,18-19,21H,3,12-17,20H2,1-2H3,(H,30,31,32) NGYRLLSCDQSONG-UHFFFAOYSA-N 436504 2-(ethylamino)-9- methyl-6-(3-(4-((4- phenylpiperazin-1- yl)methyl)-1H-1,2,3- triazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 280 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436504 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436504&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089129 439658137 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888144 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCCCC3)nn1)C2=O InChI=1S/C24H31N9O/c1-3-25-24-26-15-21-22(27-24)30(2)12-13-32(23(21)34)19-8-7-9-20(14-19)33-17-18(28-29-33)16-31-10-5-4-6-11-31/h7-9,14-15,17H,3-6,10-13,16H2,1-2H3,(H,25,26,27) ILZMMONZNUMBHP-UHFFFAOYSA-N 436505 2-(ethylamino)-9- methyl-6-(3-(4- (piperidin-1-ylmethyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 281 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436505&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089483 439658138 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888145 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCc4ccccc4C3)nn1)C2=O InChI=1S/C28H31N9O/c1-3-29-28-30-16-25-26(31-28)34(2)13-14-36(27(25)38)23-9-6-10-24(15-23)37-19-22(32-33-37)18-35-12-11-20-7-4-5-8-21(20)17-35/h4-10,15-16,19H,3,11-14,17-18H2,1-2H3,(H,29,30,31) FYSULSGRYLOAGT-UHFFFAOYSA-N 436506 6-(3-(4-((3,4- dihydroisoquinolin- 2(1H)-yl)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 282 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436506 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436506&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089147 439658139 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888146 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC4(CC3)NCCc3ccccc43)nn1)C2=O InChI=1S/C32H38N10O/c1-3-33-31-34-20-27-29(36-31)39(2)17-18-41(30(27)43)25-8-6-9-26(19-25)42-22-24(37-38-42)21-40-15-12-32(13-16-40)28-10-5-4-7-23(28)11-14-35-32/h4-10,19-20,22,35H,3,11-18,21H2,1-2H3,(H,33,34,36) OFEQBHBWBDSRLT-UHFFFAOYSA-N 436507 6-(3-(4-((3,4-dihydro- 2H-spiro[isoquinoline- 1,4'-piperidin]-1'- yl)methyl)-1H-1,2,3- triazol-1-yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 283 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436507&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138607954 439658140 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888147 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC4(CC3)CN(C(C)C)C(=O)[C@@H](C)O4)nn1)C2=O InChI=1S/C31H42N10O3/c1-6-32-30-33-17-26-27(34-30)37(5)14-15-39(29(26)43)24-8-7-9-25(16-24)41-19-23(35-36-41)18-38-12-10-31(11-13-38)20-40(21(2)3)28(42)22(4)44-31/h7-9,16-17,19,21-22H,6,10-15,18,20H2,1-5H3,(H,32,33,34)/t22-/m1/s1 SHRKRERKHXXRDE-JOCHJYFZSA-N 436508 (R)-9-((1-(3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5-e] [1,4]diazepin-6- yl)phenyl)-1H-1,2,3- triazol-4-yl)methyl)-4- isopropyl-2-methyl-1- oxa-4,9-diazaspiro[5.5] undecan-3-one::US10590140, Example 284 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436508&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089336 439658141 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888148 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNCC3CC3)nn1)C2=O InChI=1S/C23H29N9O/c1-3-25-23-26-14-20-21(27-23)30(2)9-10-31(22(20)33)18-5-4-6-19(11-18)32-15-17(28-29-32)13-24-12-16-7-8-16/h4-6,11,14-16,24H,3,7-10,12-13H2,1-2H3,(H,25,26,27) MLLSPSHXJVRFIL-UHFFFAOYSA-N 436509 6-(3-(4- (((cyclopropylmethyl) amino)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 285 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436509&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098862 439658142 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888149 CCNCc1cn(nn1)-c1cccc(c1)N1CCN(C)c2nc(NCC)ncc2C1=O InChI=1S/C21H27N9O/c1-4-22-12-15-14-30(27-26-15)17-8-6-7-16(11-17)29-10-9-28(3)19-18(20(29)31)13-24-21(25-19)23-5-2/h6-8,11,13-14,22H,4-5,9-10,12H2,1-3H3,(H,23,24,25) UENLBLWZJBQURM-UHFFFAOYSA-N 436510 2-(ethylamino)-6-(3-(4- ((ethylamino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 286 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436510&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089000 439658143 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888150 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccc(F)cc3)nn1)C2=O InChI=1S/C27H30FN9O/c1-4-29-27-30-15-24-25(31-27)35(3)12-13-36(26(24)38)22-6-5-7-23(14-22)37-18-21(32-33-37)17-34(2)16-19-8-10-20(28)11-9-19/h5-11,14-15,18H,4,12-13,16-17H2,1-3H3,(H,29,30,31) VYYGEDOELRVSSA-UHFFFAOYSA-N 436511 2-(ethylamino)-6-(3-(4- (((4-fluorobenzyl) (methyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 287 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436511&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089359 439658144 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888151 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccccn3)nn1)C2=O InChI=1S/C26H30N10O/c1-4-27-26-29-15-23-24(30-26)34(3)12-13-35(25(23)37)21-9-7-10-22(14-21)36-18-20(31-32-36)17-33(2)16-19-8-5-6-11-28-19/h5-11,14-15,18H,4,12-13,16-17H2,1-3H3,(H,27,29,30) UYPKBPVIQUPYLU-UHFFFAOYSA-N 436512 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(pyridin-2- ylmethyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 288 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436512&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088836 439658145 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888152 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3cccnc3)nn1)C2=O InChI=1S/C26H30N10O/c1-4-28-26-29-15-23-24(30-26)34(3)11-12-35(25(23)37)21-8-5-9-22(13-21)36-18-20(31-32-36)17-33(2)16-19-7-6-10-27-14-19/h5-10,13-15,18H,4,11-12,16-17H2,1-3H3,(H,28,29,30) NMZMEZDYOKXSFP-UHFFFAOYSA-N 436513 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(pyridin-3- ylmethyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 289 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436513&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089039 439658146 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888153 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNCCOCCO)nn1)C2=O InChI=1S/C23H31N9O3/c1-3-25-23-26-15-20-21(27-23)30(2)8-9-31(22(20)34)18-5-4-6-19(13-18)32-16-17(28-29-32)14-24-7-11-35-12-10-33/h4-6,13,15-16,24,33H,3,7-12,14H2,1-2H3,(H,25,26,27) CFCDIHSBOGDBOS-UHFFFAOYSA-N 436514 2-(ethylamino)-6-(3-(4- (((2-(2- hydroxyethoxy)ethyl) amino)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 290 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436514&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089056 439658147 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888154 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)(N(C)C)c3ccccc3)nn1)C2=O InChI=1S/C32H40N10O/c1-5-33-31-34-21-28-29(35-31)39(4)18-19-41(30(28)43)26-12-9-13-27(20-26)42-23-25(36-37-42)22-40-16-14-32(15-17-40,38(2)3)24-10-7-6-8-11-24/h6-13,20-21,23H,5,14-19,22H2,1-4H3,(H,33,34,35) TXIMUUXROCCRAE-UHFFFAOYSA-N 436515 6-(3-(4-((4- (dimethylamino)-4- phenylpiperidin-1- yl)methyl)-1H-1,2,3- triazol-1-yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 291 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436515&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089393 439658148 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888155 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CN3CCC(CC3)(N(C)C)c3ccccc3)c1)C2=O InChI=1S/C30H39N7O/c1-5-31-29-32-21-26-27(33-29)35(4)18-19-37(28(26)38)25-13-9-10-23(20-25)22-36-16-14-30(15-17-36,34(2)3)24-11-7-6-8-12-24/h6-13,20-21H,5,14-19,22H2,1-4H3,(H,31,32,33) QDDXNNZBUCAVPD-UHFFFAOYSA-N 436516 6-(3-((4- (dimethylamino)-4- phenylpiperidin-1- yl)methyl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 292 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436516&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089015 439658149 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888156 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)(N(C)C)c3cccc(O)c3)nn1)C2=O InChI=1S/C32H40N10O2/c1-5-33-31-34-20-28-29(35-31)39(4)16-17-41(30(28)44)25-9-7-10-26(19-25)42-22-24(36-37-42)21-40-14-12-32(13-15-40,38(2)3)23-8-6-11-27(43)18-23/h6-11,18-20,22,43H,5,12-17,21H2,1-4H3,(H,33,34,35) PWFPWNJNAIWINW-UHFFFAOYSA-N 436517 6-(3-(4-((4- (dimethylamino)-4-(3- hydroxyphenyl)piperidin- 1-yl)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 293 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436517&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089044 439658150 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888157 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)(N(C)C)c3ccccc3)cn1)C2=O InChI=1S/C33H41N9O/c1-5-34-32-35-22-29-30(37-32)39(4)18-19-41(31(29)43)27-12-9-13-28(20-27)42-24-25(21-36-42)23-40-16-14-33(15-17-40,38(2)3)26-10-7-6-8-11-26/h6-13,20-22,24H,5,14-19,23H2,1-4H3,(H,34,35,37) OHDWVCZRABERJZ-UHFFFAOYSA-N 436518 6-(3-(4-((4- (dimethylamino)-4- phenylpiperidin-1- yl)methyl)-1H-pyrazol- 1-yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 294 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436518 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436518&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088875 439658151 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888158 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)(N(C)C)c3cccc(O)c3)cn1)C2=O InChI=1S/C33H41N9O2/c1-5-34-32-35-21-29-30(37-32)39(4)16-17-41(31(29)44)26-9-7-10-27(19-26)42-23-24(20-36-42)22-40-14-12-33(13-15-40,38(2)3)25-8-6-11-28(43)18-25/h6-11,18-21,23,43H,5,12-17,22H2,1-4H3,(H,34,35,37) MWMDBPHRGRIRTE-UHFFFAOYSA-N 436519 6-(3-(4-((4- (dimethylamino)-4-(3- hydroxyphenyl)piperidin- 1-yl)methyl)-1H- pyrazol-1-yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 295 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436519 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436519&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089341 439658152 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888159 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CN3CCC(CC3)(N(C)C)c3cccc(O)c3)c1)C2=O InChI=1S/C33H41N9O2/c1-5-34-32-35-20-29-30(37-32)39(4)16-17-42(31(29)44)27-10-7-9-26(19-27)41-22-25(36-23-41)21-40-14-12-33(13-15-40,38(2)3)24-8-6-11-28(43)18-24/h6-11,18-20,22-23,43H,5,12-17,21H2,1-4H3,(H,34,35,37) IIGDSGPMUZKGKN-UHFFFAOYSA-N 436520 6-(3-(4-((4- (dimethylamino)-4-(3- hydroxyphenyl)piperidin- 1-yl)methyl)-1H- imidazol-1-yl)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 296 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436520 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436520&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089397 439658153 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888160 CN(CCC(Oc1cccc(c1)N1CCN(C)c2cc(Cl)ncc2C1=O)c1cccs1)C(=O)OCC[Si](C)(C)C InChI=1S/C29H37ClN4O4SSi/c1-32-13-14-34(28(35)23-20-31-27(30)19-24(23)32)21-8-6-9-22(18-21)38-25(26-10-7-16-39-26)11-12-33(2)29(36)37-15-17-40(3,4)5/h6-10,16,18-20,25H,11-15,17H2,1-5H3 QOFFHPJZLZQDLZ-UHFFFAOYSA-N 436521 2-(trimethylsilyl)ethyl (3-(3-(8-chloro-1- methyl-5-oxo-1,2,3,5- tetrahydro-4H- pyrido[4,3-e] [1,4]diazepin-4- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate::US10590140, Example 297 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436521 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436521&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665915 439658154 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888161 CN(CC[C@H](Oc1cccc(c1)N1CCN(C)c2cc(Cl)ncc2C1=O)c1cccs1)C(=O)OCC[Si](C)(C)C InChI=1S/C29H37ClN4O4SSi/c1-32-13-14-34(28(35)23-20-31-27(30)19-24(23)32)21-8-6-9-22(18-21)38-25(26-10-7-16-39-26)11-12-33(2)29(36)37-15-17-40(3,4)5/h6-10,16,18-20,25H,11-15,17H2,1-5H3/t25-/m0/s1 QOFFHPJZLZQDLZ-VWLOTQADSA-N 436522 2-(trimethylsilyl)ethyl (S)-(3-(3-(8-chloro-1- methyl-5-oxo-1,2,3,5- tetrahydro-4H- pyrido[4,3-e] [1,4]diazepin-4- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate::US10590140, Example 298 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436522 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436522&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665938 439658155 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888162 CN(CC[C@H](Oc1ccc(CN2CCN(C)c3cc(Cl)ncc3C2=O)cc1)c1cccs1)C(=O)OCC[Si](C)(C)C InChI=1S/C30H39ClN4O4SSi/c1-33-14-15-35(29(36)24-20-32-28(31)19-25(24)33)21-22-8-10-23(11-9-22)39-26(27-7-6-17-40-27)12-13-34(2)30(37)38-16-18-41(3,4)5/h6-11,17,19-20,26H,12-16,18,21H2,1-5H3/t26-/m0/s1 UMSHAYHHTKPDSX-SANMLTNESA-N 436523 2-(trimethylsilyl)ethyl (S)-(3-(4-((8-chloro-1- methyl-5-oxo-1,2,3,5- tetrahydro-4H- pyrido[4,3-e] [1,4]diazepin-4- yl)methyl)phenoxy)- 3-(thiophen-2- yl)propyl)(methyl) carbamate::US10590140, Example 299 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436523 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436523&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665921 439658156 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888163 CN(CCC(OCc1cccc(c1)N1CCN(C)c2cc(Cl)ncc2C1=O)c1ccccc1)C(=O)OC(C)(C)C InChI=1S/C31H37ClN4O4/c1-31(2,3)40-30(38)35(5)15-14-27(23-11-7-6-8-12-23)39-21-22-10-9-13-24(18-22)36-17-16-34(4)26-19-28(32)33-20-25(26)29(36)37/h6-13,18-20,27H,14-17,21H2,1-5H3 BKMPKEVZWPFOAA-UHFFFAOYSA-N 436524 US10590140, Example 300::tert-butyl (3-((3-(8- chloro-1-methyl-5-oxo- 1,2,3,5-tetrahydro-4H- pyrido[4,3-e] [1,4]diazepin-4- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436524 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436524&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138633114 439658157 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888164 CN(CC[C@H](Oc1ccc(CN2CCN(C)c3cc(C)ncc3C2=O)cc1)c1cccs1)C(=O)OCC[Si](C)(C)C InChI=1S/C31H42N4O4SSi/c1-23-20-27-26(21-32-23)30(36)35(16-15-33(27)2)22-24-9-11-25(12-10-24)39-28(29-8-7-18-40-29)13-14-34(3)31(37)38-17-19-41(4,5)6/h7-12,18,20-21,28H,13-17,19,22H2,1-6H3/t28-/m0/s1 KZHYXKDXAAJEFY-NDEPHWFRSA-N 436525 2-(trimethylsilyl)ethyl (S)- (3-(4-((1,8-dimethyl-5- oxo-1,2,3,5-tetrahydro- 4H-pyrido[4,3- e][1,4]diazepin-4- yl)methyl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate::US10590140, Example 301 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436525&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665931 439658158 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888165 CN(CCC(Oc1cccc(c1)N1CCN(C)c2cc(C)ncc2C1=O)c1cccs1)C(=O)OCC[Si](C)(C)C InChI=1S/C30H40N4O4SSi/c1-22-19-26-25(21-31-22)29(35)34(15-14-32(26)2)23-9-7-10-24(20-23)38-27(28-11-8-17-39-28)12-13-33(3)30(36)37-16-18-40(4,5)6/h7-11,17,19-21,27H,12-16,18H2,1-6H3 IWSKHIQUUWJASW-UHFFFAOYSA-N 436526 2-(trimethylsilyl)ethyl (3-(3-(1,8-dimethyl-5- oxo-1,2,3,5-tetrahydro- 4H-pyrido[4,3-e] [1,4]diazepin-4- yl)phenoxy)-3- (thiophen-2- yl)propyl)(methyl) carbamate::US10590140, Example 302 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436526 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436526&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 141665942 439658159 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888166 CN(CCC(OCc1cccc(c1)N1CCN(C)c2cc(C)ncc2C1=O)c1ccccc1)C(=O)OC(C)(C)C InChI=1S/C32H40N4O4/c1-23-19-28-27(21-33-23)30(37)36(18-17-34(28)5)26-14-10-11-24(20-26)22-39-29(25-12-8-7-9-13-25)15-16-35(6)31(38)40-32(2,3)4/h7-14,19-21,29H,15-18,22H2,1-6H3 FDJZGEBBTFTQHR-UHFFFAOYSA-N 436527 US10590140, Example 303::tert-butyl (3-((3-(1,8- dimethyl-5-oxo- 1,2,3,5-tetrahydro-4H- pyrido[4,3-e] [1,4]diazepin-4- yl)benzyl)oxy)-3- phenylpropyl)(methyl) carbamate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436527&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098879 439658160 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888167 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2cc(N)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-25-9-8-20(21-7-4-12-31-21)30-17-6-3-5-16(13-17)28-11-10-27(2)19-14-22(24)26-15-18(19)23(28)29/h3-7,12-15,20,25H,8-11H2,1-2H3,(H2,24,26)/t20-/m0/s1 OAKSTVOUJWQVNC-FQEVSTJZSA-N 436528 (S)-8-amino-1-methyl-4- (3-(3-(methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3-e] [1,4]diazepin-5-one::US10590140, Example 304 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436528&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089269 439658161 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888168 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(N)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S/c1-26-10-9-21(22-4-3-13-32-22)31-18-7-5-17(6-8-18)16-29-12-11-28(2)20-14-23(25)27-15-19(20)24(29)30/h3-8,13-15,21,26H,9-12,16H2,1-2H3,(H2,25,27)/t21-/m0/s1 KYBCOYYBJZXCNK-NRFANRHFSA-N 436529 (S)-8-amino-1-methyl- 4-(4-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 305 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436529&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098889 439658162 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888169 CNCCC(OCc1cccc(c1)N1CCN(C)c2cc(C)ncc2C1=O)c1ccccc1 InChI=1S/C27H32N4O2/c1-20-16-25-24(18-29-20)27(32)31(15-14-30(25)3)23-11-7-8-21(17-23)19-33-26(12-13-28-2)22-9-5-4-6-10-22/h4-11,16-18,26,28H,12-15,19H2,1-3H3 RFHXZEKMAZDDTH-UHFFFAOYSA-N 436530 1,8-dimethyl-4-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-1,2,3,4- tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 306 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436530&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098909 439658163 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888170 CNCCC(Oc1cccc(c1)N1CCN(C)c2cc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H28N4O2S/c1-17-14-21-20(16-26-17)24(29)28(12-11-27(21)3)18-6-4-7-19(15-18)30-22(9-10-25-2)23-8-5-13-31-23/h4-8,13-16,22,25H,9-12H2,1-3H3 MFIHOGLJRPBYIE-UHFFFAOYSA-N 436531 1,8-dimethyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 307 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436531&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098872 439658164 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888171 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(C)ncc3C2=O)cc1)c1cccs1 InChI=1S/C25H30N4O2S/c1-18-15-22-21(16-27-18)25(30)29(13-12-28(22)3)17-19-6-8-20(9-7-19)31-23(10-11-26-2)24-5-4-14-32-24/h4-9,14-16,23,26H,10-13,17H2,1-3H3/t23-/m0/s1 WSTIUHFTNYABQA-QHCPKHFHSA-N 436532 (S)-1,8-dimethyl-4-(4- (3-(methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 308 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436532&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089293 439658165 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888172 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C(=O)OC)C2=O InChI=1S/C18H21N5O3/c1-4-19-18-20-11-14-15(21-18)22(2)8-9-23(16(14)24)13-7-5-6-12(10-13)17(25)26-3/h5-7,10-11H,4,8-9H2,1-3H3,(H,19,20,21) PCWWOMQJNYDVAJ-UHFFFAOYSA-N 436533 US10590140, Example 309::methyl 3-(2- (ethylamino)-9-methyl- 5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzoate Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436533&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089244 439658166 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888173 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCO)c1)C2=O InChI=1S/C18H23N5O2/c1-3-19-18-20-12-15-16(21-18)22(2)8-9-23(17(15)25)14-6-4-5-13(11-14)7-10-24/h4-6,11-12,24H,3,7-10H2,1-2H3,(H,19,20,21) MKGORJFHXBDCPS-UHFFFAOYSA-N 436334 2-(ethylamino)-6-(3-(2- hydroxyethyl)phenyl)- 9-methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 113::US10590140, Example 310 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436334&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088831 439657968 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888174 CCNc1ncc2c(n1)N(C)CCN(c1cccc(Br)c1)C2=O InChI=1S/C16H18BrN5O/c1-3-18-16-19-10-13-14(20-16)21(2)7-8-22(15(13)23)12-6-4-5-11(17)9-12/h4-6,9-10H,3,7-8H2,1-2H3,(H,18,19,20) STRHISYXYVMUPL-UHFFFAOYSA-N 436333 6-(3-bromophenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 112::US10590140, Example 311 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436333&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089284 439657967 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888175 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)N1CCC(CC1)(N(C)C)c1ccccc1)C2=O InChI=1S/C29H37N7O/c1-5-30-28-31-21-25-26(32-28)34(4)18-19-36(27(25)37)24-13-9-12-23(20-24)35-16-14-29(15-17-35,33(2)3)22-10-7-6-8-11-22/h6-13,20-21H,5,14-19H2,1-4H3,(H,30,31,32) HPNLENOVBYKQIM-UHFFFAOYSA-N 436536 6-(3-(4-(dimethylamino)- 4-phenylpiperidin-1- yl)phenyl)-2-(ethylamino)- 9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 312 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436536 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436536&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089174 439658167 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888176 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C(O)=O)C2=O InChI=1S/C17H19N5O3/c1-3-18-17-19-10-13-14(20-17)21(2)7-8-22(15(13)23)12-6-4-5-11(9-12)16(24)25/h4-6,9-10H,3,7-8H2,1-2H3,(H,24,25)(H,18,19,20) BZTGRCAIKNLJFN-UHFFFAOYSA-N 436537 3-(2-(ethylamino)-9- methyl-5-oxo-5,7,8,9- tetrahydro-6H- pyrimido[4,5- e][1,4]diazepin-6- yl)benzoic acid::US10590140, Example 313 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436537&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089071 439658168 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888177 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C(=O)N1CCC(CC1)(N(C)C)c1ccccc1)C2=O InChI=1S/C30H37N7O2/c1-5-31-29-32-21-25-26(33-29)35(4)18-19-37(28(25)39)24-13-9-10-22(20-24)27(38)36-16-14-30(15-17-36,34(2)3)23-11-7-6-8-12-23/h6-13,20-21H,5,14-19H2,1-4H3,(H,31,32,33) FCBGBSXYGHKXGX-UHFFFAOYSA-N 436538 6-(3-(4-(dimethylamino)- 4-phenylpiperidine-1- carbonyl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 314 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436538 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436538&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089441 439658169 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888178 CNCCC(OCc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-14-13-23(20-7-5-4-6-8-20)33-18-19-9-11-21(12-10-19)31-16-15-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-12,17,23,27H,13-16,18H2,1-3H3 VZXSNOCJGKGVGZ-UHFFFAOYSA-N 436539 9-methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 315 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436539&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089196 439658170 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888179 CNCCC(Oc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-14-13-22(18-7-5-4-6-8-18)32-20-11-9-19(10-12-20)30-16-15-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-12,17,22,26H,13-16H2,1-3H3 WVSRUFDPKFMZJH-UHFFFAOYSA-N 436540 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 316 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436540&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089385 439658171 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888180 CNCCC(OCc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1ccccc1 InChI=1S/C26H30N4O2/c1-27-13-12-25(21-8-4-3-5-9-21)32-19-20-7-6-10-22(17-20)30-16-15-29(2)24-11-14-28-18-23(24)26(30)31/h3-11,14,17-18,25,27H,12-13,15-16,19H2,1-2H3 WYFGPTAEBOZQGD-UHFFFAOYSA-N 436541 1-methyl-4-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-1,2,3,4- tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 317 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436541&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089311 439658172 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888181 CNCCC(OCc1ccccc1N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-14-13-23(19-9-5-4-6-10-19)33-18-20-11-7-8-12-22(20)31-16-15-30(2)24-21(25(31)32)17-28-26(29-24)34-3/h4-12,17,23,27H,13-16,18H2,1-3H3 WKQJRDIJDSWUGM-UHFFFAOYSA-N 436542 9-methyl-6-(2-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 318 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436542&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089172 439658173 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888182 CNCC(Oc1ccccc1N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C24H27N5O2S/c1-25-16-21(17-9-5-4-6-10-17)31-20-12-8-7-11-19(20)29-14-13-28(2)22-18(23(29)30)15-26-24(27-22)32-3/h4-12,15,21,25H,13-14,16H2,1-3H3 RFEIFWQPGYAOPY-UHFFFAOYSA-N 436543 9-methyl-6-(2-(2- (methylamino)-1- phenylethoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 319 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436543&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088882 439658174 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888183 CNCC(OCc1ccccc1N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-16-22(18-9-5-4-6-10-18)32-17-19-11-7-8-12-21(19)30-14-13-29(2)23-20(24(30)31)15-27-25(28-23)33-3/h4-12,15,22,26H,13-14,16-17H2,1-3H3 JOCMGSVQTYBBLL-UHFFFAOYSA-N 436544 9-methyl-6-(2-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 320 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436544&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089055 439658175 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888184 CNCC(OCc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-16-22(19-7-5-4-6-8-19)32-17-18-9-11-20(12-10-18)30-14-13-29(2)23-21(24(30)31)15-27-25(28-23)33-3/h4-12,15,22,26H,13-14,16-17H2,1-3H3 XQQGWRFTVPATAL-UHFFFAOYSA-N 436545 9-methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 321 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436545&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089619 439658176 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888185 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)C(F)(F)F)c1ccccc1 InChI=1S/C26H28F3N5O2/c1-30-12-11-22(19-8-4-3-5-9-19)36-17-18-7-6-10-20(15-18)34-14-13-33(2)23-21(24(34)35)16-31-25(32-23)26(27,28)29/h3-10,15-16,22,30H,11-14,17H2,1-2H3 VODCLLAGQXKGNC-UHFFFAOYSA-N 436546 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 322 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436546&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089106 439658177 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888186 CNCCC(Oc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1cccs1 InChI=1S/C23H26N4O2S/c1-24-10-9-21(22-7-4-14-30-22)29-18-6-3-5-17(15-18)27-13-12-26(2)20-8-11-25-16-19(20)23(27)28/h3-8,11,14-16,21,24H,9-10,12-13H2,1-2H3 LAAINAAKDMZDHJ-UHFFFAOYSA-N 436547 1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 323 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436547&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089261 439658178 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888187 CCNc1cc2N(C)CCN(c3cccc(O[C@H](CCNC)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C25H31N5O2S/c1-4-27-24-16-21-20(17-28-24)25(31)30(13-12-29(21)3)18-7-5-8-19(15-18)32-22(10-11-26-2)23-9-6-14-33-23/h5-9,14-17,22,26H,4,10-13H2,1-3H3,(H,27,28)/t22-/m1/s1 JOLCTAVEKPKHAQ-JOCHJYFZSA-N 436548 (R)-8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 324 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436548 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436548&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089110 439658179 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888188 CCNc1cc2N(C)CCN(c3cccc(O[C@@H](CCNC)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C25H31N5O2S/c1-4-27-24-16-21-20(17-28-24)25(31)30(13-12-29(21)3)18-7-5-8-19(15-18)32-22(10-11-26-2)23-9-6-14-33-23/h5-9,14-17,22,26H,4,10-13H2,1-3H3,(H,27,28)/t22-/m0/s1 JOLCTAVEKPKHAQ-QFIPXVFZSA-N 436549 (S)-8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 325 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436549&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089245 439658180 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888189 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1cccs1 InChI=1S/C23H26N4O2S/c1-24-10-9-21(22-7-4-14-30-22)29-18-6-3-5-17(15-18)27-13-12-26(2)20-8-11-25-16-19(20)23(27)28/h3-8,11,14-16,21,24H,9-10,12-13H2,1-2H3/t21-/m0/s1 LAAINAAKDMZDHJ-NRFANRHFSA-N 436550 (S)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 326 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436550&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089372 439658181 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888190 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1cccs1 InChI=1S/C23H26N4O2S/c1-24-10-9-21(22-7-4-14-30-22)29-18-6-3-5-17(15-18)27-13-12-26(2)20-8-11-25-16-19(20)23(27)28/h3-8,11,14-16,21,24H,9-10,12-13H2,1-2H3/t21-/m1/s1 LAAINAAKDMZDHJ-OAQYLSRUSA-N 436551 (R)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl(propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 327 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436551&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089438 439658182 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888191 CNCCC(OCc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-16-17-6-8-18(9-7-17)29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3 RQQNIPMRBNPQOC-UHFFFAOYSA-N 436552 9-methyl-6-(4-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 328 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436552&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088743 439658183 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888192 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)C(F)(F)F)c1cccs1 InChI=1S/C23H24F3N5O2S/c1-27-9-8-18(19-7-4-12-34-19)33-16-6-3-5-15(13-16)31-11-10-30(2)20-17(21(31)32)14-28-22(29-20)23(24,25)26/h3-7,12-14,18,27H,8-11H2,1-2H3 MNOIUVGGVHWYLP-UHFFFAOYSA-N 436553 9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 329 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436553&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089499 439658184 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888193 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)C(F)(F)F)c1cccs1 InChI=1S/C24H26F3N5O2S/c1-28-9-8-19(20-7-4-12-35-20)34-15-16-5-3-6-17(13-16)32-11-10-31(2)21-18(22(32)33)14-29-23(30-21)24(25,26)27/h3-7,12-14,19,28H,8-11,15H2,1-2H3 FRIOVEHUCKYUJD-UHFFFAOYSA-N 436554 9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 330 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436554&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088903 439658185 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888194 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2cc(OC)ncc2C1=O)c1cccs1 InChI=1S/C24H28N4O3S/c1-25-10-9-21(22-8-5-13-32-22)31-18-7-4-6-17(14-18)28-12-11-27(2)20-15-23(30-3)26-16-19(20)24(28)29/h4-8,13-16,21,25H,9-12H2,1-3H3/t21-/m0/s1 DXQNIABNXYTXNP-NRFANRHFSA-N 436555 (S)-8-methoxy-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 331 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436555&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098921 439658186 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888195 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1ccccc1 InChI=1S/C25H30N6O2/c1-27-12-11-22(19-8-4-3-5-9-19)33-17-18-7-6-10-20(15-18)31-14-13-30(2)23-21(24(31)32)16-28-25(26)29-23/h3-10,15-16,22,27H,11-14,17H2,1-2H3,(H2,26,28,29) NBOBGWSKDGTTTF-UHFFFAOYSA-N 436556 (S)-2-amino-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 332 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436556&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088927 439658187 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888196 CCNc1ncc2c(n1)N(C)CCN(c1ccc(OC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)16-17-32(25(22)33)20-10-12-21(13-11-20)34-23(14-15-27-2)19-8-6-5-7-9-19/h5-13,18,23,27H,4,14-17H2,1-3H3,(H,28,29,30) GYNKWEIZOXVXQN-UHFFFAOYSA-N 436557 2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 333 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436557&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088932 439658188 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888197 CCNc1ncc2c(n1)N(C)CCN(c1ccc(COC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)22-12-10-20(11-13-22)19-35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31) XAMXFOAGBMDRHS-UHFFFAOYSA-N 436558 2-(ethylamino)-9- methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 334 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436558&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089252 439658189 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888198 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(NCc3ccccc3)ncc2C1=O)c1ccccc1 InChI=1S/C32H36N6O2/c1-33-17-16-29(26-13-7-4-8-14-26)40-23-25-12-9-15-27(20-25)38-19-18-37(2)30-28(31(38)39)22-35-32(36-30)34-21-24-10-5-3-6-11-24/h3-15,20,22,29,33H,16-19,21,23H2,1-2H3,(H,34,35,36) ITSRUFXPFLZXQT-UHFFFAOYSA-N 436559 2-(benzylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 335 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436559&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089067 439658190 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888199 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1ccccn1)c1ccccc1 InChI=1S/C32H37N7O2/c1-33-17-15-29(25-11-5-4-6-12-25)41-23-24-10-9-14-27(20-24)39-19-18-37(2)30-28(31(39)40)21-35-32(36-30)38(3)22-26-13-7-8-16-34-26/h4-14,16,20-21,29,33H,15,17-19,22-23H2,1-3H3 GVPQCNHAYHGSFL-UHFFFAOYSA-N 436560 9-methyl-2- (methyl(pyridin-2- ylmethyl)amino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 336 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436560&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088762 439658191 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888200 CCNc1ncc2c(n1)N(C)CCN(c1ccccc1COC(CCNC)c1ccccc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-22-25(31-27)32(3)16-17-33(26(22)34)23-13-9-8-12-21(23)19-35-24(14-15-28-2)20-10-6-5-7-11-20/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31) XDPQSVIISXTPBU-UHFFFAOYSA-N 436561 2-(ethylamino)-9- methyl-6-(2-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 337 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436561&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089434 439658192 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888201 CCNc1ncc2c(n1)N(C)CCN(c1ccccc1OC(CNC)c1ccccc1)C2=O InChI=1S/C25H30N6O2/c1-4-27-25-28-16-19-23(29-25)30(3)14-15-31(24(19)32)20-12-8-9-13-21(20)33-22(17-26-2)18-10-6-5-7-11-18/h5-13,16,22,26H,4,14-15,17H2,1-3H3,(H,27,28,29) WHIWBJUOEUMLRJ-UHFFFAOYSA-N 436562 2-(ethylamino)-9- methyl-6-(2-(2- (methylamino)-1- phenylethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 338 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436562&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089212 439658193 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888202 CCNc1ncc2c(n1)N(C)CCN(c1ccccc1COC(CNC)c1ccccc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-21-24(30-26)31(3)14-15-32(25(21)33)22-13-9-8-12-20(22)18-34-23(17-27-2)19-10-6-5-7-11-19/h5-13,16,23,27H,4,14-15,17-18H2,1-3H3,(H,28,29,30) BFFFFWQVXQPQRN-UHFFFAOYSA-N 436563 2-(ethylamino)-9- methyl-6-(2-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 339 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436563&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089187 439658194 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888203 CCNc1ncc2c(n1)N(C)CCN(c1ccc(COC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)14-15-32(25(22)33)21-12-10-19(11-13-21)18-34-23(17-27-2)20-8-6-5-7-9-20/h5-13,16,23,27H,4,14-15,17-18H2,1-3H3,(H,28,29,30) FPZFQDJWOPZCSG-UHFFFAOYSA-N 436564 2-(ethylamino)-9- methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 340 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436564&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089301 439658195 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888204 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1ccccn1)c1ccccc1 InChI=1S/C32H37N7O2/c1-33-17-15-29(25-11-5-4-6-12-25)41-23-24-10-9-14-27(20-24)39-19-18-37(2)30-28(31(39)40)21-35-32(36-30)38(3)22-26-13-7-8-16-34-26/h4-14,16,20-21,29,33H,15,17-19,22-23H2,1-3H3/t29-/m1/s1 GVPQCNHAYHGSFL-GDLZYMKVSA-N 436565 (R)-9-methyl-2- (methyl(pyridin-2- ylmethyl)amino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 341 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436565&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088760 439658196 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888205 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1cccnc1)c1ccccc1 InChI=1S/C32H37N7O2/c1-33-16-14-29(26-11-5-4-6-12-26)41-23-24-9-7-13-27(19-24)39-18-17-37(2)30-28(31(39)40)21-35-32(36-30)38(3)22-25-10-8-15-34-20-25/h4-13,15,19-21,29,33H,14,16-18,22-23H2,1-3H3/t29-/m1/s1 QNGRKOMRLIHMHR-GDLZYMKVSA-N 436566 (R)-9-methyl-2- (methyl(pyridin-3- ylmethyl)amino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 342 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436566&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088753 439658197 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888206 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(NCc3ccccn3)ncc2C1=O)c1ccccc1 InChI=1S/C31H35N7O2/c1-32-16-14-28(24-10-4-3-5-11-24)40-22-23-9-8-13-26(19-23)38-18-17-37(2)29-27(30(38)39)21-35-31(36-29)34-20-25-12-6-7-15-33-25/h3-13,15,19,21,28,32H,14,16-18,20,22H2,1-2H3,(H,34,35,36)/t28-/m1/s1 QLJXGOSUUYOJJV-MUUNZHRXSA-N 436567 (R)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-((pyridin-2- ylmethyl)amino)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 343 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436567&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089409 439658198 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888207 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1ccc(F)cn1)c1ccccc1 InChI=1S/C32H36FN7O2/c1-34-15-14-29(24-9-5-4-6-10-24)42-22-23-8-7-11-27(18-23)40-17-16-38(2)30-28(31(40)41)20-36-32(37-30)39(3)21-26-13-12-25(33)19-35-26/h4-13,18-20,29,34H,14-17,21-22H2,1-3H3/t29-/m1/s1 FKCYQZFDOLGMHM-GDLZYMKVSA-N 436568 (R)-2-(((5- fluoropyridin-2- yl)methyl)(methyl) amino)-9-methyl-6- (3-((3-(methylamino)- 1-phenylpropoxy) methyl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 344 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436568&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088772 439658199 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888208 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNCCF)c3cccs3)c1)C2=O InChI=1S/C26H33FN6O2S/c1-3-29-26-30-17-21-24(31-26)32(2)13-14-33(25(21)34)20-7-4-6-19(16-20)18-35-22(9-11-28-12-10-27)23-8-5-15-36-23/h4-8,15-17,22,28H,3,9-14,18H2,1-2H3,(H,29,30,31) QRAORHCJNXMYOA-UHFFFAOYSA-N 436569 2-(ethylamino)-6-(3- ((3-((2-fluoroethyl) amino)-1-(thiophen- 2-yl)propoxy)methyl) phenyl)-9-methyl- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 345 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436569&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088958 439658200 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888209 CNCC[C@H](OCc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1cccs1 InChI=1S/C23H28N6O2S/c1-25-9-8-19(20-7-4-12-32-20)31-15-16-5-3-6-17(13-16)29-11-10-28(2)21-18(22(29)30)14-26-23(24)27-21/h3-7,12-14,19,25H,8-11,15H2,1-2H3,(H2,24,26,27)/t19-/m0/s1 IUEMDBWQSYJROX-IBGZPJMESA-N 436570 (S)-2-amino-9-methyl- 6-(3-((3-(methylamino)- 1-(thiophen-2-yl) propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e][1,4] diazepin-5-one::US10590140, Example 346 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436570&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088850 439658201 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888210 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1cccs1 InChI=1S/C23H28N6O2S/c1-25-9-8-19(20-7-4-12-32-20)31-15-16-5-3-6-17(13-16)29-11-10-28(2)21-18(22(29)30)14-26-23(24)27-21/h3-7,12-14,19,25H,8-11,15H2,1-2H3,(H2,24,26,27)/t19-/m1/s1 IUEMDBWQSYJROX-LJQANCHMSA-N 436571 (R)-2-amino-9-methyl- 6-(3-((3-(methylamino)- 1-(thiophen-2-yl) propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H-pyrimido [4,5-e][1,4]diazepin- 5-one::US10590140, Example 347 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436571&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088921 439658202 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888211 CCNc1ncc2c(n1)N(C)CCN(c1ccc(COC(CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)19-9-7-18(8-10-19)17-33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29) JBARIIVHRFLJKW-UHFFFAOYSA-N 436572 2-(ethylamino)-9- methyl-6-(4-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e][1,4] diazepin-5-one::US10590140, Example 348 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436572&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089396 439658203 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888212 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3ccsc3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-15-20-22(28-24)29(3)11-12-30(23(20)31)18-6-5-7-19(14-18)32-21(8-10-25-2)17-9-13-33-16-17/h5-7,9,13-16,21,25H,4,8,10-12H2,1-3H3,(H,26,27,28) OAWHXCORWBSROR-UHFFFAOYSA-N 436573 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 349 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436573&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088825 439658204 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888213 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCNC)c3ccsc3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-15-20-22(28-24)29(3)11-12-30(23(20)31)18-6-5-7-19(14-18)32-21(8-10-25-2)17-9-13-33-16-17/h5-7,9,13-16,21,25H,4,8,10-12H2,1-3H3,(H,26,27,28)/t21-/m0/s1 OAWHXCORWBSROR-NRFANRHFSA-N 436574 (S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 350 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436574&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089476 439658205 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888214 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCNC)c3ccsc3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-15-20-22(28-24)29(3)11-12-30(23(20)31)18-6-5-7-19(14-18)32-21(8-10-25-2)17-9-13-33-16-17/h5-7,9,13-16,21,25H,4,8,10-12H2,1-3H3,(H,26,27,28)/t21-/m1/s1 OAWHXCORWBSROR-OAQYLSRUSA-N 436575 (R)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 351 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436575&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089139 439658206 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888215 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1cccs1 InChI=1S/C22H26N6O2S/c1-24-9-8-18(19-7-4-12-31-19)30-16-6-3-5-15(13-16)28-11-10-27(2)20-17(21(28)29)14-25-22(23)26-20/h3-7,12-14,18,24H,8-11H2,1-2H3,(H2,23,25,26)/t18-/m0/s1 IWLOXSUFFLVQCV-SFHVURJKSA-N 436576 (S)-2-amino-9-methyl- 6-(3-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 352 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436576&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089210 439658207 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888216 CNCCC(OCc1ccc(cc1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-17-23-25(29-19)30(3)15-16-31(26(23)32)22-11-9-20(10-12-22)18-33-24(13-14-27-2)21-7-5-4-6-8-21/h4-12,17,24,27H,13-16,18H2,1-3H3 QOLSIEVAHANYBT-UHFFFAOYSA-N 436577 2,9-dimethyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 353 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436577&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089125 439658208 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888217 CCc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H33N5O2/c1-4-25-29-18-23-26(30-25)31(3)15-16-32(27(23)33)22-12-8-9-20(17-22)19-34-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3 GTXUIJXHALCWKS-UHFFFAOYSA-N 436578 2-ethyl-9-methyl-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4ldiazepin-5-one::US10590140, Example 354 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436578&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088964 439658209 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888218 CNCC(OCc1ccc(cc1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2/c1-18-27-15-22-24(28-18)29(3)13-14-30(25(22)31)21-11-9-19(10-12-21)17-32-23(16-26-2)20-7-5-4-6-8-20/h4-12,15,23,26H,13-14,16-17H2,1-3H3 TTWWGIWHWUEGKT-UHFFFAOYSA-N 436579 2,9-dimethyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 355 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436579&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089016 439658210 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888219 CCc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H33N5O2/c1-4-25-29-18-23-26(30-25)31(3)15-16-32(27(23)33)22-12-8-9-20(17-22)19-34-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3/t24-/m1/s1 GTXUIJXHALCWKS-XMMPIXPASA-N 436580 (R)-2-ethyl-9-methyl-6- (3-((3-(methylamino)- 1-phenylpropoxy) methyl)phenyl(- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 356 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436580&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089227 439658211 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888220 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-16-25-15-19-22(26-16)27(3)11-12-28(23(19)29)17-6-4-7-18(14-17)30-20(9-10-24-2)21-8-5-13-31-21/h4-8,13-15,20,24H,9-12H2,1-3H3/t20-/m1/s1 QSGMFCUAWLYRRU-HXUWFJFHSA-N 436581 (R)-2,9-dimethyl-6-(3- (3-(methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 357 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436581&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088708 439658212 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888221 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-16-25-15-19-22(26-16)27(3)11-12-28(23(19)29)17-6-4-7-18(14-17)30-20(9-10-24-2)21-8-5-13-31-21/h4-8,13-15,20,24H,9-12H2,1-3H3/t20-/m0/s1 QSGMFCUAWLYRRU-FQEVSTJZSA-N 436582 (S)-2,9-dimethyl-6-(3- (3-(methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 358 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436582&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089351 439658213 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888222 CNCC[C@H](OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)11-12-29(24(20)30)19-7-4-6-18(14-19)16-31-21(9-10-25-2)22-8-5-13-32-22/h4-8,13-15,21,25H,9-12,16H2,1-3H3/t21-/m0/s1 DDWJAWDHKATTEZ-NRFANRHFSA-N 436583 (S)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e][1,4] diazepin-5-one::US10590140, Example 359 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436583&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088765 439658214 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888223 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)11-12-29(24(20)30)19-7-4-6-18(14-19)16-31-21(9-10-25-2)22-8-5-13-32-22/h4-8,13-15,21,25H,9-12,16H2,1-3H3/t21-/m1/s1 DDWJAWDHKATTEZ-OAQYLSRUSA-N 436584 (R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- (thiophen-2-yl) propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e][1,4] diazepin-5-one::US10590140, Example 360 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436584&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088797 439658215 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888224 CNCCC(Oc1ccc(cc1)N1CCN(C)c2ncncc2C1=O)c1ccccc1 InChI=1S/C24H27N5O2/c1-25-13-12-22(18-6-4-3-5-7-18)31-20-10-8-19(9-11-20)29-15-14-28(2)23-21(24(29)30)16-26-17-27-23/h3-11,16-17,22,25H,12-15H2,1-2H3 FFCXMGARAXXIGF-UHFFFAOYSA-N 436585 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 361 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436585&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089249 439658216 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888225 CNCC(Oc1ccccc1N1CCN(C)c2ncncc2C1=O)c1ccccc1 InChI=1S/C23H25N5O2/c1-24-15-21(17-8-4-3-5-9-17)30-20-11-7-6-10-19(20)28-13-12-27(2)22-18(23(28)29)14-25-16-26-22/h3-11,14,16,21,24H,12-13,15H2,1-2H3 YFHMASPQSRKMAD-UHFFFAOYSA-N 436586 9-methyl-6-(2-(2- (methylamino)-1- phenylethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 362 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436586&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089062 439658217 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888226 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C22H25N5O2S/c1-23-9-8-19(20-7-4-12-30-20)29-17-6-3-5-16(13-17)27-11-10-26(2)21-18(22(27)28)14-24-15-25-21/h3-7,12-15,19,23H,8-11H2,1-2H3/t19-/m1/s1 KYQUYMHBNNIIFU-LJQANCHMSA-N 436587 (R)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 363 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436587&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089042 439658218 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888227 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C22H25N5O2S/c1-23-9-8-19(20-7-4-12-30-20)29-17-6-3-5-16(13-17)27-11-10-26(2)21-18(22(27)28)14-24-15-25-21/h3-7,12-15,19,23H,8-11H2,1-2H3/t19-/m0/s1 KYQUYMHBNNIIFU-IBGZPJMESA-N 436588 (S)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 364 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436588&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089053 439658219 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888228 CNCCC(OCc1ccccc1CN1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C27H33N5O2S/c1-28-14-13-24(20-9-5-4-6-10-20)34-19-22-12-8-7-11-21(22)18-32-16-15-31(2)25-23(26(32)33)17-29-27(30-25)35-3/h4-12,17,24,28H,13-16,18-19H2,1-3H3 UEMQMDGWVIJORC-UHFFFAOYSA-N 436589 9-methyl-6-(2-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 365 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436589&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088998 439658220 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888229 CNCCC(Oc1cccc(CN2CCN(C)c3nc(SC)ncc3C2=O)c1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-21-11-7-8-19(16-21)18-31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3 QDQLRTUYAFRSQI-UHFFFAOYSA-N 436590 9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)benzyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 366 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436590&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089378 439658221 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888230 CNCCC(OCc1cccc(CN2CCN(C)c3nc(SC)ncc3C2=O)c1)c1ccccc1 InChI=1S/C27H33N5O2S/c1-28-13-12-24(22-10-5-4-6-11-22)34-19-21-9-7-8-20(16-21)18-32-15-14-31(2)25-23(26(32)33)17-29-27(30-25)35-3/h4-11,16-17,24,28H,12-15,18-19H2,1-3H3 UOPQGSXJSRXVRG-UHFFFAOYSA-N 436591 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 367 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436591&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089238 439658222 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888231 CNCCC(OCc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C27H33N5O2S/c1-28-14-13-24(22-7-5-4-6-8-22)34-19-21-11-9-20(10-12-21)18-32-16-15-31(2)25-23(26(32)33)17-29-27(30-25)35-3/h4-12,17,24,28H,13-16,18-19H2,1-3H3 BYERXQZXKHNJFV-UHFFFAOYSA-N 436592 9-methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 368 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436592&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088808 439658223 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888232 CNCCC(Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-14-13-23(20-7-5-4-6-8-20)33-21-11-9-19(10-12-21)18-31-16-15-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-12,17,23,27H,13-16,18H2,1-3H3 LIEZFUXANSELMO-UHFFFAOYSA-N 436593 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 369 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436593&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089291 439658224 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888233 CNCCC(Oc1ccccc1CN1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-14-13-23(19-9-5-4-6-10-19)33-22-12-8-7-11-20(22)18-31-16-15-30(2)24-21(25(31)32)17-28-26(29-24)34-3/h4-12,17,23,27H,13-16,18H2,1-3H3 RQSVPYIOFHPIDL-UHFFFAOYSA-N 436594 9-methyl-6-(2-(3- (methylamino)-1- phenylpropoxy)benzyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 370 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436594&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089158 439658225 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888234 CNCC(Oc1ccccc1CN1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-16-22(18-9-5-4-6-10-18)32-21-12-8-7-11-19(21)17-30-14-13-29(2)23-20(24(30)31)15-27-25(28-23)33-3/h4-12,15,22,26H,13-14,16-17H2,1-3H3 SBKBTSILVZWHRS-UHFFFAOYSA-N 436595 9-methyl-6-(2-(2- (methylamino)-1- phenylethoxy)benzyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 371 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436595&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089033 439658226 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888235 CNCC(OCc1cccc(CN2CCN(C)c3nc(SC)ncc3C2=O)c1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-16-23(21-10-5-4-6-11-21)33-18-20-9-7-8-19(14-20)17-31-13-12-30(2)24-22(25(31)32)15-28-26(29-24)34-3/h4-11,14-15,23,27H,12-13,16-18H2,1-3H3 ICMKHSPPDWZGOG-UHFFFAOYSA-N 436596 9-methyl-6-(3-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 372 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436596&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089280 439658227 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888236 CNCC(OCc1ccccc1CN1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-16-23(19-9-5-4-6-10-19)33-18-21-12-8-7-11-20(21)17-31-14-13-30(2)24-22(25(31)32)15-28-26(29-24)34-3/h4-12,15,23,27H,13-14,16-18H2,1-3H3 GXDYPAYAMKRVHY-UHFFFAOYSA-N 436597 9-methyl-6-(2-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 373 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436597&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089072 439658228 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888237 CNCC(OCc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-16-23(21-7-5-4-6-8-21)33-18-20-11-9-19(10-12-20)17-31-14-13-30(2)24-22(25(31)32)15-28-26(29-24)34-3/h4-12,15,23,27H,13-14,16-18H2,1-3H3 DQBDZMGJYJPKFK-UHFFFAOYSA-N 436598 9-methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 374 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436598&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089123 439658229 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888238 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O3/c1-27-14-13-23(20-7-5-4-6-8-20)34-21-11-9-19(10-12-21)18-31-16-15-30(2)24-22(25(31)32)17-28-26(29-24)33-3/h4-12,17,23,27H,13-16,18H2,1-3H3/t23-/m0/s1 PQNPVPGYGMGILK-QHCPKHFHSA-N 436599 (S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 375 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436599&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089035 439658230 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888239 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccccc1F InChI=1S/C26H30FN5O3/c1-28-13-12-23(20-6-4-5-7-22(20)27)35-19-10-8-18(9-11-19)17-32-15-14-31(2)24-21(25(32)33)16-29-26(30-24)34-3/h4-11,16,23,28H,12-15,17H2,1-3H3 QHEUNXSLEVVCKN-UHFFFAOYSA-N 436600 6-(4-(1-(2- fluorophenyl)-3- (methylamino)propoxy) benzyl)-2-methoxy-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 376 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436600&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088936 439658231 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888240 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ccncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H30N4O2/c1-27-14-13-25(21-6-4-3-5-7-21)32-22-10-8-20(9-11-22)19-30-17-16-29(2)24-12-15-28-18-23(24)26(30)31/h3-12,15,18,25,27H,13-14,16-17,19H2,1-2H3/t25-/m0/s1 MFMQJFYXJBOUSG-VWLOTQADSA-N 436601 (S)-1-methyl-4-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 377 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436601&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088942 439658232 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888241 CNCCC(Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3 OUAQODABUANYJQ-UHFFFAOYSA-N 436602 9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 378 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436602&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088983 439658233 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888242 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3/t20-/m0/s1 OUAQODABUANYJQ-FQEVSTJZSA-N 436603 (S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 379 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436603&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088982 439658234 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888243 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3/t20-/m1/s1 OUAQODABUANYJQ-HXUWFJFHSA-N 436604 (R)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 380 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436604&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089455 439658235 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888244 CNCCC(Oc1ccc(CN2CCN(C)c3ccncc3C2=O)cc1)c1cccs1 InChI=1S/C24H28N4O2S/c1-25-11-10-22(23-4-3-15-31-23)30-19-7-5-18(6-8-19)17-28-14-13-27(2)21-9-12-26-16-20(21)24(28)29/h3-9,12,15-16,22,25H,10-11,13-14,17H2,1-2H3 PLRRDJAYJPNCQT-UHFFFAOYSA-N 436605 1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 381 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436605&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088838 439658236 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888245 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ccncc3C2=O)cc1)c1cccs1 InChI=1S/C24H28N4O2S/c1-25-11-10-22(23-4-3-15-31-23)30-19-7-5-18(6-8-19)17-28-14-13-27(2)21-9-12-26-16-20(21)24(28)29/h3-9,12,15-16,22,25H,10-11,13-14,17H2,1-2H3/t22-/m0/s1 PLRRDJAYJPNCQT-QFIPXVFZSA-N 436606 (S)-1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 382 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436606&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098863 439658237 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888246 CCNc1cc2N(C)CCN(Cc3ccc(O[C@@H](CCNC)c4cccs4)cc3)C(=O)c2cn1 InChI=1S/C26H33N5O2S/c1-4-28-25-16-22-21(17-29-25)26(32)31(14-13-30(22)3)18-19-7-9-20(10-8-19)33-23(11-12-27-2)24-6-5-15-34-24/h5-10,15-17,23,27H,4,11-14,18H2,1-3H3,(H,28,29)/t23-/m0/s1 ZQDPPYZTUFYXQP-QHCPKHFHSA-N 436607 (S)-8-(ethylamino)-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 383 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436607&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088939 439658238 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888247 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(ncc3C2=O)N(C)C)cc1)c1cccs1 InChI=1S/C26H33N5O2S/c1-27-12-11-23(24-6-5-15-34-24)33-20-9-7-19(8-10-20)18-31-14-13-30(4)22-16-25(29(2)3)28-17-21(22)26(31)32/h5-10,15-17,23,27H,11-14,18H2,1-4H3/t23-/m0/s1 CMVIUAMERNJGJV-QHCPKHFHSA-N 436608 (S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 384 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436608&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089095 439658239 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888248 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(OC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C25H30N4O3S/c1-26-11-10-22(23-5-4-14-33-23)32-19-8-6-18(7-9-19)17-29-13-12-28(2)21-15-24(31-3)27-16-20(21)25(29)30/h4-9,14-16,22,26H,10-13,17H2,1-3H3/t22-/m0/s1 ADZLFOZXVROIJQ-QFIPXVFZSA-N 436609 (S)-8-methoxy-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 385 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436609&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098977 439658240 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888249 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(ncc3C2=O)C(F)(F)F)cc1)c1cccs1 InChI=1S/C24H26F3N5O2S/c1-28-10-9-19(20-4-3-13-35-20)34-17-7-5-16(6-8-17)15-32-12-11-31(2)21-18(22(32)33)14-29-23(30-21)24(25,26)27/h3-8,13-14,19,28H,9-12,15H2,1-2H3/t19-/m0/s1 SVLCJDSHPQXKRN-IBGZPJMESA-N 436610 (S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 386 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436610&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089289 439658241 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888250 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccsc1 InChI=1S/C24H29N5O3S/c1-25-10-8-21(18-9-13-33-16-18)32-19-6-4-17(5-7-19)15-29-12-11-28(2)22-20(23(29)30)14-26-24(27-22)31-3/h4-7,9,13-14,16,21,25H,8,10-12,15H2,1-3H3 MKPRTPUWLYUUAO-UHFFFAOYSA-N 436611 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1- (thiophen-3- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 387 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436611&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089233 439658242 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888251 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1sccc1C InChI=1S/C25H31N5O3S/c1-17-10-14-34-22(17)21(9-11-26-2)33-19-7-5-18(6-8-19)16-30-13-12-29(3)23-20(24(30)31)15-27-25(28-23)32-4/h5-8,10,14-15,21,26H,9,11-13,16H2,1-4H3 UFYUETPBFDCCSC-UHFFFAOYSA-N 436612 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(3- methylthiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 388 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436612&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089295 439658243 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888252 CCN1CCN(Cc2ccc(O[C@@H](CCNC)c3cccs3)cc2)C(=O)c2cnc(OC)cc12 InChI=1S/C26H32N4O3S/c1-4-29-13-14-30(26(31)21-17-28-25(32-3)16-22(21)29)18-19-7-9-20(10-8-19)33-23(11-12-27-2)24-6-5-15-34-24/h5-10,15-17,23,27H,4,11-14,18H2,1-3H3/t23-/m0/s1 XJNGDIZTERSHCD-QHCPKHFHSA-N 436613 (S)-1-ethyl-8- methoxy-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 389 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436613&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132099021 439658244 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888253 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1nccs1 InChI=1S/C23H28N6O3S/c1-24-9-8-19(21-25-10-13-33-21)32-17-6-4-16(5-7-17)15-29-12-11-28(2)20-18(22(29)30)14-26-23(27-20)31-3/h4-7,10,13-14,19,24H,8-9,11-12,15H2,1-3H3 WLSHIBNIFLJJDM-UHFFFAOYSA-N 436614 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1- (thiazol-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 390 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436614&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088724 439658245 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888254 CCN1CCN(Cc2ccc(O[C@@H](CCNC)c3cccs3)cc2)C(=O)c2cnccc12 InChI=1S/C25H30N4O2S/c1-3-28-14-15-29(25(30)21-17-27-13-10-22(21)28)18-19-6-8-20(9-7-19)31-23(11-12-26-2)24-5-4-16-32-24/h4-10,13,16-17,23,26H,3,11-12,14-15,18H2,1-2H3/t23-/m0/s1 KKHPQIYTBQXDHW-QHCPKHFHSA-N 436615 (S)-1-ethyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 391 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436615&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089086 439658246 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888255 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccc(C)s1 InChI=1S/C25H31N5O3S/c1-17-5-10-22(34-17)21(11-12-26-2)33-19-8-6-18(7-9-19)16-30-14-13-29(3)23-20(24(30)31)15-27-25(28-23)32-4/h5-10,15,21,26H,11-14,16H2,1-4H3 CCNHLMZWGULFFU-UHFFFAOYSA-N 436616 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(5- methylthiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 392 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436616&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089223 439658247 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888256 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1C)c1cccs1 InChI=1S/C25H31N5O3S/c1-17-14-18(7-8-20(17)33-21(9-10-26-2)22-6-5-13-34-22)16-30-12-11-29(3)23-19(24(30)31)15-27-25(28-23)32-4/h5-8,13-15,21,26H,9-12,16H2,1-4H3/t21-/m0/s1 WOOKGLDUUVUGSS-NRFANRHFSA-N 436617 (S)-2-methoxy-9- methyl-6-(3-methyl- 4-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 393 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436617&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089443 439658248 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888257 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1F)c1cccs1 InChI=1S/C24H28FN5O3S/c1-26-9-8-20(21-5-4-12-34-21)33-19-7-6-16(13-18(19)25)15-30-11-10-29(2)22-17(23(30)31)14-27-24(28-22)32-3/h4-7,12-14,20,26H,8-11,15H2,1-3H3/t20-/m0/s1 TUYHONFAVFQREZ-FQEVSTJZSA-N 436618 (S)-6-(3-fluoro-4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- methoxy-9-methyl- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 394 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436618&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088965 439658249 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888258 CCN1CCN(Cc2ccc(O[C@@H](CCNC)c3cccs3)cc2)C(=O)c2cnc(OC)nc12 InChI=1S/C25H31N5O3S/c1-4-29-13-14-30(24(31)20-16-27-25(32-3)28-23(20)29)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3/t21-/m0/s1 DJHONIICRXAUAB-NRFANRHFSA-N 436619 (S)-9-ethyl-2- methoxy-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 395 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436619&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089251 439658250 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888259 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1cc(C)cs1 InChI=1S/C25H31N5O3S/c1-17-13-22(34-16-17)21(9-10-26-2)33-19-7-5-18(6-8-19)15-30-12-11-29(3)23-20(24(30)31)14-27-25(28-23)32-4/h5-8,13-14,16,21,26H,9-12,15H2,1-4H3 DDOAELKIYNXMBU-UHFFFAOYSA-N 436620 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(4- methylthiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 396 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436620&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089246 439658251 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888260 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)c(C)c1)c1cccs1 InChI=1S/C25H31N5O3S/c1-17-14-19(33-21(9-10-26-2)22-6-5-13-34-22)8-7-18(17)16-30-12-11-29(3)23-20(24(30)31)15-27-25(28-23)32-4/h5-8,13-15,21,26H,9-12,16H2,1-4H3/t21-/m0/s1 GVFOVIPQFRUEHA-NRFANRHFSA-N 436621 (S)-2-methoxy-9- methyl-6-(2-methyl- 4-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 397 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human <100 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436621&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088761 439658252 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888261 CCN1CCN(Cc2ccc(O[C@@H](CCNC)c3cccs3)cc2)C(=O)c2cncnc12 InChI=1S/C24H29N5O2S/c1-3-28-12-13-29(24(30)20-15-26-17-27-23(20)28)16-18-6-8-19(9-7-18)31-21(10-11-25-2)22-5-4-14-32-22/h4-9,14-15,17,21,25H,3,10-13,16H2,1-2H3/t21-/m0/s1 TYSLOBOSJIJVFT-NRFANRHFSA-N 436622 (S)-9-ethyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 398 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436622&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089332 439658253 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888262 CNCC[C@H](Oc1ccc(CN2CCN(C)c3c(F)cncc3C2=O)cc1)c1cccs1 InChI=1S/C24H27FN4O2S/c1-26-10-9-21(22-4-3-13-32-22)31-18-7-5-17(6-8-18)16-29-12-11-28(2)23-19(24(29)30)14-27-15-20(23)25/h3-8,13-15,21,26H,9-12,16H2,1-2H3/t21-/m0/s1 NSNWDVLFVSGTEQ-NRFANRHFSA-N 436623 (S)-9-fluoro-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 399 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436623&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098830 439658254 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888263 CNCC[C@H](Oc1ccc(CN2CCN(C)c3c(Cl)cncc3C2=O)cc1)c1cccs1 InChI=1S/C24H27ClN4O2S/c1-26-10-9-21(22-4-3-13-32-22)31-18-7-5-17(6-8-18)16-29-12-11-28(2)23-19(24(29)30)14-27-15-20(23)25/h3-8,13-15,21,26H,9-12,16H2,1-2H3/t21-/m0/s1 ALBCCSDIBXSTFH-NRFANRHFSA-N 436624 (S)-9-chloro-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 400 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436624&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098831 439658255 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888264 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)c(F)c1)c1cccs1 InChI=1S/C24H28FN5O3S/c1-26-9-8-20(21-5-4-12-34-21)33-17-7-6-16(19(25)13-17)15-30-11-10-29(2)22-18(23(30)31)14-27-24(28-22)32-3/h4-7,12-14,20,26H,8-11,15H2,1-3H3/t20-/m0/s1 DELMUTDNAZXUCT-FQEVSTJZSA-N 436625 (S)-6-(2-fluoro-4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- methoxy-9-methyl- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 401 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human <100 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436625&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089034 439658256 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888265 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O3S/c1-25-11-10-20(21-5-4-14-33-21)32-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)31-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3/t20-/m0/s1 NSAPWHGIQPPHQR-FQEVSTJZSA-N 436626 (S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 402 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436626&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089155 439658257 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888266 CNCC[C@H](Oc1cc(F)ccc1CN1CCN(C)c2nc(OC)ncc2C1=O)c1cccs1 InChI=1S/C24H28FN5O3S/c1-26-9-8-19(21-5-4-12-34-21)33-20-13-17(25)7-6-16(20)15-30-11-10-29(2)22-18(23(30)31)14-27-24(28-22)32-3/h4-7,12-14,19,26H,8-11,15H2,1-3H3/t19-/m0/s1 CMBZNEXHDUSKHK-IBGZPJMESA-N 436627 (S)-6-(4-fluoro-2-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- methoxy-9-methyl- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 403 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436627&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089417 439658258 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888267 CCNc1ncc2c(n1)N(C)CCN(Cc1ccccc1COC(CCNC)c1ccccc1)C2=O InChI=1S/C28H36N6O2/c1-4-30-28-31-18-24-26(32-28)33(3)16-17-34(27(24)35)19-22-12-8-9-13-23(22)20-36-25(14-15-29-2)21-10-6-5-7-11-21/h5-13,18,25,29H,4,14-17,19-20H2,1-3H3,(H,30,31,32) ISZJAOXKNFZMIW-UHFFFAOYSA-N 436628 2-(ethylamino)-9- methyl-6-(2-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 404 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436628&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089524 439658259 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888268 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(COC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C28H36N6O2/c1-4-30-28-31-18-24-26(32-28)33(3)16-17-34(27(24)35)19-21-10-12-22(13-11-21)20-36-25(14-15-29-2)23-8-6-5-7-9-23/h5-13,18,25,29H,4,14-17,19-20H2,1-3H3,(H,30,31,32) FGPZFIZWOLGIDF-UHFFFAOYSA-N 436629 2-(ethylamino)-9- methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 405 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436629&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089277 439658260 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888269 CCNc1ncc2c(n1)N(C)CCN(Cc1cccc(COC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-4-30-28-31-18-24-26(32-28)33(3)15-16-34(27(24)35)19-21-9-8-10-22(17-21)20-36-25(13-14-29-2)23-11-6-5-7-12-23/h5-12,17-18,25,29H,4,13-16,19-20H2,1-3H3,(H,30,31,32) HNEKLAXKDRFZKN-UHFFFAOYSA-N 436630 2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 406 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436630&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088883 439658261 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888270 CCNc1ncc2c(n1)N(C)CCN(Cc1cccc(OC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)19-20-9-8-12-22(17-20)35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31) JNSFITWHWIMOLL-UHFFFAOYSA-N 436631 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- phenylpropoxy) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 407 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436631&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089141 439658262 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888271 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)19-20-10-12-22(13-11-20)35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31) GJWAJBQAFMDPFR-UHFFFAOYSA-N 436632 2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 408 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436632&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088830 439658263 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888272 CCNc1ncc2c(n1)N(C)CCN(Cc1ccccc1OC(CCNC)c1ccccc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-22-25(31-27)32(3)16-17-33(26(22)34)19-21-12-8-9-13-23(21)35-24(14-15-28-2)20-10-6-5-7-11-20/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31) WTYIGJXEMKJVMY-UHFFFAOYSA-N 436633 2-(ethylamino)-9- methyl-6-(2-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 409 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436633&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089435 439658264 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888273 CCNc1ncc2c(n1)N(C)CCN(Cc1ccccc1OC(CNC)c1ccccc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-21-24(30-26)31(3)14-15-32(25(21)33)18-20-12-8-9-13-22(20)34-23(17-27-2)19-10-6-5-7-11-19/h5-13,16,23,27H,4,14-15,17-18H2,1-3H3,(H,28,29,30) DBVYYIFFZGRUSZ-UHFFFAOYSA-N 436634 2-(ethylamino)-9- methyl-6-(2-(2- (methylamino)-1- phenylethoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 410 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436634&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088959 439658265 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888274 CCNc1ncc2c(n1)N(C)CCN(Cc1cccc(COC(CNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-16-23-25(31-27)32(3)13-14-33(26(23)34)18-20-9-8-10-21(15-20)19-35-24(17-28-2)22-11-6-5-7-12-22/h5-12,15-16,24,28H,4,13-14,17-19H2,1-3H3,(H,29,30,31) TZYRHPFLJFVDAN-UHFFFAOYSA-N 436635 2-(ethylamino)-9- methyl-6-(3-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 411 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436635&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089371 439658266 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888275 CCNc1ncc2c(n1)N(C)CCN(Cc1ccccc1COC(CNC)c1ccccc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-16-23-25(31-27)32(3)14-15-33(26(23)34)18-21-12-8-9-13-22(21)19-35-24(17-28-2)20-10-6-5-7-11-20/h5-13,16,24,28H,4,14-15,17-19H2,1-3H3,(H,29,30,31) MYZHSNDPAKBFSH-UHFFFAOYSA-N 436636 2-(ethylamino)-9- methyl-6-(2-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 412 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436636&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088774 439658267 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888276 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(COC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-16-23-25(31-27)32(3)14-15-33(26(23)34)18-20-10-12-21(13-11-20)19-35-24(17-28-2)22-8-6-5-7-9-22/h5-13,16,24,28H,4,14-15,17-19H2,1-3H3,(H,29,30,31) SWKNCRTZWAZJEV-UHFFFAOYSA-N 436637 2-(ethylamino)-9- methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 413 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436637&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089030 439658268 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888277 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@@H](CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)19-20-10-12-22(13-11-20)35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31)/t24-/m0/s1 GJWAJBQAFMDPFR-DEOSSOPVSA-N 436638 (S)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 414 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436638&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089038 439658269 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888278 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@H](CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)19-20-10-12-22(13-11-20)35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31)/t24-/m1/s1 GJWAJBQAFMDPFR-XMMPIXPASA-N 436639 (R)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 415 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436639&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088829 439658270 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888279 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29) CSAXPKYQQPOHMD-UHFFFAOYSA-N 436640 2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 416 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436640&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088735 439658271 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888280 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@@H](CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29)/t21-/m0/s1 CSAXPKYQQPOHMD-NRFANRHFSA-N 436641 (S)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 417 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436641&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088826 439658272 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888281 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@H](CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29)/t21-/m1/s1 CSAXPKYQQPOHMD-OAQYLSRUSA-N 436642 (R)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 418 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436642&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089046 439658273 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888282 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(ncc3C2=O)N(C)C)cc1)c1cccs1 InChI=1S/C25H32N6O2S/c1-26-12-11-21(22-6-5-15-34-22)33-19-9-7-18(8-10-19)17-31-14-13-30(4)23-20(24(31)32)16-27-25(28-23)29(2)3/h5-10,15-16,21,26H,11-14,17H2,1-4H3/t21-/m0/s1 SMXRDTCWJPEFLL-NRFANRHFSA-N 436643 (S)-2-(dimethylamino)- 9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 419 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436643&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089091 439658274 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888283 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(N)ncc3C2=O)cc1)c1cccs1 InChI=1S/C23H28N6O2S/c1-25-10-9-19(20-4-3-13-32-20)31-17-7-5-16(6-8-17)15-29-12-11-28(2)21-18(22(29)30)14-26-23(24)27-21/h3-8,13-14,19,25H,9-12,15H2,1-2H3,(H2,24,26,27)/t19-/m0/s1 CLARLFOYACHYCL-IBGZPJMESA-N 436644 (S)-2-amino-9-methyl- 6-(4-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 420 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436644&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089274 439658275 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888284 CNCCC(OCc1ccccc1CN1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C27H33N5O2/c1-20-29-17-24-26(30-20)31(3)15-16-32(27(24)33)18-22-11-7-8-12-23(22)19-34-25(13-14-28-2)21-9-5-4-6-10-21/h4-12,17,25,28H,13-16,18-19H2,1-3H3 LODMBHJYZVGTNX-UHFFFAOYSA-N 436645 2,9-dimethyl-6-(2-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 421 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436645&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089376 439658276 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888285 CNCCC(OCc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C27H33N5O2/c1-20-29-17-24-26(30-20)31(3)15-16-32(27(24)33)18-21-9-11-22(12-10-21)19-34-25(13-14-28-2)23-7-5-4-6-8-23/h4-12,17,25,28H,13-16,18-19H2,1-3H3 WLAFHFDODWULDI-UHFFFAOYSA-N 436646 2,9-dimethyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 422 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436646&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088979 439658277 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888286 CNCCC(OCc1cccc(CN2CCN(C)c3nc(C)ncc3C2=O)c1)c1ccccc1 InChI=1S/C27H33N5O2/c1-20-29-17-24-26(30-20)31(3)14-15-32(27(24)33)18-21-8-7-9-22(16-21)19-34-25(12-13-28-2)23-10-5-4-6-11-23/h4-11,16-17,25,28H,12-15,18-19H2,1-3H3 FMWMQHWFVXLGQE-UHFFFAOYSA-N 436647 2,9-dimethyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 423 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436647&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089240 439658278 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888287 CNCC(OCc1ccccc1CN1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-15-23-25(29-19)30(3)13-14-31(26(23)32)17-21-11-7-8-12-22(21)18-33-24(16-27-2)20-9-5-4-6-10-20/h4-12,15,24,27H,13-14,16-18H2,1-3H3 ITEPVROEODTXNF-UHFFFAOYSA-N 436648 2,9-dimethyl-6-(2-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 424 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436648&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089057 439658279 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888288 CNCCC(Oc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-17-23-25(29-19)30(3)15-16-31(26(23)32)18-20-9-11-22(12-10-20)33-24(13-14-27-2)21-7-5-4-6-8-21/h4-12,17,24,27H,13-16,18H2,1-3H3 JQKGMDZUFJXBNK-UHFFFAOYSA-N 436649 2,9-dimethyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 425 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436649&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088756 439658280 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888289 CCc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H33N5O2/c1-4-25-29-18-23-26(30-25)31(3)16-17-32(27(23)33)19-20-10-12-22(13-11-20)34-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3 AHDJHFNBBNZKOJ-UHFFFAOYSA-N 436650 2-ethyl-9-methyl-6-(4- (3-(methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 426 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436650&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088748 439658281 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888290 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)12-13-29(24(20)30)16-18-6-8-19(9-7-18)31-21(10-11-25-2)22-5-4-14-32-22/h4-9,14-15,21,25H,10-13,16H2,1-3H3/t21-/m1/s1 KVTOUZJEBYXKDY-OAQYLSRUSA-N 436651 (R)-2,9-dimethyl-6-(4- (3-(methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 427 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436651&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088738 439658282 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888291 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)12-13-29(24(20)30)16-18-6-8-19(9-7-18)31-21(10-11-25-2)22-5-4-14-32-22/h4-9,14-15,21,25H,10-13,16H2,1-3H3/t21-/m0/s1 KVTOUZJEBYXKDY-NRFANRHFSA-N 436652 (S)-2,9-dimethyl-6-(4- (3-(methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 428 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436652&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089191 439658283 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888292 CNCCC(Oc1cccc(CN2CCN(C)c3ncncc3C2=O)c1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-12-11-23(20-8-4-3-5-9-20)32-21-10-6-7-19(15-21)17-30-14-13-29(2)24-22(25(30)31)16-27-18-28-24/h3-10,15-16,18,23,26H,11-14,17H2,1-2H3 MCGVHXPHJLHWEZ-UHFFFAOYSA-N 436653 9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 429 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436653&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089322 439658284 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888293 CNCCC(Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(20-6-4-3-5-7-20)32-21-10-8-19(9-11-21)17-30-15-14-29(2)24-22(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3 UXFURXVOCCXVJQ-UHFFFAOYSA-N 436654 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 430 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436654&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088895 439658285 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888294 CNCCC(Oc1ccccc1CN1CCN(C)c2ncncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(19-8-4-3-5-9-19)32-22-11-7-6-10-20(22)17-30-15-14-29(2)24-21(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3 QIMLTGPXGXSYAM-UHFFFAOYSA-N 436655 9-methyl-6-(2-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 431 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436655&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089298 439658286 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888295 CNCC(Oc1ccccc1CN1CCN(C)c2ncncc2C1=O)c1ccccc1 InChI=1S/C24H27N5O2/c1-25-15-22(18-8-4-3-5-9-18)31-21-11-7-6-10-19(21)16-29-13-12-28(2)23-20(24(29)30)14-26-17-27-23/h3-11,14,17,22,25H,12-13,15-16H2,1-2H3 FLNDHBKQGNSANR-UHFFFAOYSA-N 436656 9-methyl-6-(2-(2- (methylamino)-1- phenylethoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 432 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436656&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089300 439658287 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888296 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(20-6-4-3-5-7-20)32-21-10-8-19(9-11-21)17-30-15-14-29(2)24-22(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3/t23-/m0/s1 UXFURXVOCCXVJQ-QHCPKHFHSA-N 436657 (S)-9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 433 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436657&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089162 439658288 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888297 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(20-6-4-3-5-7-20)32-21-10-8-19(9-11-21)17-30-15-14-29(2)24-22(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3/t23-/m1/s1 UXFURXVOCCXVJQ-HSZRJFAPSA-N 436658 (R)-9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 434 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436658&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088893 439658289 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888298 CNCCC(Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-10-9-20(21-4-3-13-31-21)30-18-7-5-17(6-8-18)15-28-12-11-27(2)22-19(23(28)29)14-25-16-26-22/h3-8,13-14,16,20,24H,9-12,15H2,1-2H3 DWDRNVYPUMCROH-UHFFFAOYSA-N 436659 9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 435 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436659&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088775 439658290 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888299 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-10-9-20(21-4-3-13-31-21)30-18-7-5-17(6-8-18)15-28-12-11-27(2)22-19(23(28)29)14-25-16-26-22/h3-8,13-14,16,20,24H,9-12,15H2,1-2H3/t20-/m0/s1 DWDRNVYPUMCROH-FQEVSTJZSA-N 436660 (S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 436 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436660&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089489 439658291 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888300 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-10-9-20(21-4-3-13-31-21)30-18-7-5-17(6-8-18)15-28-12-11-27(2)22-19(23(28)29)14-25-16-26-22/h3-8,13-14,16,20,24H,9-12,15H2,1-2H3/t20-/m1/s1 DWDRNVYPUMCROH-HXUWFJFHSA-N 436661 (R)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 437 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436661&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089182 439658292 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888301 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCN3CCC(CC3)(N(C)C)c3ccccc3)c1)C2=O InChI=1S/C31H41N7O/c1-5-32-30-33-23-27-28(34-30)36(4)20-21-38(29(27)39)26-13-9-10-24(22-26)14-17-37-18-15-31(16-19-37,35(2)3)25-11-7-6-8-12-25/h6-13,22-23H,5,14-21H2,1-4H3,(H,32,33,34) KRECOBDSXKYMEJ-UHFFFAOYSA-N 436662 6-(3-(2-(4- (dimethylamino)-4- phenylpiperidin-1- yl)ethyl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 438 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436662&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088731 439658293 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888302 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCN3CCCCC3)c1)C2=O InChI=1S/C23H32N6O2/c1-3-24-23-25-17-20-21(26-23)27(2)12-13-29(22(20)30)18-8-7-9-19(16-18)31-15-14-28-10-5-4-6-11-28/h7-9,16-17H,3-6,10-15H2,1-2H3,(H,24,25,26) RLWYIJTWJOMDIX-UHFFFAOYSA-N 436663 2-(ethylamino)-9- methyl-6-(3-(2- (piperidin-1- yl)ethoxy)phenyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 439 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436663&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088924 439658294 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888303 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCN3CCOCC3)c1)C2=O InChI=1S/C22H30N6O3/c1-3-23-22-24-16-19-20(25-22)26(2)7-8-28(21(19)29)17-5-4-6-18(15-17)31-14-11-27-9-12-30-13-10-27/h4-6,15-16H,3,7-14H2,1-2H3,(H,23,24,25) DLLXKBHCVQOUOP-UHFFFAOYSA-N 436664 2-(ethylamino)-9- methyl-6-(3-(2- morpholinoethoxy) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 440 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436664&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089176 439658295 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888304 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(CN3CCC(CC3)(N(C)C)c3ccccc3)o1)C2=O InChI=1S/C32H39N9O2/c1-5-33-31-34-21-26-28(35-31)39(4)18-19-41(30(26)42)25-13-9-10-23(20-25)29-37-36-27(43-29)22-40-16-14-32(15-17-40,38(2)3)24-11-7-6-8-12-24/h6-13,20-21H,5,14-19,22H2,1-4H3,(H,33,34,35) VTXYSRNIKRBQPZ-UHFFFAOYSA-N 436665 6-(3-(5-((4- (dimethylamino)-4- phenylpiperidin-1- yl)methyl)-1,3,4- oxadiazol-2-yl)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 441 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436665&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089102 439658296 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888305 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(CN3CCC(CC3)(N(C)C)c3cccc(O)c3)o1)C2=O InChI=1S/C32H39N9O3/c1-5-33-31-34-20-26-28(35-31)39(4)16-17-41(30(26)43)24-10-6-8-22(18-24)29-37-36-27(44-29)21-40-14-12-32(13-15-40,38(2)3)23-9-7-11-25(42)19-23/h6-11,18-20,42H,5,12-17,21H2,1-4H3,(H,33,34,35) NMJNERYTYHDEJS-UHFFFAOYSA-N 436666 6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)piperidin- 1-yl)methyl)-1,3,4- oxadiazol-2-yl)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 442 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human <100 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436666&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089145 439658297 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888306 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)15-16-32(25(22)33)20-11-8-12-21(17-20)34-23(13-14-27-2)19-9-6-5-7-10-19/h5-12,17-18,23,27H,4,13-16H2,1-3H3,(H,28,29,30) MGGCXTKDCMPNFI-UHFFFAOYSA-N 436369 2-(ethylamino)-9-methyl- 6-(3-(3-(methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 148 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436369&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089092 439658003 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888307 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)15-16-32(25(22)33)20-11-8-12-21(17-20)34-23(13-14-27-2)19-9-6-5-7-10-19/h5-12,17-18,23,27H,4,13-16H2,1-3H3,(H,28,29,30) MGGCXTKDCMPNFI-UHFFFAOYSA-N 436369 2-(ethylamino)-9-methyl- 6-(3-(3-(methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 148 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436369&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089092 439658003 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888308 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)15-16-32(25(22)33)20-11-8-12-21(17-20)34-23(13-14-27-2)19-9-6-5-7-10-19/h5-12,17-18,23,27H,4,13-16H2,1-3H3,(H,28,29,30)/t23-/m1/s1 MGGCXTKDCMPNFI-HSZRJFAPSA-N 436371 (R)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 149 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436371&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089090 439658005 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888309 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)15-16-32(25(22)33)20-11-8-12-21(17-20)34-23(13-14-27-2)19-9-6-5-7-10-19/h5-12,17-18,23,27H,4,13-16H2,1-3H3,(H,28,29,30)/t23-/m1/s1 MGGCXTKDCMPNFI-HSZRJFAPSA-N 436371 (R)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 149 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436371&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089090 439658005 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888310 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)15-16-32(25(22)33)20-11-8-12-21(17-20)34-23(13-14-27-2)19-9-6-5-7-10-19/h5-12,17-18,23,27H,4,13-16H2,1-3H3,(H,28,29,30)/t23-/m0/s1 MGGCXTKDCMPNFI-QHCPKHFHSA-N 436373 (S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 150 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436373&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089355 439658007 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888311 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)15-16-32(25(22)33)20-11-8-12-21(17-20)34-23(13-14-27-2)19-9-6-5-7-10-19/h5-12,17-18,23,27H,4,13-16H2,1-3H3,(H,28,29,30)/t23-/m0/s1 MGGCXTKDCMPNFI-QHCPKHFHSA-N 436373 (S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 150 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436373&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089355 439658007 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888312 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-13-12-22(18-8-5-4-6-9-18)32-20-11-7-10-19(16-20)30-15-14-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-11,16-17,22,26H,12-15H2,1-3H3 QBVVGONNVGILBA-UHFFFAOYSA-N 436374 9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 151 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436374&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088741 439658008 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888313 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-13-12-22(18-8-5-4-6-9-18)32-20-11-7-10-19(16-20)30-15-14-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-11,16-17,22,26H,12-15H2,1-3H3 QBVVGONNVGILBA-UHFFFAOYSA-N 436374 9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 151 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436374&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088741 439658008 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888314 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-13-12-22(18-8-5-4-6-9-18)32-20-11-7-10-19(16-20)30-15-14-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-11,16-17,22,26H,12-15H2,1-3H3/t22-/m1/s1 QBVVGONNVGILBA-JOCHJYFZSA-N 436375 (R)-9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 152 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436375&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088740 439658009 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888315 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-13-12-22(18-8-5-4-6-9-18)32-20-11-7-10-19(16-20)30-15-14-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-11,16-17,22,26H,12-15H2,1-3H3/t22-/m1/s1 QBVVGONNVGILBA-JOCHJYFZSA-N 436375 (R)-9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 152 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436375&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088740 439658009 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888316 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-13-12-22(18-8-5-4-6-9-18)32-20-11-7-10-19(16-20)30-15-14-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-11,16-17,22,26H,12-15H2,1-3H3/t22-/m0/s1 QBVVGONNVGILBA-QFIPXVFZSA-N 436376 (S)-9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 153 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436376&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088806 439658010 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888317 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-13-12-22(18-8-5-4-6-9-18)32-20-11-7-10-19(16-20)30-15-14-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-11,16-17,22,26H,12-15H2,1-3H3/t22-/m0/s1 QBVVGONNVGILBA-QFIPXVFZSA-N 436376 (S)-9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 153 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436376&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088806 439658010 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888318 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CNC)c3ccccc3)c1)C2=O InChI=1S/C25H30N6O2/c1-4-27-25-28-16-21-23(29-25)30(3)13-14-31(24(21)32)19-11-8-12-20(15-19)33-22(17-26-2)18-9-6-5-7-10-18/h5-12,15-16,22,26H,4,13-14,17H2,1-3H3,(H,27,28,29) ZPAUTBDMXAHDBQ-UHFFFAOYSA-N 436377 2-(ethylamino)-9- methyl-6-(3-(2- (methylamino)-1- phenylethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 154 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436377&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088920 439658011 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888319 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CNC)c3ccccc3)c1)C2=O InChI=1S/C25H30N6O2/c1-4-27-25-28-16-21-23(29-25)30(3)13-14-31(24(21)32)19-11-8-12-20(15-19)33-22(17-26-2)18-9-6-5-7-10-18/h5-12,15-16,22,26H,4,13-14,17H2,1-3H3,(H,27,28,29) ZPAUTBDMXAHDBQ-UHFFFAOYSA-N 436377 2-(ethylamino)-9- methyl-6-(3-(2- (methylamino)-1- phenylethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 154 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436377&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088920 439658011 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888320 CCNc1ncc2c(n1)N(C)CCN(c1ccc(OC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C25H30N6O2/c1-4-27-25-28-16-21-23(29-25)30(3)14-15-31(24(21)32)19-10-12-20(13-11-19)33-22(17-26-2)18-8-6-5-7-9-18/h5-13,16,22,26H,4,14-15,17H2,1-3H3,(H,27,28,29) ZPDLVPVVMUDJJV-UHFFFAOYSA-N 436384 2-(ethylamino)-9- methyl-6-(4-(2- (methylamino)-1- phenylethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 159 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436384&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089243 439658017 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888321 CCNc1ncc2c(n1)N(C)CCN(c1ccc(OC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C25H30N6O2/c1-4-27-25-28-16-21-23(29-25)30(3)14-15-31(24(21)32)19-10-12-20(13-11-19)33-22(17-26-2)18-8-6-5-7-9-18/h5-13,16,22,26H,4,14-15,17H2,1-3H3,(H,27,28,29) ZPDLVPVVMUDJJV-UHFFFAOYSA-N 436384 2-(ethylamino)-9- methyl-6-(4-(2- (methylamino)-1- phenylethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 159 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436384&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089243 439658017 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888322 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)22-12-8-9-20(17-22)19-35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31) CHQJWHDWPUGTOO-UHFFFAOYSA-N 436385 2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 160 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436385&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088848 439658018 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888323 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)22-12-8-9-20(17-22)19-35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31) CHQJWHDWPUGTOO-UHFFFAOYSA-N 436385 2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 160 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436385&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088848 439658018 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888324 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)22-12-8-9-20(17-22)19-35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31)/t24-/m1/s1 CHQJWHDWPUGTOO-XMMPIXPASA-N 436386 (R)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 161 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436386&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089079 439658019 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888325 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)22-12-8-9-20(17-22)19-35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31)/t24-/m1/s1 CHQJWHDWPUGTOO-XMMPIXPASA-N 436386 (R)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 161 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436386&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089079 439658019 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888326 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)22-12-8-9-20(17-22)19-35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31)/t24-/m0/s1 CHQJWHDWPUGTOO-DEOSSOPVSA-N 436387 (S)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 162 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436387&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088846 439658020 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888327 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)15-16-33(26(23)34)22-12-8-9-20(17-22)19-35-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3,(H,29,30,31)/t24-/m0/s1 CHQJWHDWPUGTOO-DEOSSOPVSA-N 436387 (S)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 162 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436387&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088846 439658020 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888328 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3 KVXVYTXQWCDYQC-UHFFFAOYSA-N 436388 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 163 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436388&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089018 439658021 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888329 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3 KVXVYTXQWCDYQC-UHFFFAOYSA-N 436388 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 163 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436388&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089018 439658021 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888330 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3/t23-/m1/s1 KVXVYTXQWCDYQC-HSZRJFAPSA-N 436389 (R)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 164 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436389&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089017 439658022 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888331 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3/t23-/m1/s1 KVXVYTXQWCDYQC-HSZRJFAPSA-N 436389 (R)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 164 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436389&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089017 439658022 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888332 CNCC[C@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3/t23-/m0/s1 KVXVYTXQWCDYQC-QHCPKHFHSA-N 436390 (S)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 165 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436390&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098976 439658023 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888333 CNCC[C@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3/t23-/m0/s1 KVXVYTXQWCDYQC-QHCPKHFHSA-N 436390 (S)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 165 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436390&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098976 439658023 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888334 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COCC(NC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)13-14-32(25(22)33)21-12-8-9-19(15-21)17-34-18-23(27-2)20-10-6-5-7-11-20/h5-12,15-16,23,27H,4,13-14,17-18H2,1-3H3,(H,28,29,30) PWQZZRUUAPCYPI-UHFFFAOYSA-N 436391 2-(ethylamino)-9- methyl-6-(3-((2- (methylamino)-2- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 166 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436391&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088880 439658024 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888335 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COCC(NC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)13-14-32(25(22)33)21-12-8-9-19(15-21)17-34-18-23(27-2)20-10-6-5-7-11-20/h5-12,15-16,23,27H,4,13-14,17-18H2,1-3H3,(H,28,29,30) PWQZZRUUAPCYPI-UHFFFAOYSA-N 436391 2-(ethylamino)-9- methyl-6-(3-((2- (methylamino)-2- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 166 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436391&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088880 439658024 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888336 CNC(COCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-22(19-9-5-4-6-10-19)17-32-16-18-8-7-11-20(14-18)30-13-12-29(2)23-21(24(30)31)15-27-25(28-23)33-3/h4-11,14-15,22,26H,12-13,16-17H2,1-3H3 CXMKCHCPOIXOFO-UHFFFAOYSA-N 436392 9-methyl-6-(3-((2- (methylamino)-2- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 167 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436392&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088752 439658025 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888337 CNC(COCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-22(19-9-5-4-6-10-19)17-32-16-18-8-7-11-20(14-18)30-13-12-29(2)23-21(24(30)31)15-27-25(28-23)33-3/h4-11,14-15,22,26H,12-13,16-17H2,1-3H3 CXMKCHCPOIXOFO-UHFFFAOYSA-N 436392 9-methyl-6-(3-((2- (methylamino)-2- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 167 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436392&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088752 439658025 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888338 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCNCc3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-3-28-26-29-19-23-24(30-26)31(2)14-15-32(25(23)33)21-11-7-12-22(17-21)34-16-8-13-27-18-20-9-5-4-6-10-20/h4-7,9-12,17,19,27H,3,8,13-16,18H2,1-2H3,(H,28,29,30) ARJQUHZAOAYLKD-UHFFFAOYSA-N 436394 6-(3-(3- (benzylamino)propoxy) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 169 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436394&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088713 439658027 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888339 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCNCc3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-3-28-26-29-19-23-24(30-26)31(2)14-15-32(25(23)33)21-11-7-12-22(17-21)34-16-8-13-27-18-20-9-5-4-6-10-20/h4-7,9-12,17,19,27H,3,8,13-16,18H2,1-2H3,(H,28,29,30) ARJQUHZAOAYLKD-UHFFFAOYSA-N 436394 6-(3-(3- (benzylamino)propoxy) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 169 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436394&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088713 439658027 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888340 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C(C)(C)CNC)C2=O InChI=1S/C21H30N6O/c1-6-23-20-24-13-17-18(25-20)26(5)10-11-27(19(17)28)16-9-7-8-15(12-16)21(2,3)14-22-4/h7-9,12-13,22H,6,10-11,14H2,1-5H3,(H,23,24,25) BHQPAGKRKRGPFF-UHFFFAOYSA-N 436398 2-(ethylamino)-9- methyl-6-(3-(2-methyl- 1-(methylamino) propan- 2-yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 173 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436398&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088994 439658031 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888341 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C(C)(C)CNC)C2=O InChI=1S/C21H30N6O/c1-6-23-20-24-13-17-18(25-20)26(5)10-11-27(19(17)28)16-9-7-8-15(12-16)21(2,3)14-22-4/h7-9,12-13,22H,6,10-11,14H2,1-5H3,(H,23,24,25) BHQPAGKRKRGPFF-UHFFFAOYSA-N 436398 2-(ethylamino)-9- methyl-6-(3-(2-methyl- 1-(methylamino) propan- 2-yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 173 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436398&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088994 439658031 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888342 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCNCC3)c3ccccc3)c1)C2=O InChI=1S/C28H34N6O2/c1-3-30-27-31-19-24-25(32-27)33(2)16-17-34(26(24)35)23-11-7-8-21(18-23)20-36-28(12-14-29-15-13-28)22-9-5-4-6-10-22/h4-11,18-19,29H,3,12-17,20H2,1-2H3,(H,30,31,32) XLFFYNPNRFDLQJ-UHFFFAOYSA-N 436401 2-(ethylamino)-9- methyl-6-(3-(((4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 176 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436401&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088977 439658034 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888343 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCNCC3)c3ccccc3)c1)C2=O InChI=1S/C28H34N6O2/c1-3-30-27-31-19-24-25(32-27)33(2)16-17-34(26(24)35)23-11-7-8-21(18-23)20-36-28(12-14-29-15-13-28)22-9-5-4-6-10-22/h4-11,18-19,29H,3,12-17,20H2,1-2H3,(H,30,31,32) XLFFYNPNRFDLQJ-UHFFFAOYSA-N 436401 2-(ethylamino)-9- methyl-6-(3-(((4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 176 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436401&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088977 439658034 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888344 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCNCC3)c3ccccc3)c1)C2=O InChI=1S/C27H31N5O2S/c1-31-15-16-32(25(33)23-18-29-26(35-2)30-24(23)31)22-10-6-7-20(17-22)19-34-27(11-13-28-14-12-27)21-8-4-3-5-9-21/h3-10,17-18,28H,11-16,19H2,1-2H3 STZOTCANDMGQHG-UHFFFAOYSA-N 436404 9-methyl-2- (methylthio)-6-(3-(((4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 179 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436404&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089317 439658037 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888345 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCNCC3)c3ccccc3)c1)C2=O InChI=1S/C27H31N5O2S/c1-31-15-16-32(25(33)23-18-29-26(35-2)30-24(23)31)22-10-6-7-20(17-22)19-34-27(11-13-28-14-12-27)21-8-4-3-5-9-21/h3-10,17-18,28H,11-16,19H2,1-2H3 STZOTCANDMGQHG-UHFFFAOYSA-N 436404 9-methyl-2- (methylthio)-6-(3-(((4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 179 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436404&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089317 439658037 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888346 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNCc3ccccc3)nn1)C2=O InChI=1S/C26H29N9O/c1-3-28-26-29-17-23-24(30-26)33(2)12-13-34(25(23)36)21-10-7-11-22(14-21)35-18-20(31-32-35)16-27-15-19-8-5-4-6-9-19/h4-11,14,17-18,27H,3,12-13,15-16H2,1-2H3,(H,28,29,30) XMQMKCVOYHQFMM-UHFFFAOYSA-N 436407 6-(3-(4- ((benzylamino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 182 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436407&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089181 439658040 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888347 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNCc3ccccc3)nn1)C2=O InChI=1S/C26H29N9O/c1-3-28-26-29-17-23-24(30-26)33(2)12-13-34(25(23)36)21-10-7-11-22(14-21)35-18-20(31-32-35)16-27-15-19-8-5-4-6-9-19/h4-11,14,17-18,27H,3,12-13,15-16H2,1-2H3,(H,28,29,30) XMQMKCVOYHQFMM-UHFFFAOYSA-N 436407 6-(3-(4- ((benzylamino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 182 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436407&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089181 439658040 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888348 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CCNC)nn1)C2=O InChI=1S/C21H27N9O/c1-4-23-21-24-13-18-19(25-21)28(3)10-11-29(20(18)31)16-6-5-7-17(12-16)30-14-15(26-27-30)8-9-22-2/h5-7,12-14,22H,4,8-11H2,1-3H3,(H,23,24,25) CFBFTFILZYUSEP-UHFFFAOYSA-N 436408 2-(ethylamino)-9- methyl-6-(3-(4-(2- (methylamino)ethyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 183 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436408&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089492 439658041 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888349 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CCNC)nn1)C2=O InChI=1S/C21H27N9O/c1-4-23-21-24-13-18-19(25-21)28(3)10-11-29(20(18)31)16-6-5-7-17(12-16)30-14-15(26-27-30)8-9-22-2/h5-7,12-14,22H,4,8-11H2,1-3H3,(H,23,24,25) CFBFTFILZYUSEP-UHFFFAOYSA-N 436408 2-(ethylamino)-9- methyl-6-(3-(4-(2- (methylamino)ethyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 183 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436408&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089492 439658041 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888350 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3ccccn3)c1)C2=O InChI=1S/C25H31N7O2/c1-4-27-25-29-17-20-23(30-25)31(3)14-15-32(24(20)33)18-8-7-9-19(16-18)34-22(11-13-26-2)21-10-5-6-12-28-21/h5-10,12,16-17,22,26H,4,11,13-15H2,1-3H3,(H,27,29,30) AWBSENWJRYCHOK-UHFFFAOYSA-N 436418 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (pyridin-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 193 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436418&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088900 439658051 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888351 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3ccccn3)c1)C2=O InChI=1S/C25H31N7O2/c1-4-27-25-29-17-20-23(30-25)31(3)14-15-32(24(20)33)18-8-7-9-19(16-18)34-22(11-13-26-2)21-10-5-6-12-28-21/h5-10,12,16-17,22,26H,4,11,13-15H2,1-3H3,(H,27,29,30) AWBSENWJRYCHOK-UHFFFAOYSA-N 436418 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (pyridin-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 193 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436418&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088900 439658051 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888352 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3cccnc3)c1)C2=O InChI=1S/C25H31N7O2/c1-4-28-25-29-17-21-23(30-25)31(3)13-14-32(24(21)33)19-8-5-9-20(15-19)34-22(10-12-26-2)18-7-6-11-27-16-18/h5-9,11,15-17,22,26H,4,10,12-14H2,1-3H3,(H,28,29,30) WKAZWRBRFSPHSO-UHFFFAOYSA-N 436419 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (pyridin-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 194 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436419&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088969 439658052 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888353 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3cccnc3)c1)C2=O InChI=1S/C25H31N7O2/c1-4-28-25-29-17-21-23(30-25)31(3)13-14-32(24(21)33)19-8-5-9-20(15-19)34-22(10-12-26-2)18-7-6-11-27-16-18/h5-9,11,15-17,22,26H,4,10,12-14H2,1-3H3,(H,28,29,30) WKAZWRBRFSPHSO-UHFFFAOYSA-N 436419 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (pyridin-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 194 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436419&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088969 439658052 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888354 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1ccccc1 InChI=1S/C25H30N6O2/c1-27-12-11-22(19-8-4-3-5-9-19)33-17-18-7-6-10-20(15-18)31-14-13-30(2)23-21(24(31)32)16-28-25(26)29-23/h3-10,15-16,22,27H,11-14,17H2,1-2H3,(H2,26,28,29)/t22-/m1/s1 NBOBGWSKDGTTTF-JOCHJYFZSA-N 436420 (R)-2-amino-9-methyl- 6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 195 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436420&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089211 439658053 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888355 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1ccccc1 InChI=1S/C25H30N6O2/c1-27-12-11-22(19-8-4-3-5-9-19)33-17-18-7-6-10-20(15-18)31-14-13-30(2)23-21(24(31)32)16-28-25(26)29-23/h3-10,15-16,22,27H,11-14,17H2,1-2H3,(H2,26,28,29)/t22-/m1/s1 NBOBGWSKDGTTTF-JOCHJYFZSA-N 436420 (R)-2-amino-9-methyl- 6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 195 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436420&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089211 439658053 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888356 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)C)c1ccccc1 InChI=1S/C27H34N6O2/c1-28-14-13-24(21-10-6-5-7-11-21)35-19-20-9-8-12-22(17-20)33-16-15-32(4)25-23(26(33)34)18-29-27(30-25)31(2)3/h5-12,17-18,24,28H,13-16,19H2,1-4H3/t24-/m1/s1 CDYPJHDIRLXZGD-XMMPIXPASA-N 436421 (R)-2-(dimethylamino)- 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 196 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436421&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089114 439658054 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888357 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)C)c1ccccc1 InChI=1S/C27H34N6O2/c1-28-14-13-24(21-10-6-5-7-11-21)35-19-20-9-8-12-22(17-20)33-16-15-32(4)25-23(26(33)34)18-29-27(30-25)31(2)3/h5-12,17-18,24,28H,13-16,19H2,1-4H3/t24-/m1/s1 CDYPJHDIRLXZGD-XMMPIXPASA-N 436421 (R)-2-(dimethylamino)- 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 196 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436421&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089114 439658054 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888358 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(NC)ncc2C1=O)c1ccccc1 InChI=1S/C26H32N6O2/c1-27-13-12-23(20-9-5-4-6-10-20)34-18-19-8-7-11-21(16-19)32-15-14-31(3)24-22(25(32)33)17-29-26(28-2)30-24/h4-11,16-17,23,27H,12-15,18H2,1-3H3,(H,28,29,30)/t23-/m1/s1 LYULKSAOWFGIIM-HSZRJFAPSA-N 436422 (R)-9-methyl-2- (methylamino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 197 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436422&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089173 439658055 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888359 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(NC)ncc2C1=O)c1ccccc1 InChI=1S/C26H32N6O2/c1-27-13-12-23(20-9-5-4-6-10-20)34-18-19-8-7-11-21(16-19)32-15-14-31(3)24-22(25(32)33)17-29-26(28-2)30-24/h4-11,16-17,23,27H,12-15,18H2,1-3H3,(H,28,29,30)/t23-/m1/s1 LYULKSAOWFGIIM-HSZRJFAPSA-N 436422 (R)-9-methyl-2- (methylamino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 197 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436422&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089173 439658055 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888360 CCNc1cc2N(C)CCN(c3cccc(OC(CCNC)c4ccccc4)c3)C(=O)c2cn1 InChI=1S/C27H33N5O2/c1-4-29-26-18-24-23(19-30-26)27(33)32(16-15-31(24)3)21-11-8-12-22(17-21)34-25(13-14-28-2)20-9-6-5-7-10-20/h5-12,17-19,25,28H,4,13-16H2,1-3H3,(H,29,30) KRPGVVAIUXEMBJ-UHFFFAOYSA-N 436423 8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 198 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436423&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089219 439658056 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888361 CCNc1cc2N(C)CCN(c3cccc(OC(CCNC)c4ccccc4)c3)C(=O)c2cn1 InChI=1S/C27H33N5O2/c1-4-29-26-18-24-23(19-30-26)27(33)32(16-15-31(24)3)21-11-8-12-22(17-21)34-25(13-14-28-2)20-9-6-5-7-10-20/h5-12,17-19,25,28H,4,13-16H2,1-3H3,(H,29,30) KRPGVVAIUXEMBJ-UHFFFAOYSA-N 436423 8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- phenylpropoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 198 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436423&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089219 439658056 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888362 CCNc1cc2N(C)CCN(c3cccc(COC(CCNC)c4ccccc4)c3)C(=O)c2cn1 InChI=1S/C28H35N5O2/c1-4-30-27-18-25-24(19-31-27)28(34)33(16-15-32(25)3)23-12-8-9-21(17-23)20-35-26(13-14-29-2)22-10-6-5-7-11-22/h5-12,17-19,26,29H,4,13-16,20H2,1-3H3,(H,30,31) UGLSMSONQDUWTK-UHFFFAOYSA-N 436424 8-(ethylamino)-1- methyl-4-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-1,2,3,4- tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 199 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436424&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098870 439658057 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888363 CCNc1cc2N(C)CCN(c3cccc(COC(CCNC)c4ccccc4)c3)C(=O)c2cn1 InChI=1S/C28H35N5O2/c1-4-30-27-18-25-24(19-31-27)28(34)33(16-15-32(25)3)23-12-8-9-21(17-23)20-35-26(13-14-29-2)22-10-6-5-7-11-22/h5-12,17-19,26,29H,4,13-16,20H2,1-3H3,(H,30,31) UGLSMSONQDUWTK-UHFFFAOYSA-N 436424 8-(ethylamino)-1- methyl-4-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-1,2,3,4- tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 199 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436424&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098870 439658057 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888364 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)14-15-32(25(22)33)18-19-10-12-21(13-11-19)34-23(17-27-2)20-8-6-5-7-9-20/h5-13,16,23,27H,4,14-15,17-18H2,1-3H3,(H,28,29,30) GJGWYWKLHSDJKA-UHFFFAOYSA-N 436426 2-(ethylamino)-9- methyl-6-(4-(2- (methylamino)-1- phenylethoxy)benzyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 201 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436426&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089230 439658059 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888365 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)14-15-32(25(22)33)18-19-10-12-21(13-11-19)34-23(17-27-2)20-8-6-5-7-9-20/h5-13,16,23,27H,4,14-15,17-18H2,1-3H3,(H,28,29,30) GJGWYWKLHSDJKA-UHFFFAOYSA-N 436426 2-(ethylamino)-9- methyl-6-(4-(2- (methylamino)-1- phenylethoxy)benzyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 201 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436426&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089230 439658059 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888366 CCNc1ncc2CN(CCN(C)c2n1)c1cccc(CO[C@H](CCNC)c2ccccc2)c1 InChI=1S/C27H36N6O/c1-4-29-27-30-18-23-19-33(16-15-32(3)26(23)31-27)24-12-8-9-21(17-24)20-34-25(13-14-28-2)22-10-6-5-7-11-22/h5-12,17-18,25,28H,4,13-16,19-20H2,1-3H3,(H,29,30,31)/t25-/m1/s1 JPTFPOGWDCHQKW-RUZDIDTESA-N 436428 (R)-N-ethyl-9-methyl- 6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-2- amine::US10590140, Example 203 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436428&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088970 439658061 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888367 CCNc1ncc2CN(CCN(C)c2n1)c1cccc(CO[C@H](CCNC)c2ccccc2)c1 InChI=1S/C27H36N6O/c1-4-29-27-30-18-23-19-33(16-15-32(3)26(23)31-27)24-12-8-9-21(17-24)20-34-25(13-14-28-2)22-10-6-5-7-11-22/h5-12,17-18,25,28H,4,13-16,19-20H2,1-3H3,(H,29,30,31)/t25-/m1/s1 JPTFPOGWDCHQKW-RUZDIDTESA-N 436428 (R)-N-ethyl-9-methyl- 6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-2- amine::US10590140, Example 203 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436428&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088970 439658061 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888368 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(OC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O3/c1-27-13-12-23(20-9-5-4-6-10-20)34-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)33-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3/t23-/m1/s1 XGZCTJPTWRWPPQ-HSZRJFAPSA-N 436429 (R)-2-methoxy-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 204 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436429&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088993 439658062 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888369 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(OC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O3/c1-27-13-12-23(20-9-5-4-6-10-20)34-18-19-8-7-11-21(16-19)31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)33-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3/t23-/m1/s1 XGZCTJPTWRWPPQ-HSZRJFAPSA-N 436429 (R)-2-methoxy-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 204 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436429&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088993 439658062 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888370 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(O)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O3/c1-26-12-11-22(19-8-4-3-5-9-19)33-17-18-7-6-10-20(15-18)30-14-13-29(2)23-21(24(30)31)16-27-25(32)28-23/h3-10,15-16,22,26H,11-14,17H2,1-2H3,(H,27,28,32)/t22-/m1/s1 MFVCDOIXYGRALQ-JOCHJYFZSA-N 436430 (R)-2-hydroxy-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 205 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436430&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089199 439658063 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888371 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(O)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O3/c1-26-12-11-22(19-8-4-3-5-9-19)33-17-18-7-6-10-20(15-18)30-14-13-29(2)23-21(24(30)31)16-27-25(32)28-23/h3-10,15-16,22,26H,11-14,17H2,1-2H3,(H,27,28,32)/t22-/m1/s1 MFVCDOIXYGRALQ-JOCHJYFZSA-N 436430 (R)-2-hydroxy-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 205 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436430&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089199 439658063 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888372 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-17-23-25(29-19)30(3)14-15-31(26(23)32)22-11-7-8-20(16-22)18-33-24(12-13-27-2)21-9-5-4-6-10-21/h4-11,16-17,24,27H,12-15,18H2,1-3H3/t24-/m1/s1 FGHVDUIPGXFWJC-XMMPIXPASA-N 436431 (R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 206 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436431&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088794 439658064 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888373 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-17-23-25(29-19)30(3)14-15-31(26(23)32)22-11-7-8-20(16-22)18-33-24(12-13-27-2)21-9-5-4-6-10-21/h4-11,16-17,24,27H,12-15,18H2,1-3H3/t24-/m1/s1 FGHVDUIPGXFWJC-XMMPIXPASA-N 436431 (R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 206 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436431&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088794 439658064 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888374 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-12-11-23(20-8-4-3-5-9-20)32-17-19-7-6-10-21(15-19)30-14-13-29(2)24-22(25(30)31)16-27-18-28-24/h3-10,15-16,18,23,26H,11-14,17H2,1-2H3/t23-/m1/s1 JPDXVFKPRNDKAL-HSZRJFAPSA-N 436432 (R)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 207 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436432&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088867 439658065 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888375 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-12-11-23(20-8-4-3-5-9-20)32-17-19-7-6-10-21(15-19)30-14-13-29(2)24-22(25(30)31)16-27-18-28-24/h3-10,15-16,18,23,26H,11-14,17H2,1-2H3/t23-/m1/s1 JPDXVFKPRNDKAL-HSZRJFAPSA-N 436432 (R)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 207 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436432&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088867 439658065 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888376 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-10-9-20(21-8-5-13-33-21)31-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3 QZTSBVNAYFBWIC-UHFFFAOYSA-N 436433 9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 208 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436433&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088802 439658066 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888377 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-10-9-20(21-8-5-13-33-21)31-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3 QZTSBVNAYFBWIC-UHFFFAOYSA-N 436433 9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 208 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436433&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088802 439658066 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888378 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-10-9-20(21-8-5-13-33-21)31-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3/t20-/m1/s1 QZTSBVNAYFBWIC-HXUWFJFHSA-N 436434 (R)-9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 209 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436434&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089343 439658067 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888379 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-10-9-20(21-8-5-13-33-21)31-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3/t20-/m1/s1 QZTSBVNAYFBWIC-HXUWFJFHSA-N 436434 (R)-9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 209 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436434&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089343 439658067 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888380 CNCC[C@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-10-9-20(21-8-5-13-33-21)31-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3/t20-/m0/s1 QZTSBVNAYFBWIC-FQEVSTJZSA-N 436435 (S)-9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 210 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436435&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088799 439658068 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888381 CNCC[C@H](OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-10-9-20(21-8-5-13-33-21)31-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3/t20-/m0/s1 QZTSBVNAYFBWIC-FQEVSTJZSA-N 436435 (S)-9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 210 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436435&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088799 439658068 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888382 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)c3cccs3)c1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)12-13-31(24(20)32)19-8-5-7-18(15-19)17-33-21(10-11-26-2)22-9-6-14-34-22/h5-9,14-16,21,26H,4,10-13,17H2,1-3H3,(H,27,28,29) XJHDXJNNMHSVDG-UHFFFAOYSA-N 436436 2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 211 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436436&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088833 439658069 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888383 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)c3cccs3)c1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)12-13-31(24(20)32)19-8-5-7-18(15-19)17-33-21(10-11-26-2)22-9-6-14-34-22/h5-9,14-16,21,26H,4,10-13,17H2,1-3H3,(H,27,28,29) XJHDXJNNMHSVDG-UHFFFAOYSA-N 436436 2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 211 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436436&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088833 439658069 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888384 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)12-13-31(24(20)32)19-8-5-7-18(15-19)17-33-21(10-11-26-2)22-9-6-14-34-22/h5-9,14-16,21,26H,4,10-13,17H2,1-3H3,(H,27,28,29)/t21-/m1/s1 XJHDXJNNMHSVDG-OAQYLSRUSA-N 436437 (R)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 212 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436437&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088832 439658070 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888385 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)12-13-31(24(20)32)19-8-5-7-18(15-19)17-33-21(10-11-26-2)22-9-6-14-34-22/h5-9,14-16,21,26H,4,10-13,17H2,1-3H3,(H,27,28,29)/t21-/m1/s1 XJHDXJNNMHSVDG-OAQYLSRUSA-N 436437 (R)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 212 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436437&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088832 439658070 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888386 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)12-13-31(24(20)32)19-8-5-7-18(15-19)17-33-21(10-11-26-2)22-9-6-14-34-22/h5-9,14-16,21,26H,4,10-13,17H2,1-3H3,(H,27,28,29)/t21-/m0/s1 XJHDXJNNMHSVDG-NRFANRHFSA-N 436438 (S)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 213 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436438&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098805 439658071 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888387 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)12-13-31(24(20)32)19-8-5-7-18(15-19)17-33-21(10-11-26-2)22-9-6-14-34-22/h5-9,14-16,21,26H,4,10-13,17H2,1-3H3,(H,27,28,29)/t21-/m0/s1 XJHDXJNNMHSVDG-NRFANRHFSA-N 436438 (S)-2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 213 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436438&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098805 439658071 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888388 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3cccs3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-16-19-22(28-24)29(3)12-13-30(23(19)31)17-7-5-8-18(15-17)32-20(10-11-25-2)21-9-6-14-33-21/h5-9,14-16,20,25H,4,10-13H2,1-3H3,(H,26,27,28) JRMKRCWDAUYJRA-UHFFFAOYSA-N 436439 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 214 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436439&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088768 439658072 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888389 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3cccs3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-16-19-22(28-24)29(3)12-13-30(23(19)31)17-7-5-8-18(15-17)32-20(10-11-25-2)21-9-6-14-33-21/h5-9,14-16,20,25H,4,10-13H2,1-3H3,(H,26,27,28) JRMKRCWDAUYJRA-UHFFFAOYSA-N 436439 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 214 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436439&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088768 439658072 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888390 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-16-19-22(28-24)29(3)12-13-30(23(19)31)17-7-5-8-18(15-17)32-20(10-11-25-2)21-9-6-14-33-21/h5-9,14-16,20,25H,4,10-13H2,1-3H3,(H,26,27,28)/t20-/m1/s1 JRMKRCWDAUYJRA-HXUWFJFHSA-N 436440 (R)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 215 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436440&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089019 439658073 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888391 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-16-19-22(28-24)29(3)12-13-30(23(19)31)17-7-5-8-18(15-17)32-20(10-11-25-2)21-9-6-14-33-21/h5-9,14-16,20,25H,4,10-13H2,1-3H3,(H,26,27,28)/t20-/m1/s1 JRMKRCWDAUYJRA-HXUWFJFHSA-N 436440 (R)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 215 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436440&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089019 439658073 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888392 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-16-19-22(28-24)29(3)12-13-30(23(19)31)17-7-5-8-18(15-17)32-20(10-11-25-2)21-9-6-14-33-21/h5-9,14-16,20,25H,4,10-13H2,1-3H3,(H,26,27,28)/t20-/m0/s1 JRMKRCWDAUYJRA-FQEVSTJZSA-N 436441 (S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 216 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436441&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088914 439658074 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888393 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCNC)c3cccs3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-16-19-22(28-24)29(3)12-13-30(23(19)31)17-7-5-8-18(15-17)32-20(10-11-25-2)21-9-6-14-33-21/h5-9,14-16,20,25H,4,10-13H2,1-3H3,(H,26,27,28)/t20-/m0/s1 JRMKRCWDAUYJRA-FQEVSTJZSA-N 436441 (S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 216 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436441&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088914 439658074 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888394 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S2/c1-24-10-9-19(20-8-5-13-32-20)30-17-7-4-6-16(14-17)28-12-11-27(2)21-18(22(28)29)15-25-23(26-21)31-3/h4-8,13-15,19,24H,9-12H2,1-3H3 LRBRSWLNUGPGBK-UHFFFAOYSA-N 436442 9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 217 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436442&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089059 439658075 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888395 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S2/c1-24-10-9-19(20-8-5-13-32-20)30-17-7-4-6-16(14-17)28-12-11-27(2)21-18(22(28)29)15-25-23(26-21)31-3/h4-8,13-15,19,24H,9-12H2,1-3H3 LRBRSWLNUGPGBK-UHFFFAOYSA-N 436442 9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 217 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436442&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089059 439658075 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888396 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S2/c1-24-10-9-19(20-8-5-13-32-20)30-17-7-4-6-16(14-17)28-12-11-27(2)21-18(22(28)29)15-25-23(26-21)31-3/h4-8,13-15,19,24H,9-12H2,1-3H3/t19-/m1/s1 LRBRSWLNUGPGBK-LJQANCHMSA-N 436443 (R)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 218 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436443&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098986 439658076 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888397 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S2/c1-24-10-9-19(20-8-5-13-32-20)30-17-7-4-6-16(14-17)28-12-11-27(2)21-18(22(28)29)15-25-23(26-21)31-3/h4-8,13-15,19,24H,9-12H2,1-3H3/t19-/m1/s1 LRBRSWLNUGPGBK-LJQANCHMSA-N 436443 (R)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 218 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436443&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098986 439658076 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888398 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S2/c1-24-10-9-19(20-8-5-13-32-20)30-17-7-4-6-16(14-17)28-12-11-27(2)21-18(22(28)29)15-25-23(26-21)31-3/h4-8,13-15,19,24H,9-12H2,1-3H3/t19-/m0/s1 LRBRSWLNUGPGBK-IBGZPJMESA-N 436444 (S)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 219 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436444&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089081 439658077 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888399 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S2/c1-24-10-9-19(20-8-5-13-32-20)30-17-7-4-6-16(14-17)28-12-11-27(2)21-18(22(28)29)15-25-23(26-21)31-3/h4-8,13-15,19,24H,9-12H2,1-3H3/t19-/m0/s1 LRBRSWLNUGPGBK-IBGZPJMESA-N 436444 (S)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 219 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436444&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089081 439658077 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888400 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(OC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O3S/c1-25-10-9-20(21-8-5-13-33-21)32-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)31-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3 WKIWZYVELZLXOB-UHFFFAOYSA-N 436446 2-methoxy-9-methyl-6- (3-((3-(methylamino)- 1-(thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 221 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436446&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088997 439658079 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888401 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(OC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O3S/c1-25-10-9-20(21-8-5-13-33-21)32-16-17-6-4-7-18(14-17)29-12-11-28(2)22-19(23(29)30)15-26-24(27-22)31-3/h4-8,13-15,20,25H,9-12,16H2,1-3H3 WKIWZYVELZLXOB-UHFFFAOYSA-N 436446 2-methoxy-9-methyl-6- (3-((3-(methylamino)- 1-(thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 221 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436446&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088997 439658079 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888402 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(O)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O3S/c1-24-9-8-19(20-7-4-12-32-20)31-15-16-5-3-6-17(13-16)28-11-10-27(2)21-18(22(28)29)14-25-23(30)26-21/h3-7,12-14,19,24H,8-11,15H2,1-2H3,(H,25,26,30) UYKJZILKOZJTOW-UHFFFAOYSA-N 436447 2-hydroxy-9-methyl-6- (3-((3-(methylamino)- 1-(thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 222 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436447&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089299 439658080 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888403 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(O)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O3S/c1-24-9-8-19(20-7-4-12-32-20)31-15-16-5-3-6-17(13-16)28-11-10-27(2)21-18(22(28)29)14-25-23(30)26-21/h3-7,12-14,19,24H,8-11,15H2,1-2H3,(H,25,26,30) UYKJZILKOZJTOW-UHFFFAOYSA-N 436447 2-hydroxy-9-methyl-6- (3-((3-(methylamino)- 1-(thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 222 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436447&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089299 439658080 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888404 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)11-12-29(24(20)30)19-7-4-6-18(14-19)16-31-21(9-10-25-2)22-8-5-13-32-22/h4-8,13-15,21,25H,9-12,16H2,1-3H3 DDWJAWDHKATTEZ-UHFFFAOYSA-N 436448 2,9-dimethyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 223 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436448&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088766 439658081 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888405 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)11-12-29(24(20)30)19-7-4-6-18(14-19)16-31-21(9-10-25-2)22-8-5-13-32-22/h4-8,13-15,21,25H,9-12,16H2,1-3H3 DDWJAWDHKATTEZ-UHFFFAOYSA-N 436448 2,9-dimethyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 223 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436448&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088766 439658081 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888406 CNCCC(OCc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-9-8-20(21-7-4-12-31-21)30-15-17-5-3-6-18(13-17)28-11-10-27(2)22-19(23(28)29)14-25-16-26-22/h3-7,12-14,16,20,24H,8-11,15H2,1-2H3 WXSFJWUCHFZTTH-UHFFFAOYSA-N 436449 9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 224 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436449&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088814 439658082 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888407 CNCCC(OCc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-9-8-20(21-7-4-12-31-21)30-15-17-5-3-6-18(13-17)28-11-10-27(2)22-19(23(28)29)14-25-16-26-22/h3-7,12-14,16,20,24H,8-11,15H2,1-2H3 WXSFJWUCHFZTTH-UHFFFAOYSA-N 436449 9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 224 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436449&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088814 439658082 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888408 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)13-14-32(25(22)33)21-12-8-9-19(15-21)18-34-23(17-27-2)20-10-6-5-7-11-20/h5-12,15-16,23,27H,4,13-14,17-18H2,1-3H3,(H,28,29,30) MEOLTPHCLOQZCR-UHFFFAOYSA-N 436450 2-(ethylamino)-9-methyl- 6-(3-((2-(methylamino)-1- phenylethoxy)methyl) phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 225 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436450&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088999 439658083 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888409 CCNc1ncc2c(n1)N(C)CCN(c1cccc(COC(CNC)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)13-14-32(25(22)33)21-12-8-9-19(15-21)18-34-23(17-27-2)20-10-6-5-7-11-20/h5-12,15-16,23,27H,4,13-14,17-18H2,1-3H3,(H,28,29,30) MEOLTPHCLOQZCR-UHFFFAOYSA-N 436450 2-(ethylamino)-9-methyl- 6-(3-((2-(methylamino)-1- phenylethoxy)methyl) phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 225 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436450&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088999 439658083 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888410 CNCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-16-22(19-9-5-4-6-10-19)32-17-18-8-7-11-20(14-18)30-13-12-29(2)23-21(24(30)31)15-27-25(28-23)33-3/h4-11,14-15,22,26H,12-13,16-17H2,1-3H3 SGXUKVBSKHLQJE-UHFFFAOYSA-N 436451 9-methyl-6-(3-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 226 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436451&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089205 439658084 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888411 CNCC(OCc1cccc(c1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-16-22(19-9-5-4-6-10-19)32-17-18-8-7-11-20(14-18)30-13-12-29(2)23-21(24(30)31)15-27-25(28-23)33-3/h4-11,14-15,22,26H,12-13,16-17H2,1-3H3 SGXUKVBSKHLQJE-UHFFFAOYSA-N 436451 9-methyl-6-(3-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 226 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436451&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089205 439658084 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888412 CCNc1cc2N(C)CCN(c3cccc(OC(CCNC)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C25H31N5O2S/c1-4-27-24-16-21-20(17-28-24)25(31)30(13-12-29(21)3)18-7-5-8-19(15-18)32-22(10-11-26-2)23-9-6-14-33-23/h5-9,14-17,22,26H,4,10-13H2,1-3H3,(H,27,28) JOLCTAVEKPKHAQ-UHFFFAOYSA-N 436452 8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 227 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436452&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089111 439658085 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888413 CCNc1cc2N(C)CCN(c3cccc(OC(CCNC)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C25H31N5O2S/c1-4-27-24-16-21-20(17-28-24)25(31)30(13-12-29(21)3)18-7-5-8-19(15-18)32-22(10-11-26-2)23-9-6-14-33-23/h5-9,14-17,22,26H,4,10-13H2,1-3H3,(H,27,28) JOLCTAVEKPKHAQ-UHFFFAOYSA-N 436452 8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 227 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436452&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089111 439658085 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888414 CNCCC(Oc1cccc(c1)N1CCN(C)c2cc(ncc2C1=O)N(C)C)c1cccs1 InChI=1S/C25H31N5O2S/c1-26-11-10-22(23-9-6-14-33-23)32-19-8-5-7-18(15-19)30-13-12-29(4)21-16-24(28(2)3)27-17-20(21)25(30)31/h5-9,14-17,22,26H,10-13H2,1-4H3 RPJMFEMGOQFHBY-UHFFFAOYSA-N 436454 8-(dimethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 229 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436454&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089297 439658087 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888415 CNCCC(Oc1cccc(c1)N1CCN(C)c2cc(ncc2C1=O)N(C)C)c1cccs1 InChI=1S/C25H31N5O2S/c1-26-11-10-22(23-9-6-14-33-23)32-19-8-5-7-18(15-19)30-13-12-29(4)21-16-24(28(2)3)27-17-20(21)25(30)31/h5-9,14-17,22,26H,10-13H2,1-4H3 RPJMFEMGOQFHBY-UHFFFAOYSA-N 436454 8-(dimethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 229 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436454&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089297 439658087 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888416 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)C)c1cccs1 InChI=1S/C24H30N6O2S/c1-25-11-10-20(21-9-6-14-33-21)32-18-8-5-7-17(15-18)30-13-12-29(4)22-19(23(30)31)16-26-24(27-22)28(2)3/h5-9,14-16,20,25H,10-13H2,1-4H3 YCGNFTGPXBAEMC-UHFFFAOYSA-N 436455 2-(dimethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 230 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436455&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089498 439658088 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888417 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)C)c1cccs1 InChI=1S/C24H30N6O2S/c1-25-11-10-20(21-9-6-14-33-21)32-18-8-5-7-17(15-18)30-13-12-29(4)22-19(23(30)31)16-26-24(27-22)28(2)3/h5-9,14-16,20,25H,10-13H2,1-4H3 YCGNFTGPXBAEMC-UHFFFAOYSA-N 436455 2-(dimethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 230 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436455&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089498 439658088 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888418 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-16-25-15-19-22(26-16)27(3)11-12-28(23(19)29)17-6-4-7-18(14-17)30-20(9-10-24-2)21-8-5-13-31-21/h4-8,13-15,20,24H,9-12H2,1-3H3 QSGMFCUAWLYRRU-UHFFFAOYSA-N 436456 2,9-dimethyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 231 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436456&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088711 439658089 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888419 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-16-25-15-19-22(26-16)27(3)11-12-28(23(19)29)17-6-4-7-18(14-17)30-20(9-10-24-2)21-8-5-13-31-21/h4-8,13-15,20,24H,9-12H2,1-3H3 QSGMFCUAWLYRRU-UHFFFAOYSA-N 436456 2,9-dimethyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 231 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436456&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088711 439658089 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888420 CNCCC(Oc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C22H25N5O2S/c1-23-9-8-19(20-7-4-12-30-20)29-17-6-3-5-16(13-17)27-11-10-26(2)21-18(22(27)28)14-24-15-25-21/h3-7,12-15,19,23H,8-11H2,1-2H3 KYQUYMHBNNIIFU-UHFFFAOYSA-N 436457 9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 232 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436457&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089012 439658090 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888421 CNCCC(Oc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C22H25N5O2S/c1-23-9-8-19(20-7-4-12-30-20)29-17-6-3-5-16(13-17)27-11-10-26(2)21-18(22(27)28)14-24-15-25-21/h3-7,12-15,19,23H,8-11H2,1-2H3 KYQUYMHBNNIIFU-UHFFFAOYSA-N 436457 9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 232 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436457&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089012 439658090 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888422 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C)c3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-5-29-28-30-19-24-26(31-28)33(4)16-17-34(27(24)35)23-13-9-10-21(18-23)20-36-25(14-15-32(2)3)22-11-7-6-8-12-22/h6-13,18-19,25H,5,14-17,20H2,1-4H3,(H,29,30,31)/t25-/m1/s1 GKLAATWMSQRFGB-RUZDIDTESA-N 436461 (R)-6-(3-((3- (dimethylamino)-1- phenylpropoxy)methyl) phenyl)-2-(ethylamino)-9- methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 236 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436461&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089330 439658094 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888423 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCN(C)C)c3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-5-29-28-30-19-24-26(31-28)33(4)16-17-34(27(24)35)23-13-9-10-21(18-23)20-36-25(14-15-32(2)3)22-11-7-6-8-12-22/h6-13,18-19,25H,5,14-17,20H2,1-4H3,(H,29,30,31)/t25-/m1/s1 GKLAATWMSQRFGB-RUZDIDTESA-N 436461 (R)-6-(3-((3- (dimethylamino)-1- phenylpropoxy)methyl) phenyl)-2-(ethylamino)-9- methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 236 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436461&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089330 439658094 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888424 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCN(C)C)c3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-5-29-28-30-19-24-26(31-28)33(4)16-17-34(27(24)35)23-13-9-10-21(18-23)20-36-25(14-15-32(2)3)22-11-7-6-8-12-22/h6-13,18-19,25H,5,14-17,20H2,1-4H3,(H,29,30,31)/t25-/m0/s1 GKLAATWMSQRFGB-VWLOTQADSA-N 436462 (S)-6-(3-((3- (dimethylamino)-1- phenylpropoxy)methyl) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 237 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436462&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088784 439658095 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888425 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@@H](CCN(C)C)c3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-5-29-28-30-19-24-26(31-28)33(4)16-17-34(27(24)35)23-13-9-10-21(18-23)20-36-25(14-15-32(2)3)22-11-7-6-8-12-22/h6-13,18-19,25H,5,14-17,20H2,1-4H3,(H,29,30,31)/t25-/m0/s1 GKLAATWMSQRFGB-VWLOTQADSA-N 436462 (S)-6-(3-((3- (dimethylamino)-1- phenylpropoxy)methyl) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 237 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436462&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088784 439658095 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888426 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-5-28-27-29-19-23-25(30-27)32(4)16-17-33(26(23)34)21-12-9-13-22(18-21)35-24(14-15-31(2)3)20-10-7-6-8-11-20/h6-13,18-19,24H,5,14-17H2,1-4H3,(H,28,29,30) YMFQGYSHWSFIGC-UHFFFAOYSA-N 436463 6-(3-(3- (dimethylamino)-1- phenylpropoxy)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 238 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436463&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088987 439658096 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888427 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCN(C)C)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-5-28-27-29-19-23-25(30-27)32(4)16-17-33(26(23)34)21-12-9-13-22(18-21)35-24(14-15-31(2)3)20-10-7-6-8-11-20/h6-13,18-19,24H,5,14-17H2,1-4H3,(H,28,29,30) YMFQGYSHWSFIGC-UHFFFAOYSA-N 436463 6-(3-(3- (dimethylamino)-1- phenylpropoxy)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 238 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436463&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088987 439658096 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888428 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN(C)C)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-5-27-26-28-17-22-24(29-26)31(4)14-15-32(25(22)33)20-12-9-13-21(16-20)34-23(18-30(2)3)19-10-7-6-8-11-19/h6-13,16-17,23H,5,14-15,18H2,1-4H3,(H,27,28,29) AVLCWIQTMYHXCT-UHFFFAOYSA-N 436464 6-(3-(2- (dimethylamino)-1- phenylethoxy)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 239 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436464&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089308 439658097 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888429 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CN(C)C)c3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-5-27-26-28-17-22-24(29-26)31(4)14-15-32(25(22)33)20-12-9-13-21(16-20)34-23(18-30(2)3)19-10-7-6-8-11-19/h6-13,16-17,23H,5,14-15,18H2,1-4H3,(H,27,28,29) AVLCWIQTMYHXCT-UHFFFAOYSA-N 436464 6-(3-(2- (dimethylamino)-1- phenylethoxy)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 239 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436464&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089308 439658097 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888430 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C27H34N6O/c1-4-28-27-29-19-24-25(30-27)32(3)16-17-33(26(24)34)23-14-8-12-21(18-23)13-9-15-31(2)20-22-10-6-5-7-11-22/h5-8,10-12,14,18-19H,4,9,13,15-17,20H2,1-3H3,(H,28,29,30) QIQGSCFPOMYFCX-UHFFFAOYSA-N 436465 6-(3-(3- (benzyl(methyl)amino) propyl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 240 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436465&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089159 439658098 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888431 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C27H34N6O/c1-4-28-27-29-19-24-25(30-27)32(3)16-17-33(26(24)34)23-14-8-12-21(18-23)13-9-15-31(2)20-22-10-6-5-7-11-22/h5-8,10-12,14,18-19H,4,9,13,15-17,20H2,1-3H3,(H,28,29,30) QIQGSCFPOMYFCX-UHFFFAOYSA-N 436465 6-(3-(3- (benzyl(methyl)amino) propyl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 240 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436465&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089159 439658098 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888432 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCCN(C)C)c1)C2=O InChI=1S/C21H30N6O/c1-5-22-21-23-15-18-19(24-21)26(4)12-13-27(20(18)28)17-10-6-8-16(14-17)9-7-11-25(2)3/h6,8,10,14-15H,5,7,9,11-13H2,1-4H3,(H,22,23,24) VHLVLBGGLGNCMM-UHFFFAOYSA-N 436466 6-(3-(3- (dimethylamino)propyl) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 241 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436466&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089373 439658099 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888433 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCCN(C)C)c1)C2=O InChI=1S/C21H30N6O/c1-5-22-21-23-15-18-19(24-21)26(4)12-13-27(20(18)28)17-10-6-8-16(14-17)9-7-11-25(2)3/h6,8,10,14-15H,5,7,9,11-13H2,1-4H3,(H,22,23,24) VHLVLBGGLGNCMM-UHFFFAOYSA-N 436466 6-(3-(3- (dimethylamino)propyl) phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 241 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436466&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089373 439658099 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888434 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)C)nn1)C2=O InChI=1S/C21H27N9O/c1-5-22-21-23-12-18-19(24-21)28(4)9-10-29(20(18)31)16-7-6-8-17(11-16)30-14-15(25-26-30)13-27(2)3/h6-8,11-12,14H,5,9-10,13H2,1-4H3,(H,22,23,24) GOYQKEOPQFVFBK-UHFFFAOYSA-N 436467 6-(3-(4- ((dimethylamino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 242 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436467&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089440 439658100 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888435 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)C)nn1)C2=O InChI=1S/C21H27N9O/c1-5-22-21-23-12-18-19(24-21)28(4)9-10-29(20(18)31)16-7-6-8-17(11-16)30-14-15(25-26-30)13-27(2)3/h6-8,11-12,14H,5,9-10,13H2,1-4H3,(H,22,23,24) GOYQKEOPQFVFBK-UHFFFAOYSA-N 436467 6-(3-(4- ((dimethylamino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 242 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436467&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089440 439658100 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888436 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccccc3)nn1)C2=O InChI=1S/C27H31N9O/c1-4-28-27-29-16-24-25(30-27)34(3)13-14-35(26(24)37)22-11-8-12-23(15-22)36-19-21(31-32-36)18-33(2)17-20-9-6-5-7-10-20/h5-12,15-16,19H,4,13-14,17-18H2,1-3H3,(H,28,29,30) KPPZNUCOJQDNDL-UHFFFAOYSA-N 436468 6-(3-(4- ((benzyl(methyl)amino) methyl)-1H-1,2,3- triazol-1-yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 243 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436468&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 138608016 439658101 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888437 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccccc3)nn1)C2=O InChI=1S/C27H31N9O/c1-4-28-27-29-16-24-25(30-27)34(3)13-14-35(26(24)37)22-11-8-12-23(15-22)36-19-21(31-32-36)18-33(2)17-20-9-6-5-7-10-20/h5-12,15-16,19H,4,13-14,17-18H2,1-3H3,(H,28,29,30) KPPZNUCOJQDNDL-UHFFFAOYSA-N 436468 6-(3-(4- ((benzyl(methyl)amino) methyl)-1H-1,2,3- triazol-1-yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 243 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436468&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 138608016 439658101 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888438 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CCc3ccccc3)nn1)C2=O InChI=1S/C28H33N9O/c1-4-29-28-30-18-25-26(31-28)35(3)15-16-36(27(25)38)23-11-8-12-24(17-23)37-20-22(32-33-37)19-34(2)14-13-21-9-6-5-7-10-21/h5-12,17-18,20H,4,13-16,19H2,1-3H3,(H,29,30,31) UIBHNYCFYTXLGB-UHFFFAOYSA-N 436469 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(phenethyl) amino)methyl)-1H-1,2,3- triazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 244 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436469&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088751 439658102 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888439 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CCc3ccccc3)nn1)C2=O InChI=1S/C28H33N9O/c1-4-29-28-30-18-25-26(31-28)35(3)15-16-36(27(25)38)23-11-8-12-24(17-23)37-20-22(32-33-37)19-34(2)14-13-21-9-6-5-7-10-21/h5-12,17-18,20H,4,13-16,19H2,1-3H3,(H,29,30,31) UIBHNYCFYTXLGB-UHFFFAOYSA-N 436469 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(phenethyl) amino)methyl)-1H-1,2,3- triazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 244 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436469&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088751 439658102 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888440 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CC3CC3)nn1)C2=O InChI=1S/C24H31N9O/c1-4-25-24-26-13-21-22(27-24)31(3)10-11-32(23(21)34)19-6-5-7-20(12-19)33-16-18(28-29-33)15-30(2)14-17-8-9-17/h5-7,12-13,16-17H,4,8-11,14-15H2,1-3H3,(H,25,26,27) LKHGZBCJCIQCLI-UHFFFAOYSA-N 436471 6-(3-(4- (((cyclopropylmethyl) (methyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 246 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436471&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089307 439658104 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888441 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CC3CC3)nn1)C2=O InChI=1S/C24H31N9O/c1-4-25-24-26-13-21-22(27-24)31(3)10-11-32(23(21)34)19-6-5-7-20(12-19)33-16-18(28-29-33)15-30(2)14-17-8-9-17/h5-7,12-13,16-17H,4,8-11,14-15H2,1-3H3,(H,25,26,27) LKHGZBCJCIQCLI-UHFFFAOYSA-N 436471 6-(3-(4- (((cyclopropylmethyl) (methyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 246 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436471&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089307 439658104 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888442 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccccc3)cn1)C2=O InChI=1S/C28H32N8O/c1-4-29-28-30-17-25-26(32-28)34(3)13-14-35(27(25)37)23-11-8-12-24(15-23)36-20-22(16-31-36)19-33(2)18-21-9-6-5-7-10-21/h5-12,15-17,20H,4,13-14,18-19H2,1-3H3,(H,29,30,32) KDFRVKNUWIJPTM-UHFFFAOYSA-N 436476 6-(3-(4- ((benzyl(methyl)amino) methyl)-1H-pyrazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 251 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436476&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089342 439658109 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888443 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccccc3)cn1)C2=O InChI=1S/C28H32N8O/c1-4-29-28-30-17-25-26(32-28)34(3)13-14-35(27(25)37)23-11-8-12-24(15-23)36-20-22(16-31-36)19-33(2)18-21-9-6-5-7-10-21/h5-12,15-17,20H,4,13-14,18-19H2,1-3H3,(H,29,30,32) KDFRVKNUWIJPTM-UHFFFAOYSA-N 436476 6-(3-(4- ((benzyl(methyl)amino) methyl)-1H-pyrazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 251 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436476&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089342 439658109 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888444 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CCc3ccccc3)cn1)C2=O InChI=1S/C29H34N8O/c1-4-30-29-31-19-26-27(33-29)35(3)15-16-36(28(26)38)24-11-8-12-25(17-24)37-21-23(18-32-37)20-34(2)14-13-22-9-6-5-7-10-22/h5-12,17-19,21H,4,13-16,20H2,1-3H3,(H,30,31,33) FTEMBSLZESKZCN-UHFFFAOYSA-N 436477 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(phenethyl) amino)methyl)-1H- pyrazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 252 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436477&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089154 439658110 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888445 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)CCc3ccccc3)cn1)C2=O InChI=1S/C29H34N8O/c1-4-30-29-31-19-26-27(33-29)35(3)15-16-36(28(26)38)24-11-8-12-25(17-24)37-21-23(18-32-37)20-34(2)14-13-22-9-6-5-7-10-22/h5-12,17-19,21H,4,13-16,20H2,1-3H3,(H,30,31,33) FTEMBSLZESKZCN-UHFFFAOYSA-N 436477 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(phenethyl) amino)methyl)-1H- pyrazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 252 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436477&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089154 439658110 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888446 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CN(C)Cc3ccccc3)c1)C2=O InChI=1S/C28H32N8O/c1-4-29-28-30-16-25-26(32-28)34(3)13-14-36(27(25)37)24-12-8-11-23(15-24)35-19-22(31-20-35)18-33(2)17-21-9-6-5-7-10-21/h5-12,15-16,19-20H,4,13-14,17-18H2,1-3H3,(H,29,30,32) AVTMNEXAHMXYMJ-UHFFFAOYSA-N 436478 6-(3-(4- ((benzyl(methyl)amino) methyl)-1H-imidazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 253 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436478&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088798 439658111 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888447 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CN(C)Cc3ccccc3)c1)C2=O InChI=1S/C28H32N8O/c1-4-29-28-30-16-25-26(32-28)34(3)13-14-36(27(25)37)24-12-8-11-23(15-24)35-19-22(31-20-35)18-33(2)17-21-9-6-5-7-10-21/h5-12,15-16,19-20H,4,13-14,17-18H2,1-3H3,(H,29,30,32) AVTMNEXAHMXYMJ-UHFFFAOYSA-N 436478 6-(3-(4- ((benzyl(methyl)amino) methyl)-1H-imidazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 253 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436478&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088798 439658111 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888448 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CN(C)CCc3ccccc3)c1)C2=O InChI=1S/C29H34N8O/c1-4-30-29-31-18-26-27(33-29)35(3)15-16-37(28(26)38)25-12-8-11-24(17-25)36-20-23(32-21-36)19-34(2)14-13-22-9-6-5-7-10-22/h5-12,17-18,20-21H,4,13-16,19H2,1-3H3,(H,30,31,33) LNSSJCXVEUGCAK-UHFFFAOYSA-N 436479 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(phenethyl) amino)methyl)-1H- imidazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 254 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436479&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088778 439658112 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888449 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cnc(CN(C)CCc3ccccc3)c1)C2=O InChI=1S/C29H34N8O/c1-4-30-29-31-18-26-27(33-29)35(3)15-16-37(28(26)38)25-12-8-11-24(17-25)36-20-23(32-21-36)19-34(2)14-13-22-9-6-5-7-10-22/h5-12,17-18,20-21H,4,13-16,19H2,1-3H3,(H,30,31,33) LNSSJCXVEUGCAK-UHFFFAOYSA-N 436479 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(phenethyl) amino)methyl)-1H- imidazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 254 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436479&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088778 439658112 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888450 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-28-27-29-19-24-25(30-27)32(3)15-16-33(26(24)34)22-12-8-13-23(18-22)35-17-9-14-31(2)20-21-10-6-5-7-11-21/h5-8,10-13,18-19H,4,9,14-17,20H2,1-3H3,(H,28,29,30) YLLGDFRXKJITEN-UHFFFAOYSA-N 436481 6-(3-(3- (benzyl(methyl)amino) propoxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 256 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436481&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088722 439658114 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888451 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-28-27-29-19-24-25(30-27)32(3)15-16-33(26(24)34)22-12-8-13-23(18-22)35-17-9-14-31(2)20-21-10-6-5-7-11-21/h5-8,10-13,18-19H,4,9,14-17,20H2,1-3H3,(H,28,29,30) YLLGDFRXKJITEN-UHFFFAOYSA-N 436481 6-(3-(3- (benzyl(methyl)amino) propoxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 256 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436481&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088722 439658114 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888452 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C1CCN(CCc3ccccc3)CC1)C2=O InChI=1S/C29H36N6O/c1-3-30-29-31-21-26-27(32-29)33(2)18-19-35(28(26)36)25-11-7-10-24(20-25)23-13-16-34(17-14-23)15-12-22-8-5-4-6-9-22/h4-11,20-21,23H,3,12-19H2,1-2H3,(H,30,31,32) LYLPBSIHVCVZJN-UHFFFAOYSA-N 436486 2-(ethylamino)-9- methyl-6-(3-(1- phenethylpiperidin-4- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 261 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436486&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089660 439658119 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888453 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)C1CCN(CCc3ccccc3)CC1)C2=O InChI=1S/C29H36N6O/c1-3-30-29-31-21-26-27(32-29)33(2)18-19-35(28(26)36)25-11-7-10-24(20-25)23-13-16-34(17-14-23)15-12-22-8-5-4-6-9-22/h4-11,20-21,23H,3,12-19H2,1-2H3,(H,30,31,32) LYLPBSIHVCVZJN-UHFFFAOYSA-N 436486 2-(ethylamino)-9- methyl-6-(3-(1- phenethylpiperidin-4- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 261 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436486&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089660 439658119 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888454 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-27-26-28-18-23-24(29-26)31(3)13-14-32(25(23)33)21-11-8-12-22(17-21)34-16-15-30(2)19-20-9-6-5-7-10-20/h5-12,17-18H,4,13-16,19H2,1-3H3,(H,27,28,29) FRRQCGNUGNBAIU-UHFFFAOYSA-N 436489 6-(3-(2- (benzyl(methyl)amino) ethoxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 264 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436489&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089262 439658122 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888455 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCN(C)Cc3ccccc3)c1)C2=O InChI=1S/C26H32N6O2/c1-4-27-26-28-18-23-24(29-26)31(3)13-14-32(25(23)33)21-11-8-12-22(17-21)34-16-15-30(2)19-20-9-6-5-7-10-20/h5-12,17-18H,4,13-16,19H2,1-3H3,(H,27,28,29) FRRQCGNUGNBAIU-UHFFFAOYSA-N 436489 6-(3-(2- (benzyl(methyl)amino) ethoxy)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 264 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436489&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089262 439658122 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888456 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCN(C)CCc3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-28-27-29-20-24-25(30-27)32(3)15-16-33(26(24)34)22-11-8-12-23(19-22)35-18-17-31(2)14-13-21-9-6-5-7-10-21/h5-12,19-20H,4,13-18H2,1-3H3,(H,28,29,30) PNEPGBCHAGDKHQ-UHFFFAOYSA-N 436490 2-(ethylamino)-9- methyl-6-(3-(2- (methyl(phenethyl) amino)ethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 265 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436490&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089457 439658123 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888457 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OCCN(C)CCc3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-28-27-29-20-24-25(30-27)32(3)15-16-33(26(24)34)22-11-8-12-23(19-22)35-18-17-31(2)14-13-21-9-6-5-7-10-21/h5-12,19-20H,4,13-18H2,1-3H3,(H,28,29,30) PNEPGBCHAGDKHQ-UHFFFAOYSA-N 436490 2-(ethylamino)-9- methyl-6-(3-(2- (methyl(phenethyl) amino)ethoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 265 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436490&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089457 439658123 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888458 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCN(C)CC3)c3ccccc3)c1)C2=O InChI=1S/C28H33N5O2S/c1-31-14-12-28(13-15-31,22-9-5-4-6-10-22)35-20-21-8-7-11-23(18-21)33-17-16-32(2)25-24(26(33)34)19-29-27(30-25)36-3/h4-11,18-19H,12-17,20H2,1-3H3 UGPFOLLZARPZBL-UHFFFAOYSA-N 436496 9-methyl-6-(3-(((1- methyl-4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 271 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436496&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088717 439658129 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888459 CSc1ncc2c(n1)N(C)CCN(c1cccc(COC3(CCN(C)CC3)c3ccccc3)c1)C2=O InChI=1S/C28H33N5O2S/c1-31-14-12-28(13-15-31,22-9-5-4-6-10-22)35-20-21-8-7-11-23(18-21)33-17-16-32(2)25-24(26(33)34)19-29-27(30-25)36-3/h4-11,18-19H,12-17,20H2,1-3H3 UGPFOLLZARPZBL-UHFFFAOYSA-N 436496 9-methyl-6-(3-(((1- methyl-4- phenylpiperidin-4- yl)oxy)methyl)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 271 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436496&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088717 439658129 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888460 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCN3CCC(CC3)c3cccc(O)c3)c1)C2=O InChI=1S/C29H36N6O2/c1-3-30-29-31-20-26-27(32-29)33(2)16-17-35(28(26)37)24-8-4-6-21(18-24)10-13-34-14-11-22(12-15-34)23-7-5-9-25(36)19-23/h4-9,18-20,22,36H,3,10-17H2,1-2H3,(H,30,31,32) PZUBKBDQWUCFBG-UHFFFAOYSA-N 436500 2-(ethylamino)-6-(3-(2-(4- (3-hydroxyphenyl) piperidin-1-yl)ethyl) phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 275 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436500&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089131 439658133 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888461 CCNc1ncc2c(n1)N(C)CCN(c1cccc(CCN3CCC(CC3)c3cccc(O)c3)c1)C2=O InChI=1S/C29H36N6O2/c1-3-30-29-31-20-26-27(32-29)33(2)16-17-35(28(26)37)24-8-4-6-21(18-24)10-13-34-14-11-22(12-15-34)23-7-5-9-25(36)19-23/h4-9,18-20,22,36H,3,10-17H2,1-2H3,(H,30,31,32) PZUBKBDQWUCFBG-UHFFFAOYSA-N 436500 2-(ethylamino)-6-(3-(2-(4- (3-hydroxyphenyl) piperidin-1-yl)ethyl) phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 275 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436500&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089131 439658133 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888462 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)c3ccccc3)nn1)C2=O InChI=1S/C30H35N9O/c1-3-31-30-32-19-27-28(33-30)36(2)16-17-38(29(27)40)25-10-7-11-26(18-25)39-21-24(34-35-39)20-37-14-12-23(13-15-37)22-8-5-4-6-9-22/h4-11,18-19,21,23H,3,12-17,20H2,1-2H3,(H,31,32,33) JYRQXTKKIFNFMD-UHFFFAOYSA-N 436502 2-(ethylamino)-9-methyl- 6-(3-(4-((4- phenylpiperidin-1- yl)methyl)-1H-1,2,3- triazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 278 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436502&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089352 439658135 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888463 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)c3ccccc3)nn1)C2=O InChI=1S/C30H35N9O/c1-3-31-30-32-19-27-28(33-30)36(2)16-17-38(29(27)40)25-10-7-11-26(18-25)39-21-24(34-35-39)20-37-14-12-23(13-15-37)22-8-5-4-6-9-22/h4-11,18-19,21,23H,3,12-17,20H2,1-2H3,(H,31,32,33) JYRQXTKKIFNFMD-UHFFFAOYSA-N 436502 2-(ethylamino)-9-methyl- 6-(3-(4-((4- phenylpiperidin-1- yl)methyl)-1H-1,2,3- triazol-1-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 278 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436502&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089352 439658135 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888464 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)c3cccc(O)c3)nn1)C2=O InChI=1S/C30H35N9O2/c1-3-31-30-32-18-27-28(33-30)36(2)14-15-38(29(27)41)24-7-5-8-25(17-24)39-20-23(34-35-39)19-37-12-10-21(11-13-37)22-6-4-9-26(40)16-22/h4-9,16-18,20-21,40H,3,10-15,19H2,1-2H3,(H,31,32,33) HFUHDEKDBSEMRJ-UHFFFAOYSA-N 436503 2-(ethylamino)-6-(3-(4- ((4-(3- hydroxyphenyl)piperidin- 1-yl)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 279 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436503 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436503&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088732 439658136 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888465 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCC(CC3)c3cccc(O)c3)nn1)C2=O InChI=1S/C30H35N9O2/c1-3-31-30-32-18-27-28(33-30)36(2)14-15-38(29(27)41)24-7-5-8-25(17-24)39-20-23(34-35-39)19-37-12-10-21(11-13-37)22-6-4-9-26(40)16-22/h4-9,16-18,20-21,40H,3,10-15,19H2,1-2H3,(H,31,32,33) HFUHDEKDBSEMRJ-UHFFFAOYSA-N 436503 2-(ethylamino)-6-(3-(4- ((4-(3- hydroxyphenyl)piperidin- 1-yl)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 279 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436503 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436503&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088732 439658136 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888466 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCCCC3)nn1)C2=O InChI=1S/C24H31N9O/c1-3-25-24-26-15-21-22(27-24)30(2)12-13-32(23(21)34)19-8-7-9-20(14-19)33-17-18(28-29-33)16-31-10-5-4-6-11-31/h7-9,14-15,17H,3-6,10-13,16H2,1-2H3,(H,25,26,27) ILZMMONZNUMBHP-UHFFFAOYSA-N 436505 2-(ethylamino)-9- methyl-6-(3-(4- (piperidin-1-ylmethyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 281 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436505&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089483 439658138 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888467 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN3CCCCC3)nn1)C2=O InChI=1S/C24H31N9O/c1-3-25-24-26-15-21-22(27-24)30(2)12-13-32(23(21)34)19-8-7-9-20(14-19)33-17-18(28-29-33)16-31-10-5-4-6-11-31/h7-9,14-15,17H,3-6,10-13,16H2,1-2H3,(H,25,26,27) ILZMMONZNUMBHP-UHFFFAOYSA-N 436505 2-(ethylamino)-9- methyl-6-(3-(4- (piperidin-1-ylmethyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 281 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436505&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089483 439658138 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888468 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNCC3CC3)nn1)C2=O InChI=1S/C23H29N9O/c1-3-25-23-26-14-20-21(27-23)30(2)9-10-31(22(20)33)18-5-4-6-19(11-18)32-15-17(28-29-32)13-24-12-16-7-8-16/h4-6,11,14-16,24H,3,7-10,12-13H2,1-2H3,(H,25,26,27) MLLSPSHXJVRFIL-UHFFFAOYSA-N 436509 6-(3-(4- (((cyclopropylmethyl) amino)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 285 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436509&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098862 439658142 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888469 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CNCC3CC3)nn1)C2=O InChI=1S/C23H29N9O/c1-3-25-23-26-14-20-21(27-23)30(2)9-10-31(22(20)33)18-5-4-6-19(11-18)32-15-17(28-29-32)13-24-12-16-7-8-16/h4-6,11,14-16,24H,3,7-10,12-13H2,1-2H3,(H,25,26,27) MLLSPSHXJVRFIL-UHFFFAOYSA-N 436509 6-(3-(4- (((cyclopropylmethyl) amino)methyl)-1H- 1,2,3-triazol-1- yl)phenyl)-2- (ethylamino)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 285 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436509&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098862 439658142 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888470 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccc(F)cc3)nn1)C2=O InChI=1S/C27H30FN9O/c1-4-29-27-30-15-24-25(31-27)35(3)12-13-36(26(24)38)22-6-5-7-23(14-22)37-18-21(32-33-37)17-34(2)16-19-8-10-20(28)11-9-19/h5-11,14-15,18H,4,12-13,16-17H2,1-3H3,(H,29,30,31) VYYGEDOELRVSSA-UHFFFAOYSA-N 436511 2-(ethylamino)-6-(3-(4- (((4-fluorobenzyl) (methyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 287 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436511&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089359 439658144 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888471 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccc(F)cc3)nn1)C2=O InChI=1S/C27H30FN9O/c1-4-29-27-30-15-24-25(31-27)35(3)12-13-36(26(24)38)22-6-5-7-23(14-22)37-18-21(32-33-37)17-34(2)16-19-8-10-20(28)11-9-19/h5-11,14-15,18H,4,12-13,16-17H2,1-3H3,(H,29,30,31) VYYGEDOELRVSSA-UHFFFAOYSA-N 436511 2-(ethylamino)-6-(3-(4- (((4-fluorobenzyl) (methyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-9-methyl- 6,7,8,9-tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 287 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436511&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089359 439658144 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888472 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccccn3)nn1)C2=O InChI=1S/C26H30N10O/c1-4-27-26-29-15-23-24(30-26)34(3)12-13-35(25(23)37)21-9-7-10-22(14-21)36-18-20(31-32-36)17-33(2)16-19-8-5-6-11-28-19/h5-11,14-15,18H,4,12-13,16-17H2,1-3H3,(H,27,29,30) UYPKBPVIQUPYLU-UHFFFAOYSA-N 436512 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(pyridin-2- ylmethyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 288 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436512&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088836 439658145 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888473 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3ccccn3)nn1)C2=O InChI=1S/C26H30N10O/c1-4-27-26-29-15-23-24(30-26)34(3)12-13-35(25(23)37)21-9-7-10-22(14-21)36-18-20(31-32-36)17-33(2)16-19-8-5-6-11-28-19/h5-11,14-15,18H,4,12-13,16-17H2,1-3H3,(H,27,29,30) UYPKBPVIQUPYLU-UHFFFAOYSA-N 436512 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(pyridin-2- ylmethyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 288 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436512&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088836 439658145 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888474 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3cccnc3)nn1)C2=O InChI=1S/C26H30N10O/c1-4-28-26-29-15-23-24(30-26)34(3)11-12-35(25(23)37)21-8-5-9-22(13-21)36-18-20(31-32-36)17-33(2)16-19-7-6-10-27-14-19/h5-10,13-15,18H,4,11-12,16-17H2,1-3H3,(H,28,29,30) NMZMEZDYOKXSFP-UHFFFAOYSA-N 436513 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(pyridin-3- ylmethyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 289 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436513&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089039 439658146 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888475 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-n1cc(CN(C)Cc3cccnc3)nn1)C2=O InChI=1S/C26H30N10O/c1-4-28-26-29-15-23-24(30-26)34(3)11-12-35(25(23)37)21-8-5-9-22(13-21)36-18-20(31-32-36)17-33(2)16-19-7-6-10-27-14-19/h5-10,13-15,18H,4,11-12,16-17H2,1-3H3,(H,28,29,30) NMZMEZDYOKXSFP-UHFFFAOYSA-N 436513 2-(ethylamino)-9- methyl-6-(3-(4- ((methyl(pyridin-3- ylmethyl)amino)methyl)- 1H-1,2,3-triazol-1- yl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 289 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436513&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089039 439658146 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888476 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2cc(N)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-25-9-8-20(21-7-4-12-31-21)30-17-6-3-5-16(13-17)28-11-10-27(2)19-14-22(24)26-15-18(19)23(28)29/h3-7,12-15,20,25H,8-11H2,1-2H3,(H2,24,26)/t20-/m0/s1 OAKSTVOUJWQVNC-FQEVSTJZSA-N 436528 (S)-8-amino-1-methyl-4- (3-(3-(methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3-e] [1,4]diazepin-5-one::US10590140, Example 304 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436528&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089269 439658161 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888477 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2cc(N)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-25-9-8-20(21-7-4-12-31-21)30-17-6-3-5-16(13-17)28-11-10-27(2)19-14-22(24)26-15-18(19)23(28)29/h3-7,12-15,20,25H,8-11H2,1-2H3,(H2,24,26)/t20-/m0/s1 OAKSTVOUJWQVNC-FQEVSTJZSA-N 436528 (S)-8-amino-1-methyl-4- (3-(3-(methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3-e] [1,4]diazepin-5-one::US10590140, Example 304 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436528&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089269 439658161 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888478 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(N)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S/c1-26-10-9-21(22-4-3-13-32-22)31-18-7-5-17(6-8-18)16-29-12-11-28(2)20-14-23(25)27-15-19(20)24(29)30/h3-8,13-15,21,26H,9-12,16H2,1-2H3,(H2,25,27)/t21-/m0/s1 KYBCOYYBJZXCNK-NRFANRHFSA-N 436529 (S)-8-amino-1-methyl- 4-(4-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 305 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436529&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098889 439658162 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888479 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(N)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S/c1-26-10-9-21(22-4-3-13-32-22)31-18-7-5-17(6-8-18)16-29-12-11-28(2)20-14-23(25)27-15-19(20)24(29)30/h3-8,13-15,21,26H,9-12,16H2,1-2H3,(H2,25,27)/t21-/m0/s1 KYBCOYYBJZXCNK-NRFANRHFSA-N 436529 (S)-8-amino-1-methyl- 4-(4-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 305 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436529&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098889 439658162 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888480 CNCCC(Oc1cccc(c1)N1CCN(C)c2cc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H28N4O2S/c1-17-14-21-20(16-26-17)24(29)28(12-11-27(21)3)18-6-4-7-19(15-18)30-22(9-10-25-2)23-8-5-13-31-23/h4-8,13-16,22,25H,9-12H2,1-3H3 MFIHOGLJRPBYIE-UHFFFAOYSA-N 436531 1,8-dimethyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 307 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436531&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098872 439658164 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888481 CNCCC(Oc1cccc(c1)N1CCN(C)c2cc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H28N4O2S/c1-17-14-21-20(16-26-17)24(29)28(12-11-27(21)3)18-6-4-7-19(15-18)30-22(9-10-25-2)23-8-5-13-31-23/h4-8,13-16,22,25H,9-12H2,1-3H3 MFIHOGLJRPBYIE-UHFFFAOYSA-N 436531 1,8-dimethyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 307 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436531&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098872 439658164 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888482 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(C)ncc3C2=O)cc1)c1cccs1 InChI=1S/C25H30N4O2S/c1-18-15-22-21(16-27-18)25(30)29(13-12-28(22)3)17-19-6-8-20(9-7-19)31-23(10-11-26-2)24-5-4-14-32-24/h4-9,14-16,23,26H,10-13,17H2,1-3H3/t23-/m0/s1 WSTIUHFTNYABQA-QHCPKHFHSA-N 436532 (S)-1,8-dimethyl-4-(4- (3-(methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 308 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436532&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089293 439658165 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888483 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(C)ncc3C2=O)cc1)c1cccs1 InChI=1S/C25H30N4O2S/c1-18-15-22-21(16-27-18)25(30)29(13-12-28(22)3)17-19-6-8-20(9-7-19)31-23(10-11-26-2)24-5-4-14-32-24/h4-9,14-16,23,26H,10-13,17H2,1-3H3/t23-/m0/s1 WSTIUHFTNYABQA-QHCPKHFHSA-N 436532 (S)-1,8-dimethyl-4-(4- (3-(methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 308 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436532&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089293 439658165 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888484 CNCCC(OCc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-14-13-23(20-7-5-4-6-8-20)33-18-19-9-11-21(12-10-19)31-16-15-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-12,17,23,27H,13-16,18H2,1-3H3 VZXSNOCJGKGVGZ-UHFFFAOYSA-N 436539 9-methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 315 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436539&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089196 439658170 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888485 CNCCC(OCc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-14-13-23(20-7-5-4-6-8-20)33-18-19-9-11-21(12-10-19)31-16-15-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-12,17,23,27H,13-16,18H2,1-3H3 VZXSNOCJGKGVGZ-UHFFFAOYSA-N 436539 9-methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 315 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436539&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089196 439658170 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888486 CNCCC(Oc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-14-13-22(18-7-5-4-6-8-18)32-20-11-9-19(10-12-20)30-16-15-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-12,17,22,26H,13-16H2,1-3H3 WVSRUFDPKFMZJH-UHFFFAOYSA-N 436540 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 316 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436540&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089385 439658171 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888487 CNCCC(Oc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-14-13-22(18-7-5-4-6-8-18)32-20-11-9-19(10-12-20)30-16-15-29(2)23-21(24(30)31)17-27-25(28-23)33-3/h4-12,17,22,26H,13-16H2,1-3H3 WVSRUFDPKFMZJH-UHFFFAOYSA-N 436540 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)phenyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 316 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436540&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089385 439658171 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888488 CNCC(OCc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-16-22(19-7-5-4-6-8-19)32-17-18-9-11-20(12-10-18)30-14-13-29(2)23-21(24(30)31)15-27-25(28-23)33-3/h4-12,15,22,26H,13-14,16-17H2,1-3H3 XQQGWRFTVPATAL-UHFFFAOYSA-N 436545 9-methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 321 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436545&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089619 439658176 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888489 CNCC(OCc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2S/c1-26-16-22(19-7-5-4-6-8-19)32-17-18-9-11-20(12-10-18)30-14-13-29(2)23-21(24(30)31)15-27-25(28-23)33-3/h4-12,15,22,26H,13-14,16-17H2,1-3H3 XQQGWRFTVPATAL-UHFFFAOYSA-N 436545 9-methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 321 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436545&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089619 439658176 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888490 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)C(F)(F)F)c1ccccc1 InChI=1S/C26H28F3N5O2/c1-30-12-11-22(19-8-4-3-5-9-19)36-17-18-7-6-10-20(15-18)34-14-13-33(2)23-21(24(34)35)16-31-25(32-23)26(27,28)29/h3-10,15-16,22,30H,11-14,17H2,1-2H3 VODCLLAGQXKGNC-UHFFFAOYSA-N 436546 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 322 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436546&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089106 439658177 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888491 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)C(F)(F)F)c1ccccc1 InChI=1S/C26H28F3N5O2/c1-30-12-11-22(19-8-4-3-5-9-19)36-17-18-7-6-10-20(15-18)34-14-13-33(2)23-21(24(34)35)16-31-25(32-23)26(27,28)29/h3-10,15-16,22,30H,11-14,17H2,1-2H3 VODCLLAGQXKGNC-UHFFFAOYSA-N 436546 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 322 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436546&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089106 439658177 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888492 CNCCC(Oc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1cccs1 InChI=1S/C23H26N4O2S/c1-24-10-9-21(22-7-4-14-30-22)29-18-6-3-5-17(15-18)27-13-12-26(2)20-8-11-25-16-19(20)23(27)28/h3-8,11,14-16,21,24H,9-10,12-13H2,1-2H3 LAAINAAKDMZDHJ-UHFFFAOYSA-N 436547 1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 323 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436547&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089261 439658178 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888493 CNCCC(Oc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1cccs1 InChI=1S/C23H26N4O2S/c1-24-10-9-21(22-7-4-14-30-22)29-18-6-3-5-17(15-18)27-13-12-26(2)20-8-11-25-16-19(20)23(27)28/h3-8,11,14-16,21,24H,9-10,12-13H2,1-2H3 LAAINAAKDMZDHJ-UHFFFAOYSA-N 436547 1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 323 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436547&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089261 439658178 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888494 CCNc1cc2N(C)CCN(c3cccc(O[C@@H](CCNC)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C25H31N5O2S/c1-4-27-24-16-21-20(17-28-24)25(31)30(13-12-29(21)3)18-7-5-8-19(15-18)32-22(10-11-26-2)23-9-6-14-33-23/h5-9,14-17,22,26H,4,10-13H2,1-3H3,(H,27,28)/t22-/m0/s1 JOLCTAVEKPKHAQ-QFIPXVFZSA-N 436549 (S)-8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 325 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436549&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089245 439658180 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888495 CCNc1cc2N(C)CCN(c3cccc(O[C@@H](CCNC)c4cccs4)c3)C(=O)c2cn1 InChI=1S/C25H31N5O2S/c1-4-27-24-16-21-20(17-28-24)25(31)30(13-12-29(21)3)18-7-5-8-19(15-18)32-22(10-11-26-2)23-9-6-14-33-23/h5-9,14-17,22,26H,4,10-13H2,1-3H3,(H,27,28)/t22-/m0/s1 JOLCTAVEKPKHAQ-QFIPXVFZSA-N 436549 (S)-8-(ethylamino)-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 325 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436549&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089245 439658180 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888496 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1cccs1 InChI=1S/C23H26N4O2S/c1-24-10-9-21(22-7-4-14-30-22)29-18-6-3-5-17(15-18)27-13-12-26(2)20-8-11-25-16-19(20)23(27)28/h3-8,11,14-16,21,24H,9-10,12-13H2,1-2H3/t21-/m0/s1 LAAINAAKDMZDHJ-NRFANRHFSA-N 436550 (S)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 326 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436550&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089372 439658181 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888497 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1cccs1 InChI=1S/C23H26N4O2S/c1-24-10-9-21(22-7-4-14-30-22)29-18-6-3-5-17(15-18)27-13-12-26(2)20-8-11-25-16-19(20)23(27)28/h3-8,11,14-16,21,24H,9-10,12-13H2,1-2H3/t21-/m0/s1 LAAINAAKDMZDHJ-NRFANRHFSA-N 436550 (S)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 326 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436550&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089372 439658181 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888498 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1cccs1 InChI=1S/C23H26N4O2S/c1-24-10-9-21(22-7-4-14-30-22)29-18-6-3-5-17(15-18)27-13-12-26(2)20-8-11-25-16-19(20)23(27)28/h3-8,11,14-16,21,24H,9-10,12-13H2,1-2H3/t21-/m1/s1 LAAINAAKDMZDHJ-OAQYLSRUSA-N 436551 (R)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl(propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 327 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436551&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089438 439658182 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888499 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2ccncc2C1=O)c1cccs1 InChI=1S/C23H26N4O2S/c1-24-10-9-21(22-7-4-14-30-22)29-18-6-3-5-17(15-18)27-13-12-26(2)20-8-11-25-16-19(20)23(27)28/h3-8,11,14-16,21,24H,9-10,12-13H2,1-2H3/t21-/m1/s1 LAAINAAKDMZDHJ-OAQYLSRUSA-N 436551 (R)-1-methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl(propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 327 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436551&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089438 439658182 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888500 CNCCC(OCc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-16-17-6-8-18(9-7-17)29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3 RQQNIPMRBNPQOC-UHFFFAOYSA-N 436552 9-methyl-6-(4-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 328 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436552&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088743 439658183 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888501 CNCCC(OCc1ccc(cc1)N1CCN(C)c2nc(SC)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-16-17-6-8-18(9-7-17)29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3 RQQNIPMRBNPQOC-UHFFFAOYSA-N 436552 9-methyl-6-(4-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 328 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436552&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088743 439658183 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888502 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)C(F)(F)F)c1cccs1 InChI=1S/C23H24F3N5O2S/c1-27-9-8-18(19-7-4-12-34-19)33-16-6-3-5-15(13-16)31-11-10-30(2)20-17(21(31)32)14-28-22(29-20)23(24,25)26/h3-7,12-14,18,27H,8-11H2,1-2H3 MNOIUVGGVHWYLP-UHFFFAOYSA-N 436553 9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 329 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436553&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089499 439658184 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888503 CNCCC(Oc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)C(F)(F)F)c1cccs1 InChI=1S/C23H24F3N5O2S/c1-27-9-8-18(19-7-4-12-34-19)33-16-6-3-5-15(13-16)31-11-10-30(2)20-17(21(31)32)14-28-22(29-20)23(24,25)26/h3-7,12-14,18,27H,8-11H2,1-2H3 MNOIUVGGVHWYLP-UHFFFAOYSA-N 436553 9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 329 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436553&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089499 439658184 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888504 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)C(F)(F)F)c1cccs1 InChI=1S/C24H26F3N5O2S/c1-28-9-8-19(20-7-4-12-35-20)34-15-16-5-3-6-17(13-16)32-11-10-31(2)21-18(22(32)33)14-29-23(30-21)24(25,26)27/h3-7,12-14,19,28H,8-11,15H2,1-2H3 FRIOVEHUCKYUJD-UHFFFAOYSA-N 436554 9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 330 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436554&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088903 439658185 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888505 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)C(F)(F)F)c1cccs1 InChI=1S/C24H26F3N5O2S/c1-28-9-8-19(20-7-4-12-35-20)34-15-16-5-3-6-17(13-16)32-11-10-31(2)21-18(22(32)33)14-29-23(30-21)24(25,26)27/h3-7,12-14,19,28H,8-11,15H2,1-2H3 FRIOVEHUCKYUJD-UHFFFAOYSA-N 436554 9-methyl-6-(3-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 330 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436554&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088903 439658185 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888506 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2cc(OC)ncc2C1=O)c1cccs1 InChI=1S/C24H28N4O3S/c1-25-10-9-21(22-8-5-13-32-22)31-18-7-4-6-17(14-18)28-12-11-27(2)20-15-23(30-3)26-16-19(20)24(28)29/h4-8,13-16,21,25H,9-12H2,1-3H3/t21-/m0/s1 DXQNIABNXYTXNP-NRFANRHFSA-N 436555 (S)-8-methoxy-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 331 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436555&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098921 439658186 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888507 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2cc(OC)ncc2C1=O)c1cccs1 InChI=1S/C24H28N4O3S/c1-25-10-9-21(22-8-5-13-32-22)31-18-7-4-6-17(14-18)28-12-11-27(2)20-15-23(30-3)26-16-19(20)24(28)29/h4-8,13-16,21,25H,9-12H2,1-3H3/t21-/m0/s1 DXQNIABNXYTXNP-NRFANRHFSA-N 436555 (S)-8-methoxy-1- methyl-4-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 1,2,3,4-tetrahydro-5H- pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 331 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436555&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098921 439658186 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888508 CCNc1ncc2c(n1)N(C)CCN(c1ccc(OC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)16-17-32(25(22)33)20-10-12-21(13-11-20)34-23(14-15-27-2)19-8-6-5-7-9-19/h5-13,18,23,27H,4,14-17H2,1-3H3,(H,28,29,30) GYNKWEIZOXVXQN-UHFFFAOYSA-N 436557 2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 333 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436557&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088932 439658188 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888509 CCNc1ncc2c(n1)N(C)CCN(c1ccc(OC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-18-22-24(30-26)31(3)16-17-32(25(22)33)20-10-12-21(13-11-20)34-23(14-15-27-2)19-8-6-5-7-9-19/h5-13,18,23,27H,4,14-17H2,1-3H3,(H,28,29,30) GYNKWEIZOXVXQN-UHFFFAOYSA-N 436557 2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 333 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436557&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088932 439658188 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888510 CCNc1ncc2c(n1)N(C)CCN(c1ccc(COC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)22-12-10-20(11-13-22)19-35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31) XAMXFOAGBMDRHS-UHFFFAOYSA-N 436558 2-(ethylamino)-9- methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 334 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436558&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089252 439658189 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888511 CCNc1ncc2c(n1)N(C)CCN(c1ccc(COC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)22-12-10-20(11-13-22)19-35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31) XAMXFOAGBMDRHS-UHFFFAOYSA-N 436558 2-(ethylamino)-9- methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 334 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436558&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089252 439658189 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888512 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(NCc3ccccc3)ncc2C1=O)c1ccccc1 InChI=1S/C32H36N6O2/c1-33-17-16-29(26-13-7-4-8-14-26)40-23-25-12-9-15-27(20-25)38-19-18-37(2)30-28(31(38)39)22-35-32(36-30)34-21-24-10-5-3-6-11-24/h3-15,20,22,29,33H,16-19,21,23H2,1-2H3,(H,34,35,36) ITSRUFXPFLZXQT-UHFFFAOYSA-N 436559 2-(benzylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 335 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436559&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089067 439658190 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888513 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(NCc3ccccc3)ncc2C1=O)c1ccccc1 InChI=1S/C32H36N6O2/c1-33-17-16-29(26-13-7-4-8-14-26)40-23-25-12-9-15-27(20-25)38-19-18-37(2)30-28(31(38)39)22-35-32(36-30)34-21-24-10-5-3-6-11-24/h3-15,20,22,29,33H,16-19,21,23H2,1-2H3,(H,34,35,36) ITSRUFXPFLZXQT-UHFFFAOYSA-N 436559 2-(benzylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 335 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436559&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089067 439658190 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888514 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1ccccn1)c1ccccc1 InChI=1S/C32H37N7O2/c1-33-17-15-29(25-11-5-4-6-12-25)41-23-24-10-9-14-27(20-24)39-19-18-37(2)30-28(31(39)40)21-35-32(36-30)38(3)22-26-13-7-8-16-34-26/h4-14,16,20-21,29,33H,15,17-19,22-23H2,1-3H3 GVPQCNHAYHGSFL-UHFFFAOYSA-N 436560 9-methyl-2- (methyl(pyridin-2- ylmethyl)amino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 336 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436560&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088762 439658191 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888515 CNCCC(OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1ccccn1)c1ccccc1 InChI=1S/C32H37N7O2/c1-33-17-15-29(25-11-5-4-6-12-25)41-23-24-10-9-14-27(20-24)39-19-18-37(2)30-28(31(39)40)21-35-32(36-30)38(3)22-26-13-7-8-16-34-26/h4-14,16,20-21,29,33H,15,17-19,22-23H2,1-3H3 GVPQCNHAYHGSFL-UHFFFAOYSA-N 436560 9-methyl-2- (methyl(pyridin-2- ylmethyl)amino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 336 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436560&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088762 439658191 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888516 CCNc1ncc2c(n1)N(C)CCN(c1ccc(COC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)14-15-32(25(22)33)21-12-10-19(11-13-21)18-34-23(17-27-2)20-8-6-5-7-9-20/h5-13,16,23,27H,4,14-15,17-18H2,1-3H3,(H,28,29,30) FPZFQDJWOPZCSG-UHFFFAOYSA-N 436564 2-(ethylamino)-9- methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 340 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436564&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089301 439658195 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888517 CCNc1ncc2c(n1)N(C)CCN(c1ccc(COC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C26H32N6O2/c1-4-28-26-29-16-22-24(30-26)31(3)14-15-32(25(22)33)21-12-10-19(11-13-21)18-34-23(17-27-2)20-8-6-5-7-9-20/h5-13,16,23,27H,4,14-15,17-18H2,1-3H3,(H,28,29,30) FPZFQDJWOPZCSG-UHFFFAOYSA-N 436564 2-(ethylamino)-9- methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 340 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436564&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089301 439658195 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888518 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1ccccn1)c1ccccc1 InChI=1S/C32H37N7O2/c1-33-17-15-29(25-11-5-4-6-12-25)41-23-24-10-9-14-27(20-24)39-19-18-37(2)30-28(31(39)40)21-35-32(36-30)38(3)22-26-13-7-8-16-34-26/h4-14,16,20-21,29,33H,15,17-19,22-23H2,1-3H3/t29-/m1/s1 GVPQCNHAYHGSFL-GDLZYMKVSA-N 436565 (R)-9-methyl-2- (methyl(pyridin-2- ylmethyl)amino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 341 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436565&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088760 439658196 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888519 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1ccccn1)c1ccccc1 InChI=1S/C32H37N7O2/c1-33-17-15-29(25-11-5-4-6-12-25)41-23-24-10-9-14-27(20-24)39-19-18-37(2)30-28(31(39)40)21-35-32(36-30)38(3)22-26-13-7-8-16-34-26/h4-14,16,20-21,29,33H,15,17-19,22-23H2,1-3H3/t29-/m1/s1 GVPQCNHAYHGSFL-GDLZYMKVSA-N 436565 (R)-9-methyl-2- (methyl(pyridin-2- ylmethyl)amino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 341 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436565&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088760 439658196 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888520 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1cccnc1)c1ccccc1 InChI=1S/C32H37N7O2/c1-33-16-14-29(26-11-5-4-6-12-26)41-23-24-9-7-13-27(19-24)39-18-17-37(2)30-28(31(39)40)21-35-32(36-30)38(3)22-25-10-8-15-34-20-25/h4-13,15,19-21,29,33H,14,16-18,22-23H2,1-3H3/t29-/m1/s1 QNGRKOMRLIHMHR-GDLZYMKVSA-N 436566 (R)-9-methyl-2- (methyl(pyridin-3- ylmethyl)amino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 342 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436566&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088753 439658197 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888521 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1cccnc1)c1ccccc1 InChI=1S/C32H37N7O2/c1-33-16-14-29(26-11-5-4-6-12-26)41-23-24-9-7-13-27(19-24)39-18-17-37(2)30-28(31(39)40)21-35-32(36-30)38(3)22-25-10-8-15-34-20-25/h4-13,15,19-21,29,33H,14,16-18,22-23H2,1-3H3/t29-/m1/s1 QNGRKOMRLIHMHR-GDLZYMKVSA-N 436566 (R)-9-methyl-2- (methyl(pyridin-3- ylmethyl)amino)-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 342 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436566&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088753 439658197 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888522 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(NCc3ccccn3)ncc2C1=O)c1ccccc1 InChI=1S/C31H35N7O2/c1-32-16-14-28(24-10-4-3-5-11-24)40-22-23-9-8-13-26(19-23)38-18-17-37(2)29-27(30(38)39)21-35-31(36-29)34-20-25-12-6-7-15-33-25/h3-13,15,19,21,28,32H,14,16-18,20,22H2,1-2H3,(H,34,35,36)/t28-/m1/s1 QLJXGOSUUYOJJV-MUUNZHRXSA-N 436567 (R)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-((pyridin-2- ylmethyl)amino)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 343 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436567&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089409 439658198 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888523 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(NCc3ccccn3)ncc2C1=O)c1ccccc1 InChI=1S/C31H35N7O2/c1-32-16-14-28(24-10-4-3-5-11-24)40-22-23-9-8-13-26(19-23)38-18-17-37(2)29-27(30(38)39)21-35-31(36-29)34-20-25-12-6-7-15-33-25/h3-13,15,19,21,28,32H,14,16-18,20,22H2,1-2H3,(H,34,35,36)/t28-/m1/s1 QLJXGOSUUYOJJV-MUUNZHRXSA-N 436567 (R)-9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-2-((pyridin-2- ylmethyl)amino)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 343 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436567&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089409 439658198 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888524 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1ccc(F)cn1)c1ccccc1 InChI=1S/C32H36FN7O2/c1-34-15-14-29(24-9-5-4-6-10-24)42-22-23-8-7-11-27(18-23)40-17-16-38(2)30-28(31(40)41)20-36-32(37-30)39(3)21-26-13-12-25(33)19-35-26/h4-13,18-20,29,34H,14-17,21-22H2,1-3H3/t29-/m1/s1 FKCYQZFDOLGMHM-GDLZYMKVSA-N 436568 (R)-2-(((5- fluoropyridin-2- yl)methyl)(methyl) amino)-9-methyl-6- (3-((3-(methylamino)- 1-phenylpropoxy) methyl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 344 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436568&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088772 439658199 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888525 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(ncc2C1=O)N(C)Cc1ccc(F)cn1)c1ccccc1 InChI=1S/C32H36FN7O2/c1-34-15-14-29(24-9-5-4-6-10-24)42-22-23-8-7-11-27(18-23)40-17-16-38(2)30-28(31(40)41)20-36-32(37-30)39(3)21-26-13-12-25(33)19-35-26/h4-13,18-20,29,34H,14-17,21-22H2,1-3H3/t29-/m1/s1 FKCYQZFDOLGMHM-GDLZYMKVSA-N 436568 (R)-2-(((5- fluoropyridin-2- yl)methyl)(methyl) amino)-9-methyl-6- (3-((3-(methylamino)- 1-phenylpropoxy) methyl)phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 344 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436568&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088772 439658199 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888526 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1cccs1 InChI=1S/C23H28N6O2S/c1-25-9-8-19(20-7-4-12-32-20)31-15-16-5-3-6-17(13-16)29-11-10-28(2)21-18(22(29)30)14-26-23(24)27-21/h3-7,12-14,19,25H,8-11,15H2,1-2H3,(H2,24,26,27)/t19-/m1/s1 IUEMDBWQSYJROX-LJQANCHMSA-N 436571 (R)-2-amino-9-methyl- 6-(3-((3-(methylamino)- 1-(thiophen-2-yl) propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H-pyrimido [4,5-e][1,4]diazepin- 5-one::US10590140, Example 347 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436571&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088921 439658202 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888527 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1cccs1 InChI=1S/C23H28N6O2S/c1-25-9-8-19(20-7-4-12-32-20)31-15-16-5-3-6-17(13-16)29-11-10-28(2)21-18(22(29)30)14-26-23(24)27-21/h3-7,12-14,19,25H,8-11,15H2,1-2H3,(H2,24,26,27)/t19-/m1/s1 IUEMDBWQSYJROX-LJQANCHMSA-N 436571 (R)-2-amino-9-methyl- 6-(3-((3-(methylamino)- 1-(thiophen-2-yl) propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H-pyrimido [4,5-e][1,4]diazepin- 5-one::US10590140, Example 347 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436571&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088921 439658202 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888528 CCNc1ncc2c(n1)N(C)CCN(c1ccc(COC(CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)19-9-7-18(8-10-19)17-33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29) JBARIIVHRFLJKW-UHFFFAOYSA-N 436572 2-(ethylamino)-9- methyl-6-(4-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e][1,4] diazepin-5-one::US10590140, Example 348 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436572&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089396 439658203 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888529 CCNc1ncc2c(n1)N(C)CCN(c1ccc(COC(CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)19-9-7-18(8-10-19)17-33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29) JBARIIVHRFLJKW-UHFFFAOYSA-N 436572 2-(ethylamino)-9- methyl-6-(4-((3- (methylamino)-1- (thiophen-2- yl)propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e][1,4] diazepin-5-one::US10590140, Example 348 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436572&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089396 439658203 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888530 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3ccsc3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-15-20-22(28-24)29(3)11-12-30(23(20)31)18-6-5-7-19(14-18)32-21(8-10-25-2)17-9-13-33-16-17/h5-7,9,13-16,21,25H,4,8,10-12H2,1-3H3,(H,26,27,28) OAWHXCORWBSROR-UHFFFAOYSA-N 436573 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 349 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436573&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088825 439658204 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888531 CCNc1ncc2c(n1)N(C)CCN(c1cccc(OC(CCNC)c3ccsc3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-15-20-22(28-24)29(3)11-12-30(23(20)31)18-6-5-7-19(14-18)32-21(8-10-25-2)17-9-13-33-16-17/h5-7,9,13-16,21,25H,4,8,10-12H2,1-3H3,(H,26,27,28) OAWHXCORWBSROR-UHFFFAOYSA-N 436573 2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 349 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436573&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088825 439658204 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888532 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCNC)c3ccsc3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-15-20-22(28-24)29(3)11-12-30(23(20)31)18-6-5-7-19(14-18)32-21(8-10-25-2)17-9-13-33-16-17/h5-7,9,13-16,21,25H,4,8,10-12H2,1-3H3,(H,26,27,28)/t21-/m0/s1 OAWHXCORWBSROR-NRFANRHFSA-N 436574 (S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 350 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436574&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089476 439658205 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888533 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@@H](CCNC)c3ccsc3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-15-20-22(28-24)29(3)11-12-30(23(20)31)18-6-5-7-19(14-18)32-21(8-10-25-2)17-9-13-33-16-17/h5-7,9,13-16,21,25H,4,8,10-12H2,1-3H3,(H,26,27,28)/t21-/m0/s1 OAWHXCORWBSROR-NRFANRHFSA-N 436574 (S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 350 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436574&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089476 439658205 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888534 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCNC)c3ccsc3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-15-20-22(28-24)29(3)11-12-30(23(20)31)18-6-5-7-19(14-18)32-21(8-10-25-2)17-9-13-33-16-17/h5-7,9,13-16,21,25H,4,8,10-12H2,1-3H3,(H,26,27,28)/t21-/m1/s1 OAWHXCORWBSROR-OAQYLSRUSA-N 436575 (R)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 351 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436575&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089139 439658206 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888535 CCNc1ncc2c(n1)N(C)CCN(c1cccc(O[C@H](CCNC)c3ccsc3)c1)C2=O InChI=1S/C24H30N6O2S/c1-4-26-24-27-15-20-22(28-24)29(3)11-12-30(23(20)31)18-6-5-7-19(14-18)32-21(8-10-25-2)17-9-13-33-16-17/h5-7,9,13-16,21,25H,4,8,10-12H2,1-3H3,(H,26,27,28)/t21-/m1/s1 OAWHXCORWBSROR-OAQYLSRUSA-N 436575 (R)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1- (thiophen-3- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 351 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436575&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089139 439658206 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888536 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1cccs1 InChI=1S/C22H26N6O2S/c1-24-9-8-18(19-7-4-12-31-19)30-16-6-3-5-15(13-16)28-11-10-27(2)20-17(21(28)29)14-25-22(23)26-20/h3-7,12-14,18,24H,8-11H2,1-2H3,(H2,23,25,26)/t18-/m0/s1 IWLOXSUFFLVQCV-SFHVURJKSA-N 436576 (S)-2-amino-9-methyl- 6-(3-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 352 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436576&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089210 439658207 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888537 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(N)ncc2C1=O)c1cccs1 InChI=1S/C22H26N6O2S/c1-24-9-8-18(19-7-4-12-31-19)30-16-6-3-5-15(13-16)28-11-10-27(2)20-17(21(28)29)14-25-22(23)26-20/h3-7,12-14,18,24H,8-11H2,1-2H3,(H2,23,25,26)/t18-/m0/s1 IWLOXSUFFLVQCV-SFHVURJKSA-N 436576 (S)-2-amino-9-methyl- 6-(3-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 352 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436576&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089210 439658207 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888538 CNCCC(OCc1ccc(cc1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-17-23-25(29-19)30(3)15-16-31(26(23)32)22-11-9-20(10-12-22)18-33-24(13-14-27-2)21-7-5-4-6-8-21/h4-12,17,24,27H,13-16,18H2,1-3H3 QOLSIEVAHANYBT-UHFFFAOYSA-N 436577 2,9-dimethyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 353 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436577&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089125 439658208 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888539 CNCCC(OCc1ccc(cc1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-17-23-25(29-19)30(3)15-16-31(26(23)32)22-11-9-20(10-12-22)18-33-24(13-14-27-2)21-7-5-4-6-8-21/h4-12,17,24,27H,13-16,18H2,1-3H3 QOLSIEVAHANYBT-UHFFFAOYSA-N 436577 2,9-dimethyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 353 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436577&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089125 439658208 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888540 CCc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H33N5O2/c1-4-25-29-18-23-26(30-25)31(3)15-16-32(27(23)33)22-12-8-9-20(17-22)19-34-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3 GTXUIJXHALCWKS-UHFFFAOYSA-N 436578 2-ethyl-9-methyl-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4ldiazepin-5-one::US10590140, Example 354 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436578&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088964 439658209 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888541 CCc1ncc2c(n1)N(C)CCN(c1cccc(COC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H33N5O2/c1-4-25-29-18-23-26(30-25)31(3)15-16-32(27(23)33)22-12-8-9-20(17-22)19-34-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3 GTXUIJXHALCWKS-UHFFFAOYSA-N 436578 2-ethyl-9-methyl-6-(3- ((3-(methylamino)-1- phenylpropoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4ldiazepin-5-one::US10590140, Example 354 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436578&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088964 439658209 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888542 CNCC(OCc1ccc(cc1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2/c1-18-27-15-22-24(28-18)29(3)13-14-30(25(22)31)21-11-9-19(10-12-21)17-32-23(16-26-2)20-7-5-4-6-8-20/h4-12,15,23,26H,13-14,16-17H2,1-3H3 TTWWGIWHWUEGKT-UHFFFAOYSA-N 436579 2,9-dimethyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 355 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436579&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089016 439658210 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888543 CNCC(OCc1ccc(cc1)N1CCN(C)c2nc(C)ncc2C1=O)c1ccccc1 InChI=1S/C25H29N5O2/c1-18-27-15-22-24(28-18)29(3)13-14-30(25(22)31)21-11-9-19(10-12-21)17-32-23(16-26-2)20-7-5-4-6-8-20/h4-12,15,23,26H,13-14,16-17H2,1-3H3 TTWWGIWHWUEGKT-UHFFFAOYSA-N 436579 2,9-dimethyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 355 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436579&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089016 439658210 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888544 CCc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H33N5O2/c1-4-25-29-18-23-26(30-25)31(3)15-16-32(27(23)33)22-12-8-9-20(17-22)19-34-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3/t24-/m1/s1 GTXUIJXHALCWKS-XMMPIXPASA-N 436580 (R)-2-ethyl-9-methyl-6- (3-((3-(methylamino)- 1-phenylpropoxy) methyl)phenyl(- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 356 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436580&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089227 439658211 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888545 CCc1ncc2c(n1)N(C)CCN(c1cccc(CO[C@H](CCNC)c3ccccc3)c1)C2=O InChI=1S/C27H33N5O2/c1-4-25-29-18-23-26(30-25)31(3)15-16-32(27(23)33)22-12-8-9-20(17-22)19-34-24(13-14-28-2)21-10-6-5-7-11-21/h5-12,17-18,24,28H,4,13-16,19H2,1-3H3/t24-/m1/s1 GTXUIJXHALCWKS-XMMPIXPASA-N 436580 (R)-2-ethyl-9-methyl-6- (3-((3-(methylamino)- 1-phenylpropoxy) methyl)phenyl(- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 356 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436580&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089227 439658211 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888546 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-16-25-15-19-22(26-16)27(3)11-12-28(23(19)29)17-6-4-7-18(14-17)30-20(9-10-24-2)21-8-5-13-31-21/h4-8,13-15,20,24H,9-12H2,1-3H3/t20-/m1/s1 QSGMFCUAWLYRRU-HXUWFJFHSA-N 436581 (R)-2,9-dimethyl-6-(3- (3-(methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 357 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436581&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088708 439658212 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888547 CNCC[C@@H](Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-16-25-15-19-22(26-16)27(3)11-12-28(23(19)29)17-6-4-7-18(14-17)30-20(9-10-24-2)21-8-5-13-31-21/h4-8,13-15,20,24H,9-12H2,1-3H3/t20-/m1/s1 QSGMFCUAWLYRRU-HXUWFJFHSA-N 436581 (R)-2,9-dimethyl-6-(3- (3-(methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 357 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436581&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088708 439658212 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888548 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-16-25-15-19-22(26-16)27(3)11-12-28(23(19)29)17-6-4-7-18(14-17)30-20(9-10-24-2)21-8-5-13-31-21/h4-8,13-15,20,24H,9-12H2,1-3H3/t20-/m0/s1 QSGMFCUAWLYRRU-FQEVSTJZSA-N 436582 (S)-2,9-dimethyl-6-(3- (3-(methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 358 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436582&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089351 439658213 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888549 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C23H27N5O2S/c1-16-25-15-19-22(26-16)27(3)11-12-28(23(19)29)17-6-4-7-18(14-17)30-20(9-10-24-2)21-8-5-13-31-21/h4-8,13-15,20,24H,9-12H2,1-3H3/t20-/m0/s1 QSGMFCUAWLYRRU-FQEVSTJZSA-N 436582 (S)-2,9-dimethyl-6-(3- (3-(methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 358 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436582&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089351 439658213 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888550 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)11-12-29(24(20)30)19-7-4-6-18(14-19)16-31-21(9-10-25-2)22-8-5-13-32-22/h4-8,13-15,21,25H,9-12,16H2,1-3H3/t21-/m1/s1 DDWJAWDHKATTEZ-OAQYLSRUSA-N 436584 (R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- (thiophen-2-yl) propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e][1,4] diazepin-5-one::US10590140, Example 360 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436584&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088797 439658215 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888551 CNCC[C@@H](OCc1cccc(c1)N1CCN(C)c2nc(C)ncc2C1=O)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)11-12-29(24(20)30)19-7-4-6-18(14-19)16-31-21(9-10-25-2)22-8-5-13-32-22/h4-8,13-15,21,25H,9-12,16H2,1-3H3/t21-/m1/s1 DDWJAWDHKATTEZ-OAQYLSRUSA-N 436584 (R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- (thiophen-2-yl) propoxy)methyl) phenyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e][1,4] diazepin-5-one::US10590140, Example 360 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436584&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088797 439658215 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888552 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C22H25N5O2S/c1-23-9-8-19(20-7-4-12-30-20)29-17-6-3-5-16(13-17)27-11-10-26(2)21-18(22(27)28)14-24-15-25-21/h3-7,12-15,19,23H,8-11H2,1-2H3/t19-/m0/s1 KYQUYMHBNNIIFU-IBGZPJMESA-N 436588 (S)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 364 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436588&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089053 439658219 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888553 CNCC[C@H](Oc1cccc(c1)N1CCN(C)c2ncncc2C1=O)c1cccs1 InChI=1S/C22H25N5O2S/c1-23-9-8-19(20-7-4-12-30-20)29-17-6-3-5-16(13-17)27-11-10-26(2)21-18(22(27)28)14-24-15-25-21/h3-7,12-15,19,23H,8-11H2,1-2H3/t19-/m0/s1 KYQUYMHBNNIIFU-IBGZPJMESA-N 436588 (S)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2- yl)propoxy)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 364 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436588&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089053 439658219 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888554 CNCCC(Oc1cccc(CN2CCN(C)c3nc(SC)ncc3C2=O)c1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-21-11-7-8-19(16-21)18-31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3 QDQLRTUYAFRSQI-UHFFFAOYSA-N 436590 9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)benzyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 366 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436590&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089378 439658221 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888555 CNCCC(Oc1cccc(CN2CCN(C)c3nc(SC)ncc3C2=O)c1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-13-12-23(20-9-5-4-6-10-20)33-21-11-7-8-19(16-21)18-31-15-14-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-11,16-17,23,27H,12-15,18H2,1-3H3 QDQLRTUYAFRSQI-UHFFFAOYSA-N 436590 9-methyl-6-(3-(3- (methylamino)-1- phenylpropoxy)benzyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 366 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436590&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089378 439658221 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888556 CNCCC(OCc1cccc(CN2CCN(C)c3nc(SC)ncc3C2=O)c1)c1ccccc1 InChI=1S/C27H33N5O2S/c1-28-13-12-24(22-10-5-4-6-11-22)34-19-21-9-7-8-20(16-21)18-32-15-14-31(2)25-23(26(32)33)17-29-27(30-25)35-3/h4-11,16-17,24,28H,12-15,18-19H2,1-3H3 UOPQGSXJSRXVRG-UHFFFAOYSA-N 436591 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 367 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436591&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089238 439658222 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888557 CNCCC(OCc1cccc(CN2CCN(C)c3nc(SC)ncc3C2=O)c1)c1ccccc1 InChI=1S/C27H33N5O2S/c1-28-13-12-24(22-10-5-4-6-11-22)34-19-21-9-7-8-20(16-21)18-32-15-14-31(2)25-23(26(32)33)17-29-27(30-25)35-3/h4-11,16-17,24,28H,12-15,18-19H2,1-3H3 UOPQGSXJSRXVRG-UHFFFAOYSA-N 436591 9-methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 367 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436591&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089238 439658222 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888558 CNCCC(OCc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C27H33N5O2S/c1-28-14-13-24(22-7-5-4-6-8-22)34-19-21-11-9-20(10-12-21)18-32-16-15-31(2)25-23(26(32)33)17-29-27(30-25)35-3/h4-12,17,24,28H,13-16,18-19H2,1-3H3 BYERXQZXKHNJFV-UHFFFAOYSA-N 436592 9-methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 368 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436592&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088808 439658223 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888559 CNCCC(OCc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C27H33N5O2S/c1-28-14-13-24(22-7-5-4-6-8-22)34-19-21-11-9-20(10-12-21)18-32-16-15-31(2)25-23(26(32)33)17-29-27(30-25)35-3/h4-12,17,24,28H,13-16,18-19H2,1-3H3 BYERXQZXKHNJFV-UHFFFAOYSA-N 436592 9-methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 368 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436592&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088808 439658223 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888560 CNCCC(Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-14-13-23(20-7-5-4-6-8-20)33-21-11-9-19(10-12-21)18-31-16-15-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-12,17,23,27H,13-16,18H2,1-3H3 LIEZFUXANSELMO-UHFFFAOYSA-N 436593 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 369 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436593&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089291 439658224 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888561 CNCCC(Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-14-13-23(20-7-5-4-6-8-20)33-21-11-9-19(10-12-21)18-31-16-15-30(2)24-22(25(31)32)17-28-26(29-24)34-3/h4-12,17,23,27H,13-16,18H2,1-3H3 LIEZFUXANSELMO-UHFFFAOYSA-N 436593 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 2-(methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 369 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436593&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089291 439658224 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888562 CNCC(OCc1cccc(CN2CCN(C)c3nc(SC)ncc3C2=O)c1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-16-23(21-10-5-4-6-11-21)33-18-20-9-7-8-19(14-20)17-31-13-12-30(2)24-22(25(31)32)15-28-26(29-24)34-3/h4-11,14-15,23,27H,12-13,16-18H2,1-3H3 ICMKHSPPDWZGOG-UHFFFAOYSA-N 436596 9-methyl-6-(3-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 372 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436596&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089280 439658227 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888563 CNCC(OCc1cccc(CN2CCN(C)c3nc(SC)ncc3C2=O)c1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-16-23(21-10-5-4-6-11-21)33-18-20-9-7-8-19(14-20)17-31-13-12-30(2)24-22(25(31)32)15-28-26(29-24)34-3/h4-11,14-15,23,27H,12-13,16-18H2,1-3H3 ICMKHSPPDWZGOG-UHFFFAOYSA-N 436596 9-methyl-6-(3-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 372 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436596&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089280 439658227 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888564 CNCC(OCc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-16-23(21-7-5-4-6-8-21)33-18-20-11-9-19(10-12-20)17-31-14-13-30(2)24-22(25(31)32)15-28-26(29-24)34-3/h4-12,15,23,27H,13-14,16-18H2,1-3H3 DQBDZMGJYJPKFK-UHFFFAOYSA-N 436598 9-methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 374 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436598&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089123 439658229 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888565 CNCC(OCc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O2S/c1-27-16-23(21-7-5-4-6-8-21)33-18-20-11-9-19(10-12-20)17-31-14-13-30(2)24-22(25(31)32)15-28-26(29-24)34-3/h4-12,15,23,27H,13-14,16-18H2,1-3H3 DQBDZMGJYJPKFK-UHFFFAOYSA-N 436598 9-methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-2-(methylthio)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 374 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436598&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089123 439658229 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888566 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O3/c1-27-14-13-23(20-7-5-4-6-8-20)34-21-11-9-19(10-12-21)18-31-16-15-30(2)24-22(25(31)32)17-28-26(29-24)33-3/h4-12,17,23,27H,13-16,18H2,1-3H3/t23-/m0/s1 PQNPVPGYGMGILK-QHCPKHFHSA-N 436599 (S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 375 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436599&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089035 439658230 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888567 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O3/c1-27-14-13-23(20-7-5-4-6-8-20)34-21-11-9-19(10-12-21)18-31-16-15-30(2)24-22(25(31)32)17-28-26(29-24)33-3/h4-12,17,23,27H,13-16,18H2,1-3H3/t23-/m0/s1 PQNPVPGYGMGILK-QHCPKHFHSA-N 436599 (S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 375 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436599&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089035 439658230 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888568 CNCCC(Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3 OUAQODABUANYJQ-UHFFFAOYSA-N 436602 9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 378 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436602&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088983 439658233 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888569 CNCCC(Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3 OUAQODABUANYJQ-UHFFFAOYSA-N 436602 9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 378 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436602&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088983 439658233 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888570 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3/t20-/m0/s1 OUAQODABUANYJQ-FQEVSTJZSA-N 436603 (S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 379 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436603&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088982 439658234 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888571 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3/t20-/m0/s1 OUAQODABUANYJQ-FQEVSTJZSA-N 436603 (S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 379 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436603&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088982 439658234 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888572 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3/t20-/m1/s1 OUAQODABUANYJQ-HXUWFJFHSA-N 436604 (R)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 380 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436604&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089455 439658235 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888573 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3nc(SC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S2/c1-25-11-10-20(21-5-4-14-33-21)31-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)32-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3/t20-/m1/s1 OUAQODABUANYJQ-HXUWFJFHSA-N 436604 (R)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (methylthio)-6,7,8,9- tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 380 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436604&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089455 439658235 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888574 CNCCC(Oc1ccc(CN2CCN(C)c3ccncc3C2=O)cc1)c1cccs1 InChI=1S/C24H28N4O2S/c1-25-11-10-22(23-4-3-15-31-23)30-19-7-5-18(6-8-19)17-28-14-13-27(2)21-9-12-26-16-20(21)24(28)29/h3-9,12,15-16,22,25H,10-11,13-14,17H2,1-2H3 PLRRDJAYJPNCQT-UHFFFAOYSA-N 436605 1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 381 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436605&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088838 439658236 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888575 CNCCC(Oc1ccc(CN2CCN(C)c3ccncc3C2=O)cc1)c1cccs1 InChI=1S/C24H28N4O2S/c1-25-11-10-22(23-4-3-15-31-23)30-19-7-5-18(6-8-19)17-28-14-13-27(2)21-9-12-26-16-20(21)24(28)29/h3-9,12,15-16,22,25H,10-11,13-14,17H2,1-2H3 PLRRDJAYJPNCQT-UHFFFAOYSA-N 436605 1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 381 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436605&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088838 439658236 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888576 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ccncc3C2=O)cc1)c1cccs1 InChI=1S/C24H28N4O2S/c1-25-11-10-22(23-4-3-15-31-23)30-19-7-5-18(6-8-19)17-28-14-13-27(2)21-9-12-26-16-20(21)24(28)29/h3-9,12,15-16,22,25H,10-11,13-14,17H2,1-2H3/t22-/m0/s1 PLRRDJAYJPNCQT-QFIPXVFZSA-N 436606 (S)-1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 382 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436606&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098863 439658237 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888577 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ccncc3C2=O)cc1)c1cccs1 InChI=1S/C24H28N4O2S/c1-25-11-10-22(23-4-3-15-31-23)30-19-7-5-18(6-8-19)17-28-14-13-27(2)21-9-12-26-16-20(21)24(28)29/h3-9,12,15-16,22,25H,10-11,13-14,17H2,1-2H3/t22-/m0/s1 PLRRDJAYJPNCQT-QFIPXVFZSA-N 436606 (S)-1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 382 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436606&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098863 439658237 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888578 CCNc1cc2N(C)CCN(Cc3ccc(O[C@@H](CCNC)c4cccs4)cc3)C(=O)c2cn1 InChI=1S/C26H33N5O2S/c1-4-28-25-16-22-21(17-29-25)26(32)31(14-13-30(22)3)18-19-7-9-20(10-8-19)33-23(11-12-27-2)24-6-5-15-34-24/h5-10,15-17,23,27H,4,11-14,18H2,1-3H3,(H,28,29)/t23-/m0/s1 ZQDPPYZTUFYXQP-QHCPKHFHSA-N 436607 (S)-8-(ethylamino)-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 383 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436607&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088939 439658238 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888579 CCNc1cc2N(C)CCN(Cc3ccc(O[C@@H](CCNC)c4cccs4)cc3)C(=O)c2cn1 InChI=1S/C26H33N5O2S/c1-4-28-25-16-22-21(17-29-25)26(32)31(14-13-30(22)3)18-19-7-9-20(10-8-19)33-23(11-12-27-2)24-6-5-15-34-24/h5-10,15-17,23,27H,4,11-14,18H2,1-3H3,(H,28,29)/t23-/m0/s1 ZQDPPYZTUFYXQP-QHCPKHFHSA-N 436607 (S)-8-(ethylamino)-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 383 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436607&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088939 439658238 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888580 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(ncc3C2=O)N(C)C)cc1)c1cccs1 InChI=1S/C26H33N5O2S/c1-27-12-11-23(24-6-5-15-34-24)33-20-9-7-19(8-10-20)18-31-14-13-30(4)22-16-25(29(2)3)28-17-21(22)26(31)32/h5-10,15-17,23,27H,11-14,18H2,1-4H3/t23-/m0/s1 CMVIUAMERNJGJV-QHCPKHFHSA-N 436608 (S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 384 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436608&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089095 439658239 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888581 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(ncc3C2=O)N(C)C)cc1)c1cccs1 InChI=1S/C26H33N5O2S/c1-27-12-11-23(24-6-5-15-34-24)33-20-9-7-19(8-10-20)18-31-14-13-30(4)22-16-25(29(2)3)28-17-21(22)26(31)32/h5-10,15-17,23,27H,11-14,18H2,1-4H3/t23-/m0/s1 CMVIUAMERNJGJV-QHCPKHFHSA-N 436608 (S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 384 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436608&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089095 439658239 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888582 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(OC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C25H30N4O3S/c1-26-11-10-22(23-5-4-14-33-23)32-19-8-6-18(7-9-19)17-29-13-12-28(2)21-15-24(31-3)27-16-20(21)25(29)30/h4-9,14-16,22,26H,10-13,17H2,1-3H3/t22-/m0/s1 ADZLFOZXVROIJQ-QFIPXVFZSA-N 436609 (S)-8-methoxy-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 385 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436609&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132098977 439658240 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888583 CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(OC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C25H30N4O3S/c1-26-11-10-22(23-5-4-14-33-23)32-19-8-6-18(7-9-19)17-29-13-12-28(2)21-15-24(31-3)27-16-20(21)25(29)30/h4-9,14-16,22,26H,10-13,17H2,1-3H3/t22-/m0/s1 ADZLFOZXVROIJQ-QFIPXVFZSA-N 436609 (S)-8-methoxy-1- methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 385 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436609&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132098977 439658240 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888584 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(ncc3C2=O)C(F)(F)F)cc1)c1cccs1 InChI=1S/C24H26F3N5O2S/c1-28-10-9-19(20-4-3-13-35-20)34-17-7-5-16(6-8-17)15-32-12-11-31(2)21-18(22(32)33)14-29-23(30-21)24(25,26)27/h3-8,13-14,19,28H,9-12,15H2,1-2H3/t19-/m0/s1 SVLCJDSHPQXKRN-IBGZPJMESA-N 436610 (S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 386 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436610&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089289 439658241 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888585 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(ncc3C2=O)C(F)(F)F)cc1)c1cccs1 InChI=1S/C24H26F3N5O2S/c1-28-10-9-19(20-4-3-13-35-20)34-17-7-5-16(6-8-17)15-32-12-11-31(2)21-18(22(32)33)14-29-23(30-21)24(25,26)27/h3-8,13-14,19,28H,9-12,15H2,1-2H3/t19-/m0/s1 SVLCJDSHPQXKRN-IBGZPJMESA-N 436610 (S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- (trifluoromethyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 386 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436610&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089289 439658241 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888586 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccsc1 InChI=1S/C24H29N5O3S/c1-25-10-8-21(18-9-13-33-16-18)32-19-6-4-17(5-7-19)15-29-12-11-28(2)22-20(23(29)30)14-26-24(27-22)31-3/h4-7,9,13-14,16,21,25H,8,10-12,15H2,1-3H3 MKPRTPUWLYUUAO-UHFFFAOYSA-N 436611 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1- (thiophen-3- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 387 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436611&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089233 439658242 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888587 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccsc1 InChI=1S/C24H29N5O3S/c1-25-10-8-21(18-9-13-33-16-18)32-19-6-4-17(5-7-19)15-29-12-11-28(2)22-20(23(29)30)14-26-24(27-22)31-3/h4-7,9,13-14,16,21,25H,8,10-12,15H2,1-3H3 MKPRTPUWLYUUAO-UHFFFAOYSA-N 436611 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1- (thiophen-3- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 387 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436611&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089233 439658242 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888588 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1sccc1C InChI=1S/C25H31N5O3S/c1-17-10-14-34-22(17)21(9-11-26-2)33-19-7-5-18(6-8-19)16-30-13-12-29(3)23-20(24(30)31)15-27-25(28-23)32-4/h5-8,10,14-15,21,26H,9,11-13,16H2,1-4H3 UFYUETPBFDCCSC-UHFFFAOYSA-N 436612 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(3- methylthiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 388 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436612&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089295 439658243 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888589 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1sccc1C InChI=1S/C25H31N5O3S/c1-17-10-14-34-22(17)21(9-11-26-2)33-19-7-5-18(6-8-19)16-30-13-12-29(3)23-20(24(30)31)15-27-25(28-23)32-4/h5-8,10,14-15,21,26H,9,11-13,16H2,1-4H3 UFYUETPBFDCCSC-UHFFFAOYSA-N 436612 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(3- methylthiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 388 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436612&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089295 439658243 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888590 CCN1CCN(Cc2ccc(O[C@@H](CCNC)c3cccs3)cc2)C(=O)c2cnc(OC)cc12 InChI=1S/C26H32N4O3S/c1-4-29-13-14-30(26(31)21-17-28-25(32-3)16-22(21)29)18-19-7-9-20(10-8-19)33-23(11-12-27-2)24-6-5-15-34-24/h5-10,15-17,23,27H,4,11-14,18H2,1-3H3/t23-/m0/s1 XJNGDIZTERSHCD-QHCPKHFHSA-N 436613 (S)-1-ethyl-8- methoxy-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 389 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436613&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132099021 439658244 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888591 CCN1CCN(Cc2ccc(O[C@@H](CCNC)c3cccs3)cc2)C(=O)c2cnc(OC)cc12 InChI=1S/C26H32N4O3S/c1-4-29-13-14-30(26(31)21-17-28-25(32-3)16-22(21)29)18-19-7-9-20(10-8-19)33-23(11-12-27-2)24-6-5-15-34-24/h5-10,15-17,23,27H,4,11-14,18H2,1-3H3/t23-/m0/s1 XJNGDIZTERSHCD-QHCPKHFHSA-N 436613 (S)-1-ethyl-8- methoxy-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 389 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436613&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132099021 439658244 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888592 CCN1CCN(Cc2ccc(O[C@@H](CCNC)c3cccs3)cc2)C(=O)c2cnccc12 InChI=1S/C25H30N4O2S/c1-3-28-14-15-29(25(30)21-17-27-13-10-22(21)28)18-19-6-8-20(9-7-19)31-23(11-12-26-2)24-5-4-16-32-24/h4-10,13,16-17,23,26H,3,11-12,14-15,18H2,1-2H3/t23-/m0/s1 KKHPQIYTBQXDHW-QHCPKHFHSA-N 436615 (S)-1-ethyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 391 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436615&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089086 439658246 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888593 CCN1CCN(Cc2ccc(O[C@@H](CCNC)c3cccs3)cc2)C(=O)c2cnccc12 InChI=1S/C25H30N4O2S/c1-3-28-14-15-29(25(30)21-17-27-13-10-22(21)28)18-19-6-8-20(9-7-19)31-23(11-12-26-2)24-5-4-16-32-24/h4-10,13,16-17,23,26H,3,11-12,14-15,18H2,1-2H3/t23-/m0/s1 KKHPQIYTBQXDHW-QHCPKHFHSA-N 436615 (S)-1-ethyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 1,2,3,4-tetrahydro- 5H-pyrido[4,3- e][1,4]diazepin-5-one::US10590140, Example 391 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436615&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089086 439658246 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888594 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccc(C)s1 InChI=1S/C25H31N5O3S/c1-17-5-10-22(34-17)21(11-12-26-2)33-19-8-6-18(7-9-19)16-30-14-13-29(3)23-20(24(30)31)15-27-25(28-23)32-4/h5-10,15,21,26H,11-14,16H2,1-4H3 CCNHLMZWGULFFU-UHFFFAOYSA-N 436616 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(5- methylthiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 392 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436616&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089223 439658247 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888595 CNCCC(Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1ccc(C)s1 InChI=1S/C25H31N5O3S/c1-17-5-10-22(34-17)21(11-12-26-2)33-19-8-6-18(7-9-19)16-30-14-13-29(3)23-20(24(30)31)15-27-25(28-23)32-4/h5-10,15,21,26H,11-14,16H2,1-4H3 CCNHLMZWGULFFU-UHFFFAOYSA-N 436616 2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(5- methylthiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 392 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436616&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089223 439658247 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888596 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1F)c1cccs1 InChI=1S/C24H28FN5O3S/c1-26-9-8-20(21-5-4-12-34-21)33-19-7-6-16(13-18(19)25)15-30-11-10-29(2)22-17(23(30)31)14-27-24(28-22)32-3/h4-7,12-14,20,26H,8-11,15H2,1-3H3/t20-/m0/s1 TUYHONFAVFQREZ-FQEVSTJZSA-N 436618 (S)-6-(3-fluoro-4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- methoxy-9-methyl- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 394 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436618&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088965 439658249 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888597 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1F)c1cccs1 InChI=1S/C24H28FN5O3S/c1-26-9-8-20(21-5-4-12-34-21)33-19-7-6-16(13-18(19)25)15-30-11-10-29(2)22-17(23(30)31)14-27-24(28-22)32-3/h4-7,12-14,20,26H,8-11,15H2,1-3H3/t20-/m0/s1 TUYHONFAVFQREZ-FQEVSTJZSA-N 436618 (S)-6-(3-fluoro-4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)-2- methoxy-9-methyl- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 394 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436618&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088965 439658249 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888598 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O3S/c1-25-11-10-20(21-5-4-14-33-21)32-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)31-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3/t20-/m0/s1 NSAPWHGIQPPHQR-FQEVSTJZSA-N 436626 (S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 402 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436626&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089155 439658257 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888599 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(OC)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O3S/c1-25-11-10-20(21-5-4-14-33-21)32-18-8-6-17(7-9-18)16-29-13-12-28(2)22-19(23(29)30)15-26-24(27-22)31-3/h4-9,14-15,20,25H,10-13,16H2,1-3H3/t20-/m0/s1 NSAPWHGIQPPHQR-FQEVSTJZSA-N 436626 (S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9-tetrahydro- 5H-pyrimido[4,5- e][1,4]diazepin-5-one::US10590140, Example 402 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436626&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089155 439658257 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888600 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(COC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C28H36N6O2/c1-4-30-28-31-18-24-26(32-28)33(3)16-17-34(27(24)35)19-21-10-12-22(13-11-21)20-36-25(14-15-29-2)23-8-6-5-7-9-23/h5-13,18,25,29H,4,14-17,19-20H2,1-3H3,(H,30,31,32) FGPZFIZWOLGIDF-UHFFFAOYSA-N 436629 2-(ethylamino)-9- methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 405 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436629&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089277 439658260 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888601 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(COC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C28H36N6O2/c1-4-30-28-31-18-24-26(32-28)33(3)16-17-34(27(24)35)19-21-10-12-22(13-11-21)20-36-25(14-15-29-2)23-8-6-5-7-9-23/h5-13,18,25,29H,4,14-17,19-20H2,1-3H3,(H,30,31,32) FGPZFIZWOLGIDF-UHFFFAOYSA-N 436629 2-(ethylamino)-9- methyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 405 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436629&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089277 439658260 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888602 CCNc1ncc2c(n1)N(C)CCN(Cc1cccc(COC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-4-30-28-31-18-24-26(32-28)33(3)15-16-34(27(24)35)19-21-9-8-10-22(17-21)20-36-25(13-14-29-2)23-11-6-5-7-12-23/h5-12,17-18,25,29H,4,13-16,19-20H2,1-3H3,(H,30,31,32) HNEKLAXKDRFZKN-UHFFFAOYSA-N 436630 2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 406 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436630&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088883 439658261 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888603 CCNc1ncc2c(n1)N(C)CCN(Cc1cccc(COC(CCNC)c3ccccc3)c1)C2=O InChI=1S/C28H36N6O2/c1-4-30-28-31-18-24-26(32-28)33(3)15-16-34(27(24)35)19-21-9-8-10-22(17-21)20-36-25(13-14-29-2)23-11-6-5-7-12-23/h5-12,17-18,25,29H,4,13-16,19-20H2,1-3H3,(H,30,31,32) HNEKLAXKDRFZKN-UHFFFAOYSA-N 436630 2-(ethylamino)-9- methyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 406 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436630&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088883 439658261 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888604 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)19-20-10-12-22(13-11-20)35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31) GJWAJBQAFMDPFR-UHFFFAOYSA-N 436632 2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 408 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436632&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088830 439658263 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888605 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)19-20-10-12-22(13-11-20)35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31) GJWAJBQAFMDPFR-UHFFFAOYSA-N 436632 2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 408 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436632&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088830 439658263 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888606 CCNc1ncc2c(n1)N(C)CCN(Cc1cccc(COC(CNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-16-23-25(31-27)32(3)13-14-33(26(23)34)18-20-9-8-10-21(15-20)19-35-24(17-28-2)22-11-6-5-7-12-22/h5-12,15-16,24,28H,4,13-14,17-19H2,1-3H3,(H,29,30,31) TZYRHPFLJFVDAN-UHFFFAOYSA-N 436635 2-(ethylamino)-9- methyl-6-(3-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 411 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436635&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089371 439658266 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888607 CCNc1ncc2c(n1)N(C)CCN(Cc1cccc(COC(CNC)c3ccccc3)c1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-16-23-25(31-27)32(3)13-14-33(26(23)34)18-20-9-8-10-21(15-20)19-35-24(17-28-2)22-11-6-5-7-12-22/h5-12,15-16,24,28H,4,13-14,17-19H2,1-3H3,(H,29,30,31) TZYRHPFLJFVDAN-UHFFFAOYSA-N 436635 2-(ethylamino)-9- methyl-6-(3-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 411 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436635&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089371 439658266 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888608 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(COC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-16-23-25(31-27)32(3)14-15-33(26(23)34)18-20-10-12-21(13-11-20)19-35-24(17-28-2)22-8-6-5-7-9-22/h5-13,16,24,28H,4,14-15,17-19H2,1-3H3,(H,29,30,31) SWKNCRTZWAZJEV-UHFFFAOYSA-N 436637 2-(ethylamino)-9- methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 413 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436637&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089030 439658268 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888609 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(COC(CNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-16-23-25(31-27)32(3)14-15-33(26(23)34)18-20-10-12-21(13-11-20)19-35-24(17-28-2)22-8-6-5-7-9-22/h5-13,16,24,28H,4,14-15,17-19H2,1-3H3,(H,29,30,31) SWKNCRTZWAZJEV-UHFFFAOYSA-N 436637 2-(ethylamino)-9- methyl-6-(4-((2- (methylamino)-1- phenylethoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 413 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436637&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089030 439658268 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888610 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@@H](CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)19-20-10-12-22(13-11-20)35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31)/t24-/m0/s1 GJWAJBQAFMDPFR-DEOSSOPVSA-N 436638 (S)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 414 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436638&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089038 439658269 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888611 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@@H](CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)19-20-10-12-22(13-11-20)35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31)/t24-/m0/s1 GJWAJBQAFMDPFR-DEOSSOPVSA-N 436638 (S)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 414 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436638&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089038 439658269 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888612 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@H](CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)19-20-10-12-22(13-11-20)35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31)/t24-/m1/s1 GJWAJBQAFMDPFR-XMMPIXPASA-N 436639 (R)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 415 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436639&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088829 439658270 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888613 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@H](CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H34N6O2/c1-4-29-27-30-18-23-25(31-27)32(3)16-17-33(26(23)34)19-20-10-12-22(13-11-20)35-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3,(H,29,30,31)/t24-/m1/s1 GJWAJBQAFMDPFR-XMMPIXPASA-N 436639 (R)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 415 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436639&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088829 439658270 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888614 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29) CSAXPKYQQPOHMD-UHFFFAOYSA-N 436640 2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 416 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436640&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088735 439658271 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888615 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29) CSAXPKYQQPOHMD-UHFFFAOYSA-N 436640 2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 416 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436640&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088735 439658271 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888616 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@@H](CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29)/t21-/m0/s1 CSAXPKYQQPOHMD-NRFANRHFSA-N 436641 (S)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 417 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436641&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088826 439658272 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888617 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@@H](CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29)/t21-/m0/s1 CSAXPKYQQPOHMD-NRFANRHFSA-N 436641 (S)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 417 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436641&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088826 439658272 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888618 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@H](CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29)/t21-/m1/s1 CSAXPKYQQPOHMD-OAQYLSRUSA-N 436642 (R)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 418 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436642&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089046 439658273 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888619 CCNc1ncc2c(n1)N(C)CCN(Cc1ccc(O[C@H](CCNC)c3cccs3)cc1)C2=O InChI=1S/C25H32N6O2S/c1-4-27-25-28-16-20-23(29-25)30(3)13-14-31(24(20)32)17-18-7-9-19(10-8-18)33-21(11-12-26-2)22-6-5-15-34-22/h5-10,15-16,21,26H,4,11-14,17H2,1-3H3,(H,27,28,29)/t21-/m1/s1 CSAXPKYQQPOHMD-OAQYLSRUSA-N 436642 (R)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 418 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436642&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089046 439658273 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888620 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(ncc3C2=O)N(C)C)cc1)c1cccs1 InChI=1S/C25H32N6O2S/c1-26-12-11-21(22-6-5-15-34-22)33-19-9-7-18(8-10-19)17-31-14-13-30(4)23-20(24(31)32)16-27-25(28-23)29(2)3/h5-10,15-16,21,26H,11-14,17H2,1-4H3/t21-/m0/s1 SMXRDTCWJPEFLL-NRFANRHFSA-N 436643 (S)-2-(dimethylamino)- 9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 419 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436643&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089091 439658274 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888621 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(ncc3C2=O)N(C)C)cc1)c1cccs1 InChI=1S/C25H32N6O2S/c1-26-12-11-21(22-6-5-15-34-22)33-19-9-7-18(8-10-19)17-31-14-13-30(4)23-20(24(31)32)16-27-25(28-23)29(2)3/h5-10,15-16,21,26H,11-14,17H2,1-4H3/t21-/m0/s1 SMXRDTCWJPEFLL-NRFANRHFSA-N 436643 (S)-2-(dimethylamino)- 9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 419 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436643&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089091 439658274 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888622 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(N)ncc3C2=O)cc1)c1cccs1 InChI=1S/C23H28N6O2S/c1-25-10-9-19(20-4-3-13-32-20)31-17-7-5-16(6-8-17)15-29-12-11-28(2)21-18(22(29)30)14-26-23(24)27-21/h3-8,13-14,19,25H,9-12,15H2,1-2H3,(H2,24,26,27)/t19-/m0/s1 CLARLFOYACHYCL-IBGZPJMESA-N 436644 (S)-2-amino-9-methyl- 6-(4-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 420 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436644&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089274 439658275 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888623 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(N)ncc3C2=O)cc1)c1cccs1 InChI=1S/C23H28N6O2S/c1-25-10-9-19(20-4-3-13-32-20)31-17-7-5-16(6-8-17)15-29-12-11-28(2)21-18(22(29)30)14-26-23(24)27-21/h3-8,13-14,19,25H,9-12,15H2,1-2H3,(H2,24,26,27)/t19-/m0/s1 CLARLFOYACHYCL-IBGZPJMESA-N 436644 (S)-2-amino-9-methyl- 6-(4-(3-(methylamino)- 1-(thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 420 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436644&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089274 439658275 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888624 CNCCC(OCc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C27H33N5O2/c1-20-29-17-24-26(30-20)31(3)15-16-32(27(24)33)18-21-9-11-22(12-10-21)19-34-25(13-14-28-2)23-7-5-4-6-8-23/h4-12,17,25,28H,13-16,18-19H2,1-3H3 WLAFHFDODWULDI-UHFFFAOYSA-N 436646 2,9-dimethyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 422 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436646&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088979 439658277 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888625 CNCCC(OCc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C27H33N5O2/c1-20-29-17-24-26(30-20)31(3)15-16-32(27(24)33)18-21-9-11-22(12-10-21)19-34-25(13-14-28-2)23-7-5-4-6-8-23/h4-12,17,25,28H,13-16,18-19H2,1-3H3 WLAFHFDODWULDI-UHFFFAOYSA-N 436646 2,9-dimethyl-6-(4-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 422 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436646&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088979 439658277 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888626 CNCCC(OCc1cccc(CN2CCN(C)c3nc(C)ncc3C2=O)c1)c1ccccc1 InChI=1S/C27H33N5O2/c1-20-29-17-24-26(30-20)31(3)14-15-32(27(24)33)18-21-8-7-9-22(16-21)19-34-25(12-13-28-2)23-10-5-4-6-11-23/h4-11,16-17,25,28H,12-15,18-19H2,1-3H3 FMWMQHWFVXLGQE-UHFFFAOYSA-N 436647 2,9-dimethyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 423 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436647&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089240 439658278 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888627 CNCCC(OCc1cccc(CN2CCN(C)c3nc(C)ncc3C2=O)c1)c1ccccc1 InChI=1S/C27H33N5O2/c1-20-29-17-24-26(30-20)31(3)14-15-32(27(24)33)18-21-8-7-9-22(16-21)19-34-25(12-13-28-2)23-10-5-4-6-11-23/h4-11,16-17,25,28H,12-15,18-19H2,1-3H3 FMWMQHWFVXLGQE-UHFFFAOYSA-N 436647 2,9-dimethyl-6-(3-((3- (methylamino)-1- phenylpropoxy)methyl) benzyl)-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 423 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436647&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089240 439658278 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888628 CNCCC(Oc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-17-23-25(29-19)30(3)15-16-31(26(23)32)18-20-9-11-22(12-10-20)33-24(13-14-27-2)21-7-5-4-6-8-21/h4-12,17,24,27H,13-16,18H2,1-3H3 JQKGMDZUFJXBNK-UHFFFAOYSA-N 436649 2,9-dimethyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 425 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436649&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088756 439658280 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888629 CNCCC(Oc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1ccccc1 InChI=1S/C26H31N5O2/c1-19-28-17-23-25(29-19)30(3)15-16-31(26(23)32)18-20-9-11-22(12-10-20)33-24(13-14-27-2)21-7-5-4-6-8-21/h4-12,17,24,27H,13-16,18H2,1-3H3 JQKGMDZUFJXBNK-UHFFFAOYSA-N 436649 2,9-dimethyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 425 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436649&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088756 439658280 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888630 CCc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H33N5O2/c1-4-25-29-18-23-26(30-25)31(3)16-17-32(27(23)33)19-20-10-12-22(13-11-20)34-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3 AHDJHFNBBNZKOJ-UHFFFAOYSA-N 436650 2-ethyl-9-methyl-6-(4- (3-(methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 426 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436650&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088748 439658281 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888631 CCc1ncc2c(n1)N(C)CCN(Cc1ccc(OC(CCNC)c3ccccc3)cc1)C2=O InChI=1S/C27H33N5O2/c1-4-25-29-18-23-26(30-25)31(3)16-17-32(27(23)33)19-20-10-12-22(13-11-20)34-24(14-15-28-2)21-8-6-5-7-9-21/h5-13,18,24,28H,4,14-17,19H2,1-3H3 AHDJHFNBBNZKOJ-UHFFFAOYSA-N 436650 2-ethyl-9-methyl-6-(4- (3-(methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 426 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436650&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088748 439658281 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888632 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)12-13-29(24(20)30)16-18-6-8-19(9-7-18)31-21(10-11-25-2)22-5-4-14-32-22/h4-9,14-15,21,25H,10-13,16H2,1-3H3/t21-/m1/s1 KVTOUZJEBYXKDY-OAQYLSRUSA-N 436651 (R)-2,9-dimethyl-6-(4- (3-(methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 427 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436651&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088738 439658282 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888633 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)12-13-29(24(20)30)16-18-6-8-19(9-7-18)31-21(10-11-25-2)22-5-4-14-32-22/h4-9,14-15,21,25H,10-13,16H2,1-3H3/t21-/m1/s1 KVTOUZJEBYXKDY-OAQYLSRUSA-N 436651 (R)-2,9-dimethyl-6-(4- (3-(methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 427 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436651&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088738 439658282 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888634 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)12-13-29(24(20)30)16-18-6-8-19(9-7-18)31-21(10-11-25-2)22-5-4-14-32-22/h4-9,14-15,21,25H,10-13,16H2,1-3H3/t21-/m0/s1 KVTOUZJEBYXKDY-NRFANRHFSA-N 436652 (S)-2,9-dimethyl-6-(4- (3-(methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 428 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436652&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089191 439658283 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888635 CNCC[C@H](Oc1ccc(CN2CCN(C)c3nc(C)ncc3C2=O)cc1)c1cccs1 InChI=1S/C24H29N5O2S/c1-17-26-15-20-23(27-17)28(3)12-13-29(24(20)30)16-18-6-8-19(9-7-18)31-21(10-11-25-2)22-5-4-14-32-22/h4-9,14-15,21,25H,10-13,16H2,1-3H3/t21-/m0/s1 KVTOUZJEBYXKDY-NRFANRHFSA-N 436652 (S)-2,9-dimethyl-6-(4- (3-(methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 428 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436652&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089191 439658283 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888636 CNCCC(Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(20-6-4-3-5-7-20)32-21-10-8-19(9-11-21)17-30-15-14-29(2)24-22(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3 UXFURXVOCCXVJQ-UHFFFAOYSA-N 436654 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 430 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436654&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088895 439658285 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888637 CNCCC(Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(20-6-4-3-5-7-20)32-21-10-8-19(9-11-21)17-30-15-14-29(2)24-22(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3 UXFURXVOCCXVJQ-UHFFFAOYSA-N 436654 9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 430 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436654&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088895 439658285 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888638 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(20-6-4-3-5-7-20)32-21-10-8-19(9-11-21)17-30-15-14-29(2)24-22(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3/t23-/m0/s1 UXFURXVOCCXVJQ-QHCPKHFHSA-N 436657 (S)-9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 433 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 1750 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436657&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089162 439658288 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888639 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(20-6-4-3-5-7-20)32-21-10-8-19(9-11-21)17-30-15-14-29(2)24-22(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3/t23-/m0/s1 UXFURXVOCCXVJQ-QHCPKHFHSA-N 436657 (S)-9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 433 Sodium-dependent noradrenaline transporter Homo sapiens 750 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436657&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089162 439658288 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888640 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(20-6-4-3-5-7-20)32-21-10-8-19(9-11-21)17-30-15-14-29(2)24-22(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3/t23-/m1/s1 UXFURXVOCCXVJQ-HSZRJFAPSA-N 436658 (R)-9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 434 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436658&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088893 439658289 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888641 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1ccccc1 InChI=1S/C25H29N5O2/c1-26-13-12-23(20-6-4-3-5-7-20)32-21-10-8-19(9-11-21)17-30-15-14-29(2)24-22(25(30)31)16-27-18-28-24/h3-11,16,18,23,26H,12-15,17H2,1-2H3/t23-/m1/s1 UXFURXVOCCXVJQ-HSZRJFAPSA-N 436658 (R)-9-methyl-6-(4-(3- (methylamino)-1- phenylpropoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 434 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436658&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088893 439658289 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888642 CNCCC(Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-10-9-20(21-4-3-13-31-21)30-18-7-5-17(6-8-18)15-28-12-11-27(2)22-19(23(28)29)14-25-16-26-22/h3-8,13-14,16,20,24H,9-12,15H2,1-2H3 DWDRNVYPUMCROH-UHFFFAOYSA-N 436659 9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 435 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436659&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132088775 439658290 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888643 CNCCC(Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-10-9-20(21-4-3-13-31-21)30-18-7-5-17(6-8-18)15-28-12-11-27(2)22-19(23(28)29)14-25-16-26-22/h3-8,13-14,16,20,24H,9-12,15H2,1-2H3 DWDRNVYPUMCROH-UHFFFAOYSA-N 436659 9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 435 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436659&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132088775 439658290 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888644 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-10-9-20(21-4-3-13-31-21)30-18-7-5-17(6-8-18)15-28-12-11-27(2)22-19(23(28)29)14-25-16-26-22/h3-8,13-14,16,20,24H,9-12,15H2,1-2H3/t20-/m0/s1 DWDRNVYPUMCROH-FQEVSTJZSA-N 436660 (S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 436 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human 300 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436660&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089489 439658291 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888645 CNCC[C@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-10-9-20(21-4-3-13-31-21)30-18-7-5-17(6-8-18)15-28-12-11-27(2)22-19(23(28)29)14-25-16-26-22/h3-8,13-14,16,20,24H,9-12,15H2,1-2H3/t20-/m0/s1 DWDRNVYPUMCROH-FQEVSTJZSA-N 436660 (S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 436 Sodium-dependent noradrenaline transporter Homo sapiens 300 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436660&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089489 439658291 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888646 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-10-9-20(21-4-3-13-31-21)30-18-7-5-17(6-8-18)15-28-12-11-27(2)22-19(23(28)29)14-25-16-26-22/h3-8,13-14,16,20,24H,9-12,15H2,1-2H3/t20-/m1/s1 DWDRNVYPUMCROH-HXUWFJFHSA-N 436661 (R)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 437 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human >3000 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436661&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089182 439658292 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888647 CNCC[C@@H](Oc1ccc(CN2CCN(C)c3ncncc3C2=O)cc1)c1cccs1 InChI=1S/C23H27N5O2S/c1-24-10-9-20(21-4-3-13-31-21)30-18-7-5-17(6-8-18)15-28-12-11-27(2)22-19(23(28)29)14-25-16-26-22/h3-8,13-14,16,20,24H,9-12,15H2,1-2H3/t20-/m1/s1 DWDRNVYPUMCROH-HXUWFJFHSA-N 436661 (R)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl)propoxy)benzyl)- 6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 437 Sodium-dependent noradrenaline transporter Homo sapiens >1000 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436661&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089182 439658292 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8 888648 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(CN3CCC(CC3)(N(C)C)c3cccc(O)c3)o1)C2=O InChI=1S/C32H39N9O3/c1-5-33-31-34-20-26-28(35-31)39(4)16-17-41(30(26)43)24-10-6-8-22(18-24)29-37-36-27(44-29)21-40-14-12-32(13-15-40,38(2)3)23-9-7-11-25(42)19-23/h6-11,18-20,42H,5,12-17,21H2,1-4H3,(H,33,34,35) NMJNERYTYHDEJS-UHFFFAOYSA-N 436666 6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)piperidin- 1-yl)methyl)-1,3,4- oxadiazol-2-yl)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 442 Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] Human <100 US Patent 10.7270/Q2WM1HGR aid1804311 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=848&target=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436666&enzyme=Voltage-dependent+calcium+channel+subunit+alpha-2%2Fdelta-1+%5B25-1103%5D&column=ki&startPg=0&Increment=50&submit=Search 132089145 439658297 1 EPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARYSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL 7MIX,7MIY,7UHF,7UHG,7VFS,7VFU,7VFV,7VFW,7XLQ,8E59,8E5A,8E5B,8EPL,8EPM Voltage-dependent calcium channel subunit alpha-2/delta-1 CA2D1_HUMAN P54289 Q17R45 Q9UD80 Q9UD81 Q9UD82 888649 CCNc1ncc2c(n1)N(C)CCN(c1cccc(c1)-c1nnc(CN3CCC(CC3)(N(C)C)c3cccc(O)c3)o1)C2=O InChI=1S/C32H39N9O3/c1-5-33-31-34-20-26-28(35-31)39(4)16-17-41(30(26)43)24-10-6-8-22(18-24)29-37-36-27(44-29)21-40-14-12-32(13-15-40,38(2)3)23-9-7-11-25(42)19-23/h6-11,18-20,42H,5,12-17,21H2,1-4H3,(H,33,34,35) NMJNERYTYHDEJS-UHFFFAOYSA-N 436666 6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)piperidin- 1-yl)methyl)-1,3,4- oxadiazol-2-yl)phenyl)- 2-(ethylamino)-9- methyl-6,7,8,9- tetrahydro-5H- pyrimido[4,5-e] [1,4]diazepin-5-one::US10590140, Example 442 Sodium-dependent noradrenaline transporter Homo sapiens <100.0 US Patent 10.7270/Q2WM1HGR aid1804312 US10590140 Cuevas-Cordobes, F; Almansa-Rosales, C 3/17/2020 12/7/2020 ESTEVE PHARMACEUTICALS, S.A. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=436666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2274&target=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=436666&enzyme=Sodium-dependent+noradrenaline+transporter&column=ki&startPg=0&Increment=50&submit=Search 132089145 439658297 1 MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYNREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTWNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLCLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFYRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFAIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSSMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTSILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHLVAQRDIRQFQLQHWLAI Sodium-dependent noradrenaline transporter SC6A2_HUMAN P23975 B2R707 B4DX48 Q96KH8